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ABSTRACT 
Rabies and canine distemper are fatal diseases of mammals and of concern in the 
Serengeti, Tanzania both for public health and wildlife conservation. This study 
investigates the epidemiology of these diseases through cross-sectional and longitudinal 
studies of two domestic dog populations bordering the Serengeti National Park. 
Chapter 2 demonstrates differences in demographic and behavioural characteristics 
between the two populations, leading to predictions of distinct patterns of rabies and 
canine distemper infection, and the requirement for different strategies of disease 
control. Chapter 3 compares the use of three rabies serological tests for 
seroepidemiological studies of domestic dogs. Non-specificity precluded use of the 
indirect ELISA, but a liquid-phase blocking ELISA (BE) and neutralization test 
(RFFIT) demonstrated rabies seropositivity among unvaccinated Serengeti dogs. The 
poor agreement between BE and RFFIT in unvaccinated dogs led to an investigation of 
specificity, which indicated that the BE was the more specific assay. In Chapter 4, 
incidence data and virus typing suggested that dogs, not wildlife, are the reservoir of 
rabies in the Serengeti. Case surveillance data indicated that rabies persists in higher- 
density dog populations, but occurs only sporadically in lower-density dog and wild 
carnivore populations. Rabies seropositivity occurred in dogs remaining healthy, 
demonstrating the existence of atypical infections. Mathematical models showed that 
rabies persistence in Serengeti dogs was more likely if seropositives were infectious 
carriers, rather than slow-incubators or immune animals. In Chapter 5, analysis of 
case-morbidity, mortality and age-seroprevalence data indicated that canine distemper 
was stably endemic in higher-density dog populations, but sporadically epidemic in 
lower-density dog populations. In conclusion, higher-density dog populations to the 
west of the Serengeti National Park are the most likely reservoir of both rabies and 
canine distemper in the Serengeti and disease control strategies should therefore focus 
on controlling infection in these populations. 
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Chapter 1 
GENERAL INTRODUCTION 
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SUMMARY 
The demography and behaviour of host populations are major determinants of the 
dynamics of microparasite infections. The starting point of this study of rabies and 
canine distemper virus (CDV) in the Serengeti is therefore an investigation of 
demographic and ecological characteristics of two domestic dog populations 
surrounding the Serengeti National Park (Chapter 2). The problems of disease 
detection in the Serengeti prompt an exploration of epidemiological approaches that do 
not rely on case incidence data. Since previous surveys have shown that rabies antibody 
may be detected in healthy individuals, this study investigates the use of rabies serology 
for epidemiological studies. First, Chapter 3 examines the validity of three serological 
tests, by assessing their ability to measure specific rabies antibody in canine sera. In 
Chapter 4, results from the most specific and reproducible of these tests are used, in 
combination with reported clinical histories, to investigate the dynamics of rabies in 
naturally-infected dogs and the possible role of atypical infections in disease 
maintenance. Chapter 4 also examines the evidence for domestic dogs or wildlife 
populations as reservoirs of rabies, and uses the results to draw conclusions about 
suitable strategies for rabies control in the Serengeti. Chapter 5 deals exclusively with 
CDV and focuses on the specific question of reservoirs in the Serengeti. This chapter 
draws principally on data from demographic and CDV serological studies in domestic 
dogs and uses these, in combination with endemic theory, to identify reservoirs of 
infection and to design appropriate CDV control measures for the Serengeti. 
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Rabies 
Rabies is a fatal disease that has been recognized for many thousand of years and today 
persists throughout the world in a variety of mammalian populations. Despite the long 
history of the disease, and over a century of experimental research, there are aspects of 
rabies epidemiology and pathogenesis that remain poorly understood. This applies 
particularly to infections in nature, stimulating this investigation into the behaviour and 
dynamics of rabies in a naturally-infected population. 
Although human and domestic dog rabies occurs throughout the tropics, the Serengeti 
region of Tanzania was selected for this study principally because of the threat of rabies 
to its wild carnivore populations. The Serengeti domestic dog population was also 
particularly well suited to seroepidemiological studies, since very few dogs have been 
vaccinated against rabies. For this investigation, we chose to focus on domestic dogs, 
not wildlife, because (a) the domestic dog is thought to be a key species in the 
epidemiology of rabies throughout Africa, (b) preliminary molecular epidemiological 
studies pointed to a link between domestic dog rabies and the disease in African wild 
dogs in the Serengeti (Gascoyne et al., 1993b), (c) domestic dog rabies is a greater 
threat to public health, and (d) domestic dog populations are more tractable than 
wildlife. 
Rabies has been the subject of many extensive reviews and texts (recent examples 
include Campbell & Charlton, 1988; Nicholson, 1990; Baer, 1991; King & Turner, 
1993; Rupprecht et al., 1994; Swanepoel, 1994). This chapter does not therefore 
intend to provide a further comprehensive overview, but focuses on specific aspects of 
the disease relevant to this study. 
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Rabies Virus 
The rabies virus is a member of the genus Lyssavirus (Lyssa: Greek, meaning madness) 
belonging to the family Rhabdoviridae (Rhabdo: Greek, meaning rod), which are 
characterized by non-segmented negative-sense RNA. The genus comprises rabies and 
five additional serotypes and genotypes (Lagos bat virus, Mokola, Duvenhage, 
European bat Lyssavirus 1 and 2). Within the Rhabdoviridae is also the genus 
Vesiculovirus (type species, vesicular stomatitis virus), as well as many other isolates 
from vertebrates, insects and plants (Kemp et al., 1973; Buckley, 1975; Tesh, 1983). 
The latter are included in the family because of their characteristic morphology, but 
most have not been definitively characterized (Rupprecht et al., 1991). 
The molecular, antigenic and genetic structure of the rabies virus has been extensively 
studied, with recent reviews by Wunner (1991), Rupprecht et al. (1991), and Tordo 
and Kouknetzoff (1993). The genomic RNA contains five genes, each of which codes 
for a structural protein, the nucleoprotein (N), phosphoprotein (NS or Ml), matrix 
protein (M or M2), glycoprotein (G) and polymerase (L). Here our interest is primarily 
in the N and G proteins, first, because of their role in immunoprotection, and second, 
because virus isolates from different geographic areas and species can be distinguished 
on the basis of N- and G- monoclonal (Mab) reactivity and nucleotide sequencing of the 
N and G protein genes (Wiktor et al., 1980). In this study, reactivity to Mab-N panels 
and sequencing of the N-protein gene are used to characterise virus isolates from the 
Serengeti and to identify epidemiological relationships. 
Pathogenesis and Immunology 
The pathogenesis of rabies has been studied for over a century and has recently been 
reviewed by Baer and Lentz (1991), Iwasaki (1991) and Charlton (1994). Here, we 
focus on four aspects of the natural history of infection which are relevant to our 
interpretation of rabies serology in unvaccinated domestic dogs: (a) transmission, (b) 
the early stages of infection, (c) the development of humoral immunity, and (d) atypical 
rabies. 
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Transmission 
It is considered that most cases of naturally transmitted rabies result from the bite of an 
infective animal. Rabies can also be transmitted across intact mucous membranes, for 
example, following oral ingestion (Kantorovich et al., 1963; Fischmann and Ward, 
1968; Correa-Giron et al., 1970; Bell and Moore, 1971), by aerosol inhalation 
(Constantine, 1962; Winkler et al., 1972) and has been reported from infected corneal 
transplants (Houff et al., 1979). To achieve infection by the oral route, higher doses are 
usually required than for intramuscular infection (Baer et al., 1971; Ramsden and 
Johnston, 1975), although species vary considerably in their susceptibility to oral 
infection (Wandeler, 1993a). Of particular interest to this study is the finding that foxes 
and skunks fed mice infected with street virus can develop serum neutralizing antibody 
and survive challenge infection (Ramsden and Johnston, 1975), suggesting a possible 
route for immunizing, rather than fatal, infections in nature. 
The frequency with which non-bite transmission occurs in nature and its importance in 
rabies epidemiology are still unknown. A rabies epidemic in kudu (Tragelaphus 
strepsiceros) in Namibia from 1977 to 1985 was thought to have spread orally through 
shared browse or mutual grooming (Barnard et al., 1982). The rapid spread of 
infection within social carnivore groups, without widespread evidence of bite wounds, 
also suggests that non-bite transmission may occur in canids, for example, through 
mouth-licking (Gascoyne et al., 1993a, Maas, 1993, Kat et al., 1995). 
The Early Stages of Infection 
Although the neurotropism of the virus has long been recognized, the early stages of 
infection are still poorly understood and are relevant to this study because of their 
importance in the development of immune responses. There is still no unequivocal 
explanation for the variable and prolonged incubation periods that are characteristic of 
rabies in all species. However virus has been detected in myocytes up to 28 days after 
infection in skunks (Charlton and Casey, 1981) with evidence that replication may also 
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occur (Murphy et al., 1973; Charlton and Casey, 1979; Charlton, 1994). Virus retention 
in myocytes also provides the opportunity for using immunoglobulin therapy and 
vaccine in post-exposure treatment to eliminate infectious particles before they enter the 
central nervous system (Charlton, 1994). Presumably, at this early stage, rabies virus is 
also exposed to the immune system. However, in clinical disease, antibody is usually 
only detected in the terminal stages of the illness (Hemachudha, 1994; Foggin, 1988; 
Chaparro and Esterhuysen, 1993). 
The Development of Humoral Immunity 
Our interest in the roles of N and G protein in immunoprotection is stimulated in this 
study because we aim to interpret results of two rabies serological tests that may differ 
in their detection of anti-N and anti-G antibody. Virus neutralizing antibody, stimulated 
by the G protein of the rabies virus, undoubtedly plays a critical role in the immune 
response, and can protect against challenge infection as effectively as inactivated 
vaccine (Wunner et at., 1983). However, the importance of the N protein in 
immunoprotection is becoming increasingly apparent (Fu et al., 1994). N protein can 
protect mice (Lodmell et al., 1991) and dogs (Fekadu et at., 1992) against peripheral 
infection in the absence of neutralization antibody, and also has a role in recovery from 
rabies in dogs (Fekadu et a1., 1992). N protein can further augment immunity, through 
induction of specific T helper cells and non-specific lymphokine (interleuldn-2 and 
interferon) responses (Dietzschold et al., 1989). 
The general explanation for the late appearance of antibody in clinical disease is that the 
intrinsic neurotropism of the rabies virus protects it from immune surveillance and virus 
must multiply in the CNS before sufficient antigen is released to induce serum 
neutralizing antibody (King and Turner, 1993). However, this assumption is challenged 
by the detection of rabies antibody in a proportion of healthy animals and people in 
rabies-endemic areas (Tables 1.1a-c). These findings raise a number of questions about 
immune responses in natural infections and suggest they may have little in common with 
experimental infections, on which most of our knowledge is based. 
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Atypical Rabies 
Our interest in atypical rabies concerns first, the interpretation of rabies seropositivity in 
healthy animals and second, the role of atypical infections in the persistence of rabies in 
the Serengeti. The first issue is addressed in this section, the second in relation to the 
dynamics of microparasite infections 
Not all rabies infections result in clinical disease and death. As early as 1882, Pasteur 
wrote that "dogs can sicken and survive rabies" and "it is probable that many silent 
cases of rabies escape detection" (Pasteur, 1882). In reviewing the evidence for atypical 
infections, Fekadu (1991) identified four courses of atypical infections in dogs: (i) 
recovery from illness, (ii) inapparent ('aborted') infection, (iii) a prolonged latent period 
(sometimes equated with incubation period), and (iv) an infectious carrier state. 
Andral and Serie (1957) were the first to demonstrate an association between serum 
rabies antibody and atypical rabies infection, in dogs recovering from neurological signs 
and in a proportion of dogs remaining healthy. Recovery from clinical disease was later 
confirmed in dogs following experimental infection (Fekadu and Baer, 1980), with one 
dog excreting virus in saliva for several months after recovery and developing high 
levels of neutralizing antibody in serum and cerebro-spinal fluid (CSF) (Fekadu et al., 
1981). Fekadu (1991) and Carey (1985) consider the finding of rabies neutralizing 
antibody in healthy individuals evidence for non-fatal infection (Tables l. la-c). 
However, in the majority of these serosurveys the fate of the individual is unknown, so 
we cannot rule out early expression of antibody in animals incubating the disease. 
Nonetheless, studies of seropositive raccoons, monitored over three years (Bigler et al., 
1983), indicate that seropositive animals do not invariably succumb to rabies infection. 
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The confidence with which we are able to interpret serological findings is highly 
dependent upon the quality of data generated from serological tests. This applies both 
to the data shown in Tables l. la-c, in which results are obtained from a wide range of 
serological assays, and for this study, in which we use serology to examine the evidence 
for atypical infections in domestic dogs from the Serengeti. 
Rabies Serological Tests 
A wide range of serological tests have been described for the measurement of rabies 
antibody in sera (reviewed by Smith, 1991). Currently, only two are considered 
reference techniques by World Health Organization (WHO) - the mouse neutralization 
test (MNT) (Atanasiu, 1973) and the rapid fluorescent focus inhibition test (RFFIT) 
(Smith et al., 1973), a cell culture neutralization test. WHO recommendations are based 
on the fact that both tests measure inhibition of infectivity, a biological property 
correlated with protection. Although the RFFIT is considered a reliable technique 
(Lyng, 1994), problems remain with a lack of consistency of results in some studies and 
the practical difficulties of processing large numbers of samples (Table 1.2). 
Although all reference centres adopt RFFIT protocols, or modifications thereof, details 
of methodology vary greatly between laboratories, exacerbating the inherent variability 
of a biological test system. A recent survey of 11 European laboratories revealed 
methodological inconsistencies at each step of the RFFIT procedure and wide inter- 
laboratory variability in titres obtained, with two- to eight-fold differences in titres 
recorded for 11 sera tested (Cliquet et al., 1995; Barrat et al., 1995). An additional 
concern about serum neutralization tests is that non-specific, cytotoxic factors that 
inhibit viral growth will be detected as antibody, a problem that has been identified in 
several wild carnivore species (Barton and Campbell, 1988). 
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Table 1.2. A review of the advantages and disadvantages of neutralization tests and 
ELISA techniques for measurement of rabies antibody. 
::: LýISAýP. YANTAGES 
Mouse neutralization test (MNT) 
( Atanasiu, 1973) 
. 
S 
S 
S 
S 
S 
S 
S 
. 
S 
S 
S 
S 
S 
Measures a biological property " 
correlated with protection 
Proven value over 50 years " 
Data from challenge " 
experiments available 
Protocol standardised " 
Can be used in all species 
WHO reference technique " 
Measures a biological property " 
correlated with protection 
Data from challenge " 
experiments available 
Can be used in all species' " 
Relatively rapid - results 
available in 24-48 hours " 
Requires large numbers of 
mice and specialised facilities 
Expensive 
Time-consuming (requires a 
minimum of 14 days) 
Biological test with inherent 
variability 
Use of live infective virus 
Requires specialised facilities 
with tissue culture capability 
Biological test system with 
inherent variability 
Lack of standardisation 
between laboratories 
Use of live infective virus 
Rapid fluorescent focus inhibition 
test (RFFIT) 
(Smith eta!., 1973) 
Enzyme immunosorbent assays 
(Atanasiu et a!., 1982; Nicholson 
and Prestage, 1982; Bhatia et al., 
1984; Perrin et al., 1986; Barton 
and Campbell, 1988; Grassi et at., 
1989; Thraenhart et al., 1989; 
Mebatsion et al., 1989. Wandeler et 
at., 1989, Elmgren et al. 1993, 
Esterhuysen et al., 1995) 
0 
Simplicity " 
Rapidity - results available in 4 
hours 
No specialised facilities needed " 
Sensitivity - detects antibody 
response after vaccination " 
earlier than RFFIT 
Published data show good " 
correlation with neutralization 
tests 
0 
Specificity requires purified 
antigen necessitating 
purification procedures 
Lack of specificity problematic 
in some systems2 
Some systems may not be able 
to test sera of all species 
Recently developed for rabies 
antibody detection and less 
information available 
Does not measure a biological 
function and few challenge 
data available 
Not a WHO reference 
technique 
1. Non-specific neutralizing activity may be problematic with sera from some species (Barton and 
Campbell, 1988). 
2. Specificity can be increased with use of monoclonal antibodies in competitive systems. 
38 
Enzyme-immunosorbent assays (ELISAs) are gaining increasing popularity as a rapid 
and sensitive method of detecting rabies antibody (Table 1.2). A disadvantage of many 
ELISA systems has been that a single system could not be used to test sera of all 
species, but this problem has largely been overcome by using competitive systems or by 
replacing species-specific anti-immunoglobulin with enzyme-linked protein A 
(Mebatsion et al., 1989; Esterhuysen et al., 1995). A further disadvantage has been 
that highly purified antigen is often needed to avoid non-specific binding and this 
requires elaborate purification procedures. Recently, however, ELISA specificity has 
been improved through competitive systems and the use of monoclonal antibody 
(Elmgren et al., 1993). Despite these advances, no ELISA system has yet been 
recommended for use as a reference technique for measuring rabies antibody in dogs by 
WHO or by the Office International des Epizooties (OIE). 
In Chapter 3, we compare the performance of a WHO-reference RFFIT with two 
ELISA protocols for measurement of rabies antibody in the sera of unvaccinated and 
vaccinated domestic dogs. 
Rabies Epidemiology 
Rabies occurs in all continents except Australasia and Antarctica. Most other rabies-free 
areas are islands (for example UK, Japan, Hawaii, Mauritius) or geographically isolated 
peninsulas (such as Norway and Sweden), where control measures can be stringently 
enforced. 
All mammals are susceptible to rabies but not all mammals are capable of maintaining 
infection as reservoir hosts. In different parts of its global range, rabies is maintained by 
different mammalian species. With the exception of bat rabies, principal reservoirs for 
rabies are species in the order Carnivora, small to medium sized omnivores, with high 
intrinsic population growth rates (Wandeler, 1991). Characteristically, these species 
are opportunistic foragers, capable of living at high population densities close to human 
habitation (Wandeler, 1991). 
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Case surveillance data together with monoclonal antibody and genetic studies show 
that a single distinct virus strain ('virus biotype') is maintained by a single principal 
host species in any given geographic area (Carey, 1985; Smith, 1989; Rupprecht et al., 
1991, Bourhy et al., 1993; King et al., 1994). Although other species may sporadically 
acquire infection from the major host, they appear unable to sustain the infection 
independently. There is evidence that susceptibility varies between rabies isolates and 
hosts (Sikes, 1962; Sikes, 1970); foxes infected with fox virus, for example, show 
higher susceptibility to infection and a greater degree of salivary virus excretion than 
foxes infected with dog isolates (Blancou, 1988). Virus biotypes may therefore reflect 
adaptations to the host, allowing rabies to be maintained in independent cycles of 
infection by the reservoir species. However, the link between antigenic or molecular 
variation and specific biological properties has not yet been demonstrated. 
Accounts of rabies epidemiology frequently use the terms 'urban' and 'sylvatic' rabies to 
distinguish infection cycles maintained primarily by domestic dogs and wild carnivores 
respectively. However, domestic dog rabies is not restricted to urban environments. 
Indeed, throughout much of rural sub-Saharan Africa (with the exception of some parts 
of southern Africa), the domestic dog appears to play a key role in maintenance and 
transmission, accounting for the majority of reported and confirmed cases (WHO, 
1992a; WHO, 1993a and b; King, 1993). In rural areas, however, there remain doubts 
as to whether canine rabies is always independent from wildlife (Wandeler, 1993b; 
Wandeler et al., 1993). In Chapter 3, we address this question, by assessing the 
evidence for domestic dogs and/or wildlife as reservoirs of rabies in the Serengeti. 
Throughout the world, over 90% of human rabies deaths are attributable to dog bites 
(e. g. WHO 1992a, 1993a and b, 1994a). Even in countries where wildlife rabies 
predominates, the domestic dog provides a link between wildlife and man and still 
represents the greatest risk to human health. The true incidence of human rabies is hard 
to assess from official records. Recent surveys of the WHO, for example, reported 
1,784 human rabies cases worldwide in 1990 (WHO, 1993a), 1,326 in 1991 (1993b) 
and 34,931 in 1992 (WHO, 1994a). The magnitude of this variation is influenced 
largely by figures from India (for example, 30 cases in 1990,34 in 1991 and 30,000 in 
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1992) and is almost certainly an artefact of reporting (Warrell and Warrell, 1988). 
Nonetheless, it is estimated that 99.9% of human deaths from rabies occur in the tropics 
(Acha & Arambulo, 1985), and almost all cases originate in countries that have not yet 
controlled dog rabies. 
Rabies in Africa 
Although references to rabies in Africa are more recent than the ancient records from 
Mesopotamia and Greece (for historical reviews, see Steele and Fernandez, 1991; Baer, 
1994), it has been proposed that the ancestral virus for the Lyssavirus genus evolved in 
West Africa, since three of the four Lyssavirus serogroups have been recorded in that 
area (Shope, 1970; Swanepoel, 1994). The modern form of canine rabies virus may 
have been introduced into Africa by domestic animals accompanying traders, since 
nucleotide sequencing has shown similarities between European, New World and some 
West African isolates (Smith et al., 1992). 
The history of rabies in east Africa is less well documented than that in southern Africa, 
which has been described by Foggin (1988), King et al. (1994) and Swanepoel (1994). 
In Tanzania, canine rabies was first recorded in 1932 (Rweyemamu et al., 1973) in the 
Mara Region of northwestern Tanzania, of which the Serengeti forms a part. Cases 
continued until 1947 when control measures, such as quarantine, and stray dog 
destruction appeared to contain the disease (Rweyemamu et al., 1973). Rabies 
reappeared in the Mara Region in 1955, but was controlled by the implementation of 
mass vaccination and stray dog culling, with no cases reported between 1958 and 1977 
(Rweyemamu et al., 1973; Magembe, 1985a). 
In the late 1970s, a rabies epidemic, associated with increasing mobility and density of 
human populations, spread rapidly northwards through Tanzania reaching the Mara 
region in 1978 (Magembe, 1985a). In this epidemic, dog rabies was most frequently 
recorded, with occasional reports in domestic ungulates and other carnivores (mainly 
jackals and hyaenas). Widespread culling of domestic dogs failed to control the disease 
and cases have been reported since that time (Magembe, 1985b). 
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Since 1985, official rabies data for Tanzania have been fragmentary. The few data 
available for human rabies show 69 cases in 1980,83 in 1981,19 in 1982 (Magembe, 
1985a), and 126 human deaths in 1986 and 1987 combined (Loretu, 1993). Despite 
local reports of an increasing incidence of the disease in the late 1980s and early 1990s, 
only 41 animal cases were reported in the official records between 1986 and 1991 
(Loretu, 1993), compared with the 547 cases confirmed between 1966 and 1974 
(Magembe, 1985a). 
In Tanzania, as in many other parts of Africa, there are several reasons why rabies is 
likely to be a much larger problem than is suggested by official records. First, over the 
past 20 years, human populations have doubled in many developing countries and 
increased mobilization has resulted in rapid expansion in rural areas. Second, limited 
financial resources available to government veterinary services restrict the proportion of 
rabies cases reported and diagnosed. Even in Europe, where conditions for effective 
surveillance are much more favourable, it was estimated that the 150,894 wild animal 
cases confirmed by laboratory diagnosis between 1978 and 1988 represented only 10% 
to 20% of the true number of incident cases (Blancou et al., 1988). Third, many other 
southern and eastern African countries (including Kenya) are currently reporting record 
numbers of cases (Perry, 1993a; King, 1993), and there is no reason to expect this 
trend to be different in Tanzania. 
With so few rabies-cases confirmed throughout much of Africa, there is clearly a need 
to develop epidemiological approaches that do not rely on case incidence data, and in 
this study, we explore the use of rabies serology. Although seroepidemiological studies 
are common for many microparasite infections, this is the first to use serology to 
investigate the dynamics of rabies infections in a naturally-infected population of 
domestic dogs. 
42 
Control of Dog Rabies 
Traditional approaches to dog rabies control include mass vaccination of dogs, 
movement restriction and stray dog control. In several countries where dogs have been 
the sole reservoir of infection (for example, UK, Malaysia, Japan and Uruguay), these 
measures have led to elimination of the disease (Meslin et a!., 1994). In Europe and 
north America, effective vaccination and control of dogs has dramatically reduced the 
incidence of canine rabies, and wildlife is now the most important reservoir of disease. 
The recent implementation of large-scale oral vaccination programmes is now leading 
to the successful immunization of wildlife in many parts of Europe (Wandeler et al., 
1988; Brochier et al., 1991; Aubert et al., 1994) and north America (Campbell, 1994) 
and there is optimism that wildlife rabies, too, can be eliminated. 
In many developing countries, however, the incidence of rabies is increasing and there is 
still a considerable gap between the availability of safe and effective vaccines, and their 
application for dog rabies control. In the face of an increasing levels of infection and a 
decline in dog vaccination coverage in many African countries, there is a strong 
argument for developing new approaches to rabies control. Oral vaccines and delivery 
systems for dogs are currently undergoing field trials (WHO, 1994b). However for 
Africa, oral vaccination is unlikely to provide an immediate solution to the economic 
and logistic problems that are currently constraining dog rabies control (Perry and 
Wandeler, 1993). 
A common theme is the effective targeting of vaccine to protect segments of the 
population at greatest risk (Perry, 1993b, 1995) and we apply this principle to rabies 
control in the Serengeti. The design of strategic rabies control measures in Serengeti 
draws on several elements of this study, relating both to domestic dog demography and 
behaviour (Chapter 2) and the identification of reservoir populations (Chapter 4). 
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Canine Distemper 
Canine distemper (CD) is a systemic viral disease of domestic dogs and other carnivore 
species. Canine distemper virus (CDV) is in the genus Morbillivirus, part of the family of 
Paramyxovinises. Morbilliviruses are characterized by non-segmented, single-stranded 
RNA and include within the genus the rinderpest virus of cattle, phocine distemper virus of 
seals, dolphin morbillivirus, peste de petits ruminants virus affecting sheep and goats, and the 
measles virus affecting man. CDV infection has been reported is many free-ranging 
carnivore populations throughout the world, in some instances associated with disease 
outbreaks and, in others, identified only by the presence of antibodies (Table 1.3). The CDV 
epidemic in lions (Panthera leo) of the Serengeti National Park, Tanzania (Roelke-Parker et 
al., 1996) prompted this investigation of CDV in the domestic dog population surrounding 
the Serengeti National Park. 
Despite widespread vaccination of dogs, CD occurs worldwide and is the most common 
neurological infection in dogs (Zurbriggen & Vandevelde, 1994). The disease can present 
with a wide spectrum of clinical signs involving the respiratory tract (dyspnoea, coughing, 
conjunctivitis), alimentary system (anorexia, vomiting, diarrhoea), skin (pustular skin lesions, 
hyperkeratosis) and CNS (ataxia, tremors, myoclonus, convulsions) (for a review, see 
Greene, 1984; Appel, 1987). The severity of infection ranges from inapparent or mild 
clinical signs to severe disease with approximately 50% mortality (Appel, 1967). 
The Infection Cycle 
The classic course of infection involves inhalation of airborne virus from respiratory 
exudates (Gorham, 1966). During the incubation period, virus initially replicates in 
lymphatic tissue of the respiratory tract but is rapidly disseminated throughout the body. By 
six days (the latent period), virus can be demonstrated in conjunctival swabs of all infected 
animals (Appel, 1967). Clinical manifestations depend in part upon host immunity, with the 
severity of the disease inversely related to antibody titres. Thus, seven to ten days post 
infection, an estimated 25% to 75% of susceptible dogs develop vigorous humoral and 
cellular immune responses and recover with no clinical signs of disease. Intermediate 
44 
Table 1.3. Evidence for canine distemper virus (CDV) infection in some free-living 
wildlife populations. 
Gvütence for infection 
Canida 
Gray fox Southeastern U. S. A. CD diagnosed in 125/157 Davidson et a!., 
(Urocyon (80%) sick or dead foxes 1992 
cinereoargenteus) submitted, 1972-1989 
Coyote (Canis Texas, U. S. A. Serological survey Trainer & 
latrans) l 1ß0 (37%) seropositive Knowlton, 1968 
Colorado, U. S. A Serological survey Gese et a!, 1991 
41/12 (57%) seropositive 
Wolf (Canis lupus) U. S. A and Canada Serological survey Johnson et a!., 1994 
5/17 (29%) seropositive 
Raccoon dog Japan 3-month epidemic, with >70% Machida et al., 
(Nyctereutes mortality in study area 1993 
procyonoides) 
Bat-eared fox Serengeti, Tanzania Confirmed mortality Roelke-Parker et 
(Otocyon al., 1996 
megalotis) 
Jackal Masai Mara Serological survey Alexander et al., 
(Canis mesonzelas, National Reserve, 4/55 (9.0%) seropositive 1994 
C. aureus, C. Kenya 
adustus 
African wild dog Bushmanland, Serological survey Laurenson ei al., 
(Lycaon pictus) Namibia 4/6 (66.7%) seropositive submitted 
manuscript b 
Mustelidae 
Black-footed ferret Wyoming, U. S. A. Epidemic causing decline of Williams et at.. 
(Mustela nigripes) population from 129 animals to 1988 
< 20. 
Stone marten Germany Epidemic van Moll et al., 
(Mariesfoina) 54/146 (37.0%) antigen 1995 
positive 
Procyonidae 
Raccoon (Procyon New Jersey, U. S. A. 17 epidemics, involving 615 Roscoe, 1993 
lotor) raccoons 
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Table 1.3. Continued. 
''Species .': Area Evidence 
forThfecliost Reference 
Viverridae 
Masked palm civet Japan Confirmed mortality Machida et at., 
Pa uma larvata 1992 
Hvaenidae 
Spotted hyaena Serengeti National Confirmed mortality Roelke-Parker et 
(Crocuta crocuta) Park, Tanzania a!., 1996 
Hofer & East, 1995 
Masai Mara National Serological survey Alexander et al., 
Reserve, Kenya 11/44 (25%), 1979-1982 1995 
19/63 (30%), 1990-1992 
Phocidae 
Seal (Phoca Lake Baikal, Russia Epidemic 1987/1988 Mamaev et al., 
sibirica) Virus isolate characterised as 1995 
CDV associated with domestic 
dogs 
Felidae 
Bobcat (Lynx Canada Mortality in a single animal Woodford, 1994 
rufus) 
Lion (Panthera Serengeti National Epidemic Roelke-Parker et 
leo) Park, Tanzania and 54 confirmed mortalities al., 1996 
Masai Mara National 63/72 (87.5%) seropositive 
Reserve, Kenya 
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responders tend to develop sub-acute clinical signs that resolve as antibody levels increase, 
and those failing to respond develop acute systemic disease, which usually appears between 
two to four weeks after infection (the incubation period) (Appel, 1967). Some dogs survive 
the acute neurological phase, but these animals have a tendency to develop a chronic 
progressive demyelinating disease, in which virus persistence in the CNS plays an essential 
role (Zurbriggen et al., 1995). 
In the acute disease, virus is shed in all body secretions (Appel, 1987) and it is assumed that 
animals are infectious until they recover or die (usually for a period of one to two weeks). 
However, virus excretion has been reported for 60 to 90 days in sub-acute disease (Greene, 
1984). There is no evidence for virus excretion in chronically-infected animals, in which 
invasion of the CNS occurs via selective spread of cell processes (Zurbriggen et al., 1995). 
The intracellular persistence of CDV in these infections suggests that these animals are 
unlikely to be infectious, even though infective virus has been isolated from brain and 
bladder of dogs suffering from chronic demyelinating encephalitis (Imagawa et al., 1980). 
Although the carrier state has never been demonstrated for CDV (or indeed any other 
morbillivirus), Gorham (1966) postulated that a few carriers must exist to ensure virus 
persistence between generations. The question of ®V persistence in reservoir populations 
of the Serengeti is explored in Chapter 5. 
Serology 
Reliable measurement of antibodies to CDV appears to be less problematic than for rabies, 
although, in comparison with rabies, few data are available for inter-laboratory comparisons. 
Because of the correlation between neutralization and protection, most laboratories adopt 
neutralization tests, such as the microneutralization test used in this study (Appel and 
Robson, 1973) or the plaque reduction assay (Chalmers and Baxendale, 1994). ELISAs 
have also been developed, although antigen purification is necessary to increase test 
specificity (Bernard et al., 1982). 
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Control of Canine Distemper Virus 
Control of CDV is centred around immunization of dogs using modified live vaccines based 
on cell-adapted strains (e. g. Onderstepoort strain) or canine cell culture adaptations (e. g. 
Rockborn strain) (for a review, see Appel, 1987). For pups under three months of age, it has 
been common practice to vaccinate with modified live measles virus, which provides a 
degree of cross-protection and is not neutralized by maternal antibody. However high-titre 
CDV vaccines have recently been developed that protect pups against challenge infection 
more effectively than measles virus (Chalmers & Baxendale, 1994). Given the large 
proportion of pups in many rural African populations, vaccination of pups may be important 
to ensure adequate herd immunity. 
Although modified live vaccines produce effective immunity in dogs for several years, 
commercial preparations can be pathogenic for non-domestic carnivores, with vaccine- 
induced deaths reported in several species (reviewed by Montali et al., 1983). Recent trials 
have demonstrated the safety of commercial live vaccines in east African lions, with 
serological evidence for protection (Kock et al., under review), and raise the possibility of 
vaccinating individuals as a mans of protecting lions in the Serengeti-Mara ecosystem 
However, in this study (Chapter 5), we adopt a broader approach to the control of CDV in 
Serengeti's wildlife, focusing on the identification of reservoir populations to target control 
measures, rather than protection of individuals in any given population. 
Microparasite Infection Dynamics 
The past 15 years have seen rapid developments in quantitative epidemiology and epidemic 
theory, as described in detail by Anderson and May (1991). Mathematical models have 
proved a useful tool for understanding and interpreting the behaviour of infections and for 
designing appropriate control strategies, particularly with respect to human infections. 
However, in comparison with human diseases, relatively little is known about the population 
biology of infections in natural animal populations. Here, we apply simple theory to specific 
questions about the maintenance and control of rabies and CDV in Serengeti domestic dog 
populations. 
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Calculation of Ro, the Basic Reproduction Number 
Central to an understanding of the dynamics of infectious diseases is the concept of Ro, the 
basic reproduction number, which denotes the rate of spread of an infection through a host 
population. For a microparasite, Ro is defined as the average number of secondary infections 
arising from the introduction of one infectious individual into a susceptible population. 
Assuming a mass-action principle for transmission of infection, the magnitude of Ro is 
linearly proportion to the density of susceptible individuals, such that 
Ro= MD (1.1) 
where 0 is the transmission coefficient, S the density of susceptibles and D the duration of 
infectiousness. 
In a stable endemic state, each case produces, on average, one secondary case, so that the 
effective reproduction number, R, = 1. Assuming weak homogeneous mixing (Anderson 
and May, 1991), the number of secondary infections is proportional to the fraction of 
susceptible animals, x, so that, at equilibrium, 
R =Rox =1 (1.2) 
and Ro =1 Ix (13) 
A second direct method of estimating Ro in an endemic situation has been developed for 
directly-transmitted microparasites, such that 
Ro =1 +L/(A-M) (1.4) 
where L is the life expectancy of the host, A the average age to infection and M the duration 
of maternal antibody (Anderson and May, 1991). This expression assumes a stationary 
population, where births equal deaths, but is easily adjusted for a growing population by 
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replacing L with the reciprocal of the per capita birth rate, B (Anderson and May, 1991; 
Anderson, 1992). This imdification will be used in Chapter 5. 
This simple expression clearly shows how the value of Ro depends on social and behavioural 
factors affecting contact rate (and hence A) and on host demography (which influences L 
and B). Hence, a useful starting point for studying the behaviour of rabies and CDV is an 
examination of the demographic and behavioural characteristics of Serengeti domestic dog 
populations, and this forms the subject of Chapter 2. A knowledge of host demography and 
behaviour is also important to assess the validity of the assumptions underlying these 
calculations and their application in simple epidemic theory. This is discussed briefly in 
Chapter 2. In Chapter 5, we use both approaches to estimate values of Ro for CDV in a 
domestic dog population of the Serengeti, incorporating demographic data from Chapter 2 
and age-seroprevalence data from Chapter 5. 
A practical application of Ro is the design of vaccination strategies. The logic behind mass 
vaccination is to reduce the fraction susceptible below the threshold level at which infection 
can be sustained. To eradicate infection, the effective reproductive rate must be maintained 
less than 1 and this is achieved if the proportion vaccinated, exceeds a critical threshold, p,, 
where 
Pc = 1-x (15) 
and hence, P, = I- 1/ Ro (1.6) 
This expression is used in Chapter 5 to determine the critical fraction that needs to be 
vaccinated to prevent outbreaks of ®V in Serengeti dogs. 
Thresholds for Establishment and Persistence 
For microparasite infections, which require close contact for transmission, there is 
thought to be a threshold density, below which the probability of contact between 
susceptible and individuals is too low to ensure transmission (Anderson and May, 1991; 
Nokes, 1992). 
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However, satisfying the threshold density for invasion, Ro, is no guarantee of 
persistence. As an epidemic proceeds, susceptible hosts are progressively lost, through 
death or acquired immunity, and the number of infected individuals drops. Persistence 
in the trough between epidemics depends on replenishing the pool of susceptibles, 
mainly through birth, but also through immigration or loss of immunity. Infections are 
therefore more likely to persist in populations large enough to generate sufficient 
susceptibles by birth and those with high birth rates. Indeed, empirical data support the 
view of a critical community size (CCS) for persistence, with human island populations 
of about 300,000 required to maintain measles (Bartlett, 1960; Black, 1966) and bison 
herds of about 300 to maintain brucellosis (Dobson and Hudson, 1995). 
Problems remain, however, reconciling empirical observations with theoretical 
predictions and this is emerging as a central issue in our understanding of microparasite 
infection dynamics (Dye et al., 1995). Models have particular difficulty explaining 
persistence where the infectiousness of a microparasite is high, the contact rate between 
susceptible and infectious individuals high, and where the infectious period is short relative 
to the rate of generation of new susceptibles. The development of measles models usefully 
illustrates these problems, and, as a morbillivirus, rnemles also provides a useful starting 
point for thinking about the infection dynamics of CDV. 
Basic compartmental models capture many of the complex dynamics of measles, but have 
difficulty explaining persistence without invoking unrealistically low levels of infection 
between epidemics, as well as an unrealistically large CCS (Olsen and Schaffer, 1990; Rand 
and Wilson, 1991). Inclusion of seasonal forcing and age-structuring leads to more realistic 
predictions of the CCS, but also results in the loss of dynamic patterns (Bolker, 1993). 
Currently, models incorporating spatial heterogeneity in the form of tnetapopulations 
provide the best simultaneous explanation for observed dynamics and persistence (Bolker 
and Grenfell, 1995). The importance of spatial heterogeneity in persistence has been 
emphasized for several other infections, including rabies in foxes and phocine distemper 
virus in seals (reviewed by Bolker et al., 1995). 
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Observations of persistent infections in low-density populations are also difficult to explain 
in theory. An example is the maintenance of rabies in arctic fox populations (Crandell, 
1991). Spatial considerations may be important here, too, because of the uneven distribution 
of the population and wide fluctuations in abundance (Wandeler et al., 1994). However, 
several authors raise an alternative suggestion that carrier animals may play a role (C randell, 
1991; Wandeler et al., 1994). 
The question of rabies and CDV persistence in the Serengeti is a central therm, of this study. 
In Chapter 4, we outline how existing models of fox rabies have difficulty explaining disease 
persistence and review the different mechanisms that have been proposed to account for 
rabies persistence in different host populations. We then use mathematical mxdels to 
explore, theoretically, the role of three putative mechanisms in rabies maintenance in 
Serengeti domestic dogs. In Chapter 5, we compare predictions that are generated by 
endemic theory with observations of CDV persistence in different Serengeti dog 
populations. 
Canine Disease and Conservation 
The essential dilemma in conservation today is reconciling the needs of a rapidly 
expanding human population with wildlife protection. A growth in rural human 
populations is usually associated with an increase in domestic animal populations, and 
such an increase has been documented for the dog population in Zimbabwe (Brooks, 
1990). The principle of mass action, together with a threshold population size for 
maintenance of infection, suggests that as dog numbers increase, so does the likelihood 
of disease persistence. One probable outcome of increasing human populations is 
therefore the establishment of microparasite infections in domestic animal reservoirs 
and, with expansion into wildlife areas, the heightened risk of transmission between 
domestic animals and wildlife. 
The principle of a threshold population size and density might suggest that endangered 
populations, which are typically small, are relatively protected from microparasite 
infections (Lyle and Dobson, 1993), particularly from highly virulent pathogens that 
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require large population sizes for maintenance (Dobson and May, 1986). However, 
where microparasites can be transmitted between a wide range of host species, short- 
lived epidemics can be initiated in populations too small to sustain infections 
independently. Further, because most individuals in a small population are rarely 
exposed to a pathogen, there is little opportunity for the acquisition of immunity. 
Rabies and CDV are therefore of particular concern in conservation for two main 
reasons. First, they can be transmitted between a wide range of mammal species, 
including domestic dogs, and second, they are highly virulent pathogens, inflicting 
substantial host mortality. It is not surprising to find, therefore, that both rabies and 
CDV have had a major impact on several endangered carnivore populations, and almost 
certainly pose a threat to the survival of several others. 
For example, recent outbreaks of rabies in the highly endangered Serengeti population 
of African wild dogs (Lycaon pictus) have reduced the population by more than a third 
(Gascoyne et al., 1993a; Kat et al., 1995). Elsewhere, rabies has inflicted high 
mortality on the small population of Blanford's fox (Vulpes cana) in Israel (Macdonald, 
1993) and threatens the survival of the Ethiopian wolf (Canis simensis) in the Bale 
Mountains National Park (Gotelli and Sillero-Zubiri, 1992; Sillero-Zubiri et al., 1996). 
This outbreak was of particular concern because Bale Mountains contains more than 
half the entire population of Ethiopian wolves, which are probably the world's most 
endangered canid (Ginsberg and Macdonald, 1990). 
Similarly, a CDV epidemic in Wyoming in 1985 reduced the numbers of black-footed 
ferrets (Mustela nigripes) to less than 20, after which surviving animals were brought 
into captivity for breeding and reintroduction (Williams et al, 1988). CDV may have 
been a factor in the virtual disappearance of African wild dogs from the Serengeti-Mara 
region in 1991 (Burrows, 1995), since the disease was epidemic in domestic dogs of the 
Masai Mara at the time (Alexander and Appel, 1994). However no cases of CDV were 
confirmed in wildlife during this epidemic. 
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Traditionally, the principal motivation for controlling disease in wildlife has been to 
reduce risks for man or his livestock. Disease control measures have relied mainly on 
culling host populations to reduce densities below the threshold for persistence. 
However, both theory and practice suggest that culling alone is unlikely to be 
successful in controlling rabies for many reservoir host populations (Anderson et al., 
1981; Aubert, 1993). In contrast, the success of oral vaccination programmes in wildlife 
demonstrates not only the efficacy of this approach, but also the feasibility of combining 
disease control with ecological sensitivity. 
As concerns grow about the impacts of epidemics on threatened species, disease control 
is increasingly becoming part of management strategies for wildlife protection. For 
example, following confirmed outbreaks of rabies in African wild dogs in the Serengeti, 
rabies vaccination was carried out in the two remaining wild dog packs, using 
inactivated vaccines previously tested on captive animals (Gascoyne et al., 1993a). 
However, undiagnosed deaths and disappearances of wild dogs 8 to 10 months later led 
to the suggestion that vaccination was a contributory factor in mortality (Burrows, 
1992; Burrows et al., 1995). Although many authors consider an outbreak of disease, 
such as CDV, a more plausible explanation for pack disappearances (Macdonald et al., 
1992; Kat et al., 1995; Ginsberg et al., 1995), this case history highlights the need for 
careful evaluation before embarking on vaccination programmes in endangered wildlife. 
Against this background, the aim of this study is to identify reservoir populations of 
rabies and canine distemper that will provide a basis for regional disease control in the 
Serengeti, rather than attempting to vaccinate specific wild animal populations at risk. 
We hope to develop effective and sustainable strategies that will minimize the threats of 
both rabies and canine distemper to vulnerable wild carnivore populations, and at the 
same time reduce public health concerns about rabies for people in the Serengeti. 
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Chapter 2 
DEMOGRAPHIC AND ECOLOGICAL CHARACTERISTICS OF 
DOMESTIC DOG POPULATIONS IN THE SERENGETI: 
IMPLICATIONS FOR THE EPIDEMIOLOGY AND CONTROL 
OF RABIES AND CANINE DISTEMPER 
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SUMMARY 
The demographic and ecological characteristics of hosts have a profound influence on 
the dynamics of microparasite infections and their control. Domestic dogs are thought 
to be the major reservoir for rabies and canine distemper throughout the developing 
world and there has been a growing interest in dog ecology studies as part of rabies 
control programmes. In this study, demographic and behavioural data were collected 
from domestic dog populations in two districts adjacent to the Serengeti National Park 
- an agropastoralist area to the west of the park (Serengeti District - SD) and a 
pastoralist area to the east (Ngorongoro District - ND). Cross-sectional and 
longitudinal studies were conducted from 1992-1994 to evaluate population size and 
density, birth and death rates, rates of population growth, behavioural characteristics 
and accessibility for vaccination. The SD dog population was stable, with constant age- 
specific fecundity and mortality rates between years. In contrast, there were differences 
in age-specific mortality in ND between years. An increase in juvenile mortality in 1994 
was associated with an epidemic of canine distemper and was reflected in a change in 
the age distribution and per capita birth rates across years. Birth and death rates were 
higher in SD than in ND in non-epidemic years. This, together with a higher population 
size and density in SD, indicates that rabies and canine distemper virus are more likely 
to persist in SD than in ND. A vaccination coverage of 64% - 78% was achieved 
through central-point vaccination in SD, but in ND, high-coverage vaccination could 
only be achieved by visiting households. Age-specific mortality rates were used to 
determine the frequency of vaccination required to maintain coverage above the critical 
threshold to prevent rabies outbreaks. Results suggested that rabies vaccination 
campaigns should be conducted at intervals of less than one year in SD. 
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INTRODUCTION 
The exact nature of viral infection patterns in host populations is dependent on 
numerous factors, the most important of which are related to (i) the behavioural and 
demographic characteristics of the host, (ii) the natural history of infection in the host, 
and (iii) the mode of transmission between hosts (Nokes, 1992). 
Most directly-transmitted microparasites need close contact between susceptible and 
infectious individuals for transmission, and are therefore dependent on factors affecting 
contact rate, such as host population density, social behaviour and mixing rates. Other 
features of disease dynamics (such as the duration of epidemics, periodicity of infection 
and likelihood of disease persistence) are influenced by the rate of introduction of 
susceptible hosts in a population (by birth, immigration or loss of immunity) relative to 
rates of transmission. The dynamics of microparasite infections can be simulated by 
mathematical models, and such models provide a useful framework for studying dog 
demography and ecology as determinants for infection processes (Anderson and May, 
1991). In Table 2.1, we summarize the demographic and behavioural data collected in 
this study and their relevance to the epidemiology of rabies and canine distemper in the 
Serengeti. 
A knowledge of the population biology and behaviour of host species is also essential 
for the design and implementation of appropriate control strategies, to ensure that a 
certain proportion of the population is always immunized. The importance of host 
ecology has long been recognized in rabies control and applies whether the target 
reservoir host is a wild carnivore or the domestic dog (Wandeler, 1985; Beran and 
Frith, 1988; WHO, 1987; Wandeler et al, 1993; Perry, 1993a and b). Because domestic 
dogs are considered to be the primary reservoir of rabies throughout the developing 
world, guidelines have been developed by the World Health Organization (WHO) for 
studying domestic dog ecology and these now form an essential part of 
recommendations for dog rabies control (WHO, 1987; WHO/WSPA 1990). The 
development of standardised methodologies has stimulated studies of dog populations 
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Table 2.1. Demographic and ecological data collected and their relevance to the 
epidemiology and control of rabies and canine distemper in Serengeti domestic dogs. 
;;; `; Data cölleeted in this';:; ; . 
4rameters 
derived 
from if Wnceor'gPidemiölögx` Rd cöýetrol.. off `? < 
ata. and canine 
Dog abundance Population size/density Threshold population density for persistence of 
infection 
Number of vaccine doses required 
Survival by age Birth rates Rate of generation of susceptibles 
Fecundity by age Death rates Life expectancy (L), calculation of R0, estimation 
Age distribution Rate of increase of required vaccination coverage 
Sex ratio Frequency of vaccination required to maintain 
coverage 
Choice of age groups for vaccination to optimize 
coverage 
Age Age-seroprevalence Age-specific infection, average age to infection 
(A), proportion susceptible (x) 
Calculation of Ro 
-Sex Explanatory variables for Factors affecting contact rate, hence transmission 
-Function of dog infection rate 
-Intra- and inter-species Regression coefficients Risk factors for infection 
interactions Odds ratios (case control Identification of high-risk segments of population 
-Dog movement studies) for control 
-Geographic location 
-Seasonal breeding 
-Dog accessibility for Choice of appropriate control strategy 
parenteral vaccination (eg parenteral/oral vaccination; dog removal; 
-Ownership movement restriction) 
-Public attitudes 
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throughout the developing world (Beran and Frith, 1988; Matter, 1989; Bögel & Joshi, 
1990; Brooks, 1990; Wandeler et al.. 1993; de Balogh et al., 1993; Kitala et al., 1993; 
WHO, 1994b). These studies have generated a large volume of data, such as estimates 
of dog abundance and density, population age/sex structures, dog accessibility, and to a 
lesser extent, birth and death rates. In terms of rabies control, these provide useful 
assessments of dog accessibility and population size for parenteral or oral vaccination 
programmes (e. g. Matter, 1989; Bögel and Joshi, 1990; Wandeler et al., 1993; de 
Balogh et al., 1993). But, in general, dog demographic data have been under-used, 
both in terms of strategic application of rabies control measures and in epidemiological 
studies. For example, consistently high estimates of dog population turn-over suggest 
the need for a high frequency of vaccination, but dog vaccination campaigns are 
generally still conducted on the traditional yearly basis. The short life expectancy of 
dogs and the substantial proportion of young dogs in many rural African populations 
also raises the possibility that pup vaccination may provide a way of achieving adequate 
vaccination coverage (Perry, 1995). Although there have been qualitative assessments 
of data in terms of rabies epidemiology (Beran and Frith, 1988; Wandeler et al, 1993), 
few results have been used quantitatively. There is clearly scope for greater exploitation 
of demographic and behavioural data to target specific segments of the population in 
order to optimize vaccination coverage and/or cost-effectiveness of control (Perry, 
1993a; Perry, 1995). These issues are particularly important given the failure of existing 
dog rabies control programmes to halt the increase of rabies throughout Africa (King, 
1993) and the substantial economic burden of the disease in developing countries 
(Meslin et al., 1994). 
In this chapter, we present cross-sectional and longitudinal data from two domestic 
dog populations adjacent to the Serengeti National Park, obtained from questionnaire 
surveys of owners, longitudinal survivorship studies and vaccination trials. We provide 
estimates of birth and death rates, life expectancy, population growth rates and describe 
some behavioural characteristics, which lead to predictions about the pattern of 
infectious diseases in each population and strategies for disease control. In subsequent 
chapters, demographic parameters are used further, in combination with seroprevalence 
59 
data, to identify reservoirs of infection and to investigate mechanisms by which rabies 
and canine distemper persist in Serengeti dog populations. 
MATERIALS AND METHODS 
Study Area 
The study area was the Serengeti ecological region of North-western Tanzania (350 to 
360 E, 10 30' to 30 7' S). Two areas around the Serengeti National Park were selected 
for the study, defined from administrative district boundaries. These were the 
Ngorongoro District (ND), comprising the Loliondo Game Control Area (LGCA) and 
the Ngorongoro Conservation Area (NCA), and the Serengeti District (SD) (Figs. 2.1a- 
c). ND is a multiple-use controlled wildlife area, inhabited predominantly by Maasai 
people who practice traditional pastoralism, and recently, limited cultivation. In these 
areas, the household unit is the boma, a circular enclosure typically comprising 5-20 
huts, occupied by one Maasai elder with one or more wives and children. In the study 
area of SD, there is more extensive cultivation, agropastoralism is the dominant pattern 
of land use and the human population is of more diverse tribal origin. 
Preliminary studies have shown that demographic features of dog populations in LGCA 
and NCA were broadly similar but differed from those of SD (Gascoyne, 1994). 
Throughout this study, data are therefore presented at the District level, comparing 
populations in ND with those of SD. 
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Field Studies 
Study Period 1 (September 1992 to February 1993) 
For simplicity, this period will be referred to subsequently as 1992. Villages were 
selected from areas close to the border of the Serengeti National Park, within SD and 
both subdivisions of ND (LGCA and NCA) (Fig. 2.1a). Villages were selected to cover 
as wide a geographic range as possible within the three study areas. In higher-density 
villages (Mugumu - M, Loliondo -L and Wasso - W; Fig. 2.1 a), one in five households 
was visited by visiting each street systematically. In rural villages of SD, households 
were sampled within each of four quadrants, using the village centre (site of 
administrative offices) as the central reference point. One in five households situated 
along a transect was visited within each quadrant, starting from the village centre and 
working towards the periphery. In low-density pastoralist areas, each boma in a village 
that was accessible by vehicle and/or 15 minutes walking was visited. Remote bomas 
were not sampled. LGCA, NCA and SD were each visited three times for questionnaire 
surveys. 
Questionnaires were drawn up along WHO guidelines (WHO, 1987), to obtain 
information on each household and to obtain data for each dog sampled (English 
translations of questionnaires are shown in the Appendix). Questionnaire surveys were 
carried out in Kiswahili by local veterinary assistants seconded from the district 
livestock office, and who were therefore familiar with the area. I was present during 
each interview and checked questions and answers at the time of the questioning. Two 
assistants were employed in each of the areas (SD, LGCA and NCA). All veterinary 
assistants spoke English as well as Kiswahili. Where Kiswahili was not spoken, a 
Maasai interpreter was used to translate from Maa to Kiswahili. I was unable to verify 
questions and answers given in Maa. 
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Figure 2.1a. A map of the Serengeti National Park and surrounding regions, showing 
the location of study villages (0 ) within the Serengeti District, Loliondo Game Control 
Area and Ngorongoro Conservation Area that were visited in 1992. The Ngorongoro 
Crater is shown by the large open circle. 
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Questionnaire data were verified by observations, where possible. In 68.8% of 
households, all dogs reported in the questionnaires were observed at the time of the 
interview. The consistency of owners' responses on dogs' ages was checked through 
repeat questionning in subsequent field periods. 
Blood sampling of dogs was conducted during these questionnaire surveys, as described 
in detail in Chapter 3. Dogs were identified using the owner's name, dog's name, and a 
written description which included colour, markings, coat length and texture, size, tail 
conformation and ear notches. The appearance of dogs was sufficiently heterogeneous 
to allow photographs to be taken for verification. 
Study Period 2 (September 1993 to December 1993) 
During this period, selected villages from each study area were re-visited (Fig. 2. lb). 
The focus of the second field study was the collection of longitudinal data, with the 
result that full questionnaires were not collected for cross-sectional studies. Villages 
were visited for follow-up of rabies seropositive and seronegative dogs (see Chapter 4). 
Practical constraints precluded re-visiting each village sampled in 1992. Mortality data 
were obtained from as many dogs of the original study as possible. If a dog had died, 
information was obtained from owners on the month of death and the suspected cause 
of mortality. Using the name of the owner and dog and written description of the dog, 
individuals could be identified with a reasonable degree of certainty. The identity of 
dogs was checked from photographs. Plastic collars that were fitted during 1992 failed 
to survive the follow-up period and could not therefore be used for identification. 
Rabies vaccination Trials 
During the second field period, accessibility of dogs for vaccination was determined 
from trial vaccinations in collaboration with local veterinary officers. Accessibility was 
determined from vaccinations were conducted in one high-density village (Loliondo), 
two medium-density agropastoralist villages in SD (Matare and Kisangura) and three 
low-density pastoralist villages in ND (Nainokanoka, Oloirobi, and Endulen). 
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Figure 2.1b. Location of study villages (0) visited during 1993. 
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Rabies vaccination programmes were advertised through village leaders and children at 
primary schools one to two days prior to vaccination Vaccination stations were set up 
at central sites in each village. Data were obtained on age and sex of dogs brought for 
vaccination, age of person bringing dog, the distance travelled to the vaccination point, 
and total number of dogs in the household. All dogs brought for vaccination were 
identified with a plastic collar and owners issued with a vaccination certificate. Within a 
week of vaccination, households within a1 km radius of the vaccination point were 
visited systematically to determine the proportion of vaccinated dogs and reasons why 
other dogs were not brought for vaccination 
During this period, as many dogs as possible from the original study population were 
re-bled for longitudinal rabies scrosurveys. Dogs were also bled at the time of 
vaccination to assess pre-vaccination titres and for cross-sectional serosurveys of rabies 
and canine distemper (see Chapters 3,4 and 5). 
Stucky Period 3 (August 1994 to December 1994) 
During this period, study villages were re-visited (Fig. 2.1c) to obtain survivorship data 
and repeat blood samples from dogs in the 1992 and 1993 study groups. Additional 
cross-sectional serological and demographic data were obtained by house-to-house 
visits. All dogs were vaccinated against rabies at the time of blood sampling. 
Demographic and Ecological Data 
Population Six and Density 
Where possible, population sizes were estimated from ratios of people to dogs (WHO, 
1987) In SD, human population sizes were obtained using projected estimates from 
1988 human census data with a growth rate of 2.9% per annum in SD and 3.8% in ND 
(Bureau of Statistics, 1991). There was often a reluctance amongst Maasai elders to 
divulge the number of people in the household, so population size estimates in 
pastoralist areas of ND were based on the number of dogs per boma. The number of 
permanently occupied bomas in ND was obtained from aerial surveys conducted by 
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Figure 2.1c. Location of study villages (40) visited during 1994. 
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Tanzania Wildlife Conservation Monitoring, Serengeti Wildlife Research Institute in 
1991. Estimated projections for 1992-1994 were based on a constant ratio of people to 
boma. The area of each district was obtained from the administrative offices of ND 
(Loliondo) and SD (Mugumu). 
Photographic mark-recapture techniques for estimating dog population size (WHO, 
1987) were carried out in a few locations, but rejected for general use in this study for 
several reasons: households were often widely dispersed, making the technique 
logistically difficult; dog populations in any one village were small, hence large standard 
errors were associated with estimates; there was no evidence for a large population of 
`unowned' dogs that would be missed by owner questionnaire surveys. 
The change in population size, N, across years provides an estimate of the finite rate of 
increase, X, and intrinsic growth rate, r, from the expression 
X= e''=N, +, /N1 (2.1) 
where N, and N,., are the population sizes in years t and t+I respectively. 
Age 
Age is a key parameter in demographic and epidemiological studies with many 
populations showing age-specific rates of reproduction, mortality and infection. Here, 
age of dogs is used for determination of age-specific survival and fecundity, and hence 
for estimation of birth rates, death rates, population growth rate and life expectancy. 
In subsequent chapters, dogs' ages are also used to calculate age-seroprevalence 
patterns. 
The age of dogs was determined by asking owners both the age of the dog and its date 
of birth. Ages were classified by year, with dogs classified in age class x being aged 
between x and x+l (i. e. dogs classified as I are between I and 2 years old). If the 
owner was unable to give the exact age, the dog was classified as pup (0-3 months), 
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juvenile (4-6 months) or adult (> 6 months) on the basis of visual inspection. Where 
there was uncertainty between juvenile and adult classification, teeth were examined for 
the presence of permanent canines, which on average erupt at 6 months of age (Getty, 
1975). Age distributions were determined using the known ages of dogs. Because the 
age of dogs under six months could be determined with relative accuracy, dogs of 
unknown age were likely to be older than six months. To adjust for the proportion of 
dogs with unknown ages, these animals were assigned to age groups older than six 
months, according to the age distribution of the known population. 
The age distribution of SD and ND dog populations was analysed according to 
Caughley (1977). The standing age distribution of a population, S. may be expressed 
as the proportion of individuals in the age class x (fX) relative to the proportion in the 
first class, Jo, 
S. = fý+, fo (2.2) 
The proportion in the first age class included the sampled frequency of dogs 3-12 
months of age (from dog questionnaires) and the proportion of pups <3 months of age 
(from household questionnaires). 
In a population where age-specific mortality and fecundity have been constant for some 
time, the age distribution converges towards stability and SX is related to survival by the 
expression 
Sx = lx C r` (2.3) 
where I., is the probability of surviving to age, x, and r the intrinsic rate of increase of a 
population. 
In a population with a stable age distribution, the finite birth rate, b (the rate of 
increase of a population in the absence of mortality), is related to Sx as follows, 
eb=£Sr/(USX-1) (2.4) 
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Mortality 
Age-specific mortality rates were determined from survivorship of a group of adult and 
juvenile dogs (> 3 months of age) from 1992-3 and from 1993-4. The effect of age, 
region and year on age-specific mortality was analysed using logistic regression. 
Mortality was classified as a binary variable, with dogs surviving a 12-month period 
scored as 0, those dying as 1. A logistic curve was fitted to the binary data using the 
logit link function with binomial errors and the parameters of the logistic models estimated 
by maximum likelihood (McCullagh and Neider, 1989). The analysis was carried out in 
GENSTAT 5.3 (Payne ei al., 1993). 
The process of model-fitting was based on stepwise deletion, as described in detail by 
Crawley (1994), and is used throughout this thesis. All explanatory variables and interaction 
teams were initially included in the model (the full model) and the model simplified by 
dropping the least significant terms first. The significance of variables was determined by x2- 
tests that assessed the significance of the increase in deviance caused by removal of any 
given term from the current model. Once all remaining variables were significant, the 
resulting model was described as the minimum adequate model. The individual effect of 
variables in the minimum adequate model was measured by the change in deviance following 
deletion of a single significant term from the model, hence controlling for the effects of all 
other significant variables. 
In this analysis of mortality, explanatory variables in the full model included age, sex, year 
and region with their interaction terms. Age was included as a continuous variable (age) or a 
categorical variable (age class), the classification explaining a greater proportion of the total 
deviance being used in the final model. 
Neonatal mortality was determined by asking owners the fate of pups born during the 
past year. Neonatal mortality rates were calculated from litters born at least three 
months' previously. The number of pups dying in each litter was recorded as a 
proportion of the number of pups born and the data converted into probability values by 
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fitting a logistic curve, using the logit link function with binomial errors. Explanatory 
variables in the full model included age of dam, year and region with their interaction terms. 
The significance of each parameter was determined by step-wise deletion from the full 
model, as described above. 
Fecundity 
Age-specific fecundity was determined from cross-sectional questionnaire studies of 
female reproduction, based on the number of litters per female per year and the mean 
litter size in each age group (since not all owners could indicate how many pups were 
born in each litter). Fecundity was expressed as the number of female pups born per 
female per year (mx). The sex ratio at birth was assumed to be 1: 1 (see Results - sex 
ratio). 
Per capita birth rates were calculated from data averaged across age classes, using the 
number of litters/female, mean litter size and proportion of mature females (>12 
months) in the population. The rate of recruitment of 3-month old pups was 
determined from the number of pups per year surviving to 3 months divided by the 
number in the population greater than 3 months. 
The effect of year and region on mx (averaged for each age group) was investigated by 
regression analysis using a second-order polynomial model in GENSTAT 5.3 (Payne et 
aL, 1993), which explained a large proportion of the total variance. The linear model 
was constructed as described above. The response variable m., was continuously 
distributed, so the significance of terms tested using F-ratios. Fecundity (mx) was 
regressed on age and year, region and a year/region interaction term fitted as 
explanatory variables. 
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Lifetables 
Longitudinal data. Lifetables were constructed as described by Caughley (1977), using 
age-specific mortality in study cohorts, and questionnaire data on female reproduction 
to measure mx (number of female pups born/female). The proportion surviving in each 
age class (px) was used to determine the probability of surviving to age x, lx, where 
!x=P. (P. 
-r) (2.5) 
The intrinsic rate of increase of the population (r), was calculated from the Lotka 
equation as follows (Caughley, 1977) : 
E lx mr e-'x =1 (2.6) 
This was solved iteratively using a programme written in BASIC. 
For SD, values of r were calculated using combined data from each year. An indication 
of the variance of r was obtained using !x and mx schedules from different years. 
Cross-sectional data. The relationship between l and Sx (Eq. 2.3) allows a stable age 
distribution to be used to calculate survival schedules and life expectancy, if an estimate 
of r is available. Using estimates of r from Eq. 2.1 for SD, each age frequency was 
multiplied by e'x. A log-polynomial was fitted to the curve, to ensure that no frequency 
in age class, x+1, exceeded that in age class x (Caughley, 1977). Smoothed 
frequencies were then divided by the number in the first age class, to give a table of I. 
Life Expectancy 
Life expectancy in each age group (ei) was calculated for an imaginary cohort of dogs 
using age-specific survivorship schedules obtained from longitudinal studies. Life 
expectancy was calculated as follows (Newell, 1988): 
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ex = Td., (2.7) 
where T. = IL,, -L(., _, ) (2.8) 
and L, r = (lx + las+») / (2.9) 
In this study, we use the mean life expectancy together with the average age to infection 
to draw inferences about the likelihood of canine distemper virus infection becoming 
established. The mean life expectancy (L) was calculated by weighting age-specific 
values by the proportion of dogs in each age class. 
Sex 
For individual dog data, sex was recorded at the time of blood sampling or vaccination. 
Population data were obtained from household questionnaires on the sex of dogs in the 
household in each of the three age classes - pups, juvenile and adults (see Appendix). 
Sex was classified as binary data for each individual and analysed using logistic 
regression. A logistic curve was fitted to binary data (females 0, males 1), as described 
previously. Explanatory variables in the full model included age of dog, year and region 
with their interaction terms. The significance of each of these terms was determined by 
stepwise deletion, as described above. 
Chi-squared tests were used to determine whether population sex ratios differed 
significantly from an expected ratio of 1: 1 amongst pups, juveniles and adults. 
Seasonality of Breeding 
Data on the number of litters born in each month were provided by owner 
questionnaires. The effect of region and year on the number of litters born during the 
dry season (June to November) and the wet season (December to May) was analysed in 
GENSTAT 5.3 (Payne et ad., 1993) as count data, using a generalized linear model with 
Poisson errors (Crawley, 1994). 
72 
Behavioural Characteristics 
The following information was obtained from questionnaire surveys: function of dogs 
(guarding, herding, hunting or companionship), proximity of wildlife to household, 
nature of dog/wildlife interactions, origin of dog, number of dogs being bitten (by 
wildlife and/or dogs), the degree of confinement or restraint of dog. 
Behavioural traits were analysed to identify heterogeneities associated with sex, age, 
year or region that might affect contact rate and hence disease transmission. These 
variables were classified as binary data as follows: function - dogs used for guarding 
only 0, dogs going away from the house for herding/hunting 1; bite history - not bitten 
during past 12 months 0, bitten 1; source of dog - acquired from own dog 0; acquired 
from other households 1; illness - no history of illness during the past 12 months 0, 
illness reported (unspecified) 1. Logistic regression analysis was used to investigate the 
effects of year, age, sex, region on binary variables, as described previously. 
Further analyses of case-incidence data for CDV, and behavioural traits as risk factors 
for rabies and CDV infection are carried out in Chapters 4 and 5. 
Vaccination Strategies 
The 95% confidence limits for the theoretical vaccination coverage required to prevent 
rabies outbreaks in dogs (pa) fall between 55% and 71% (Coleman and Dye, 1996). 
These are probably stringent criteria for Serengeti dogs, since they have been 
established from infection characteristics of high-density, urban populations where 
contact rates are likely to be higher than in Serengeti. 
We use age-specific mortality rates, age distributions and population growth rates to 
compare the hypothetical decline in vaccination coverage of study populations after a 
single vaccination campaign in which 70% of the population is vaccinated. The lower 
95% confidence limit (55%) is used to determine the frequency of repeat-vaccinations 
required to prevent rabies outbreaks. 
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We compared rates of decline using different strategies to achieve 70% vaccination 
coverage. For ND, these were: (i) vaccinating adults only ( dogs > 12 months); (ii) 
vaccinating adults and juveniles (4-12 months), (iii) vaccinating 70% adults, juveniles 
and pups (0-3 months). Because juvenile and adult mortality rates did not differ 
significantly in SD (see results), only strategies (i) and (iii) were compared. ND analysis 
used data from 1992-3 (a non-epidemic year), but data were combined for SD as there 
was no significant difference in age-specific mortality between years. Vaccinated pups 
were assumed to die at neonatal mortality rates for two months following vaccination 
and at juvenile rates up to 12 months. Vaccinated juveniles were assumed to die at 
juvenile rates for 8 months and thereafter at the adult rate. 
RESULTS 
Sample Sizes. Sample sizes for cross-sectional household and dog questionnaires and 
for longitudinal studies are shown below. 
Table 2.2. The number of households in questionnaire surveys and number of dogs in 
cross-sectional and longitudinal studies. 
Area Households* Dogs in cross- Dogs in 
sectional studies longitudinal 
studies 
1992- 1993- 
1992 1993 1994 1992 1993 1994 1993 1994 
Serengeti District 116 115 140 186 132 276 165 177 
Ngorongoro District`s 
Loliondo Game Control 127 47 65 175 112 128 93 127 
Area (LGCA) 
Ngorongoro Conservation 
Area (NCA) 79 41 102 123 43 176 72 76 
TOTAL 322 203 307 484 287 580 330 380 
* Full questionnaires were conducted only in 1992 and 1994. 
° Translation from Maa to Kiswahili was necessary in 113/373 (30.2%) of households. 
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Table 2.3a. The estimated size and density of domestic dog populations in Serengeti District. 
Hiýmaa: Estºmated. :: Pä i latiön timafed 
households people dog' population pu ation 
size. '. `' density 
1992 
Rural 166 95 953 5.74 19572 
Mugumu 61 65 462 7.57 1796 5.72 
town 
1993 ?=1.15 
Rural 148 98 761 5.14 22490 (r = 0.139 
1994 ll = 1.10 
Rural 257 165 1238 4.82 24679 (r = 0.093 
Table 2.3b. The estimated size and density of domestic dog populations in Ngorongoro District. 
Ho.:. 
bouseholds*- people household . ;: d 09 o atätýon>; " 
Inas bomä 
1992 
Pastoralist 445 168 2.65 65961 
Loliondo 29 44 242 0.66 8.34 5212 
1993 
Pastoralist 83 36 2.31 5966' 
Loliondo 137 176 975 0.78 7.12 6332 
1994 
Pastoralist 153 76 2.01 53961 
Loliondo 18 28 176 0.64 9.78 4782 
? '. . ctiniated '" :. 
PÖ uilation EsCunäted >`< 
total rate of populät 
elation : increase densit 
d slkn 2 
1992 7117 0.46 
A=0.927 
1993 6599 (r =-0.076 0.43 
X=0.890 
1994 5874 r =-0.116 0.38 
1. Based on dog: boma ratio 
2. Based on human: dog ratio 
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Population size and density 
There were considerably more dogs in SD than in ND and dog densities in SD were an 
order of magnitude higher than in ND (Table 2.3). These estimates indicated growth of 
the population in SD and a decline in ND over the three-year period. 
Age 
Consistent ages were reported for 54 out 61 (88.5%) dogs between 1992 and 1993, and 
for 53 out of 62 (85.5%) dogs between 1993 and 1994. The ages of 11 dogs differed 
by one year, four differed by two years and one differed by five years. Thus, 95.1% of 
dogs' reported ages were consistent to within one year of that expected. 
Age distribution 
The age distribution of SD and ND populations is shown in Fig. 2.2a and b. The 
percentage of dogs with unknown ages in SD was 10.7% in 1992 and 2.5% in 1994. In 
ND, the ages of 15.9% dogs were not given in 1992 and 1.3% in 1994. There were 
significant differences in the proportion of dogs in each age class between districts (X27 
= 26.0, p<0.001), with a greater proportion of younger dogs in SD. Significant 
differences were seen in ND between 1992 and 1994 (X2 7= 14.1, p<O. 05), with fewer 
young dogs in 1994 compared to 1992. There were no significant differences in age 
structure between years in SD (X27 = 2.49, p>0.05). 
Mortality 
Age-specific mortality is shown in Figs 2.3a and b, using neonatal mortality data from 
questionnaires and longitudinal data for dogs >3 months of age. Results of mortality 
analysis are shown in Tables 2.4a and b. There was no significant difference in 
mortality between age groups or across years in SD. In ND, mortality was significantly 
higher in 1993-94 than in 1992-93 and was significantly higher in older dogs. Because 
there was no significant effect of sex on mortality above 3 months of age, data were 
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Fig. 2.2. The age distribution of dog populations. 
a. Serengeti District 
Q 1992, n= 177 
1994, n= 281 
012345 
Age class (years) 
b. Ngorongoro District 
6 >ý 
1992, n= 233 
1994, n= 303 
11 0123456 >ý 
Age class (years) 
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Figure 2.3. Age-specific monthly mortality rates. Neonatal mortality (0-3 months) was 
determined from questionnaire surveys, juvenile and adult mortality from longitudinal 
studies. 
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Table 2.4a. Logistic model of mortality in Serengeti District. The model had a total 
deviance of 412.2 with 321 degrees of freedom. The chi-square value is the difference in 
deviance between successive models resulting from stepwise deletion of variables. 
a, E 
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Itic C-) 
4ýi 
,ý v 
to 
Of 
O 
v 
¢ 
ý 
Omi 
=S 
v 
to 
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4- 
O 
ý 
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vii 
vý °' 
Variable tested 
a 1234567 7.4 11 
b 123456 7.2 9 Age class. Year. Sex 0.2 2 NS 
c 12345 7.1 8 Year. Sex 0.1 1 NS 
d 1234 6.7 6 Age class. Sex 0.4 2 NS 
e 123 5.5 4 Age class. Year 1.1 2 NS 
f 12 5.5 3 Sex 0 1 NS 
g 1 3.7 2 Year 1.8 1 NS 
0 0 Age class 3.7 2 NS 
NS p>0.05 
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Table 2.4b. Logistic model of mortality in Ngorongoro District. The model had a total 
deviance of 376.6 with 291 degrees of freedom. The chi-square is the difference 
between each model and the one above it, except for model h, which is compared with 
model f (the minimum adequate model). 
a) u E 
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a 
Variable tested 
a 1234567 49.1 11 
b 123456 46.9 9 Age class. Year. Sex 2.2 2 NS 
c 12345 46.5 8 Year. Sex 0.4 1 NS 
d 1234 45.1 6 Age class. Sex 1.4 2 NS 
e 123 42.8 4 Age class. Year 2.3 2 NS 
f 12 41.3 3 Sex 1.5 1 NS 
g 1 19.4 2 Year 21.9 1 *** 
h 2 17.4 1 Age class 23.8 2 *** 
NS p>0.05 
*** p<0.001 
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combined for calculation of !x schedules to minimise sampling error arising from the 
relatively small amount of female data. 
Cause of death 
Causes of deaths were reported by owners in both retrospective questionnaire surveys 
in 1991-2 and for dog survivorship studies in 1992-3 and 1993-4. Mortality caused by 
wild animals was more commonly reported in ND than SD, accounting for 28% 
(n=357) of deaths in 1991-2 in ND and 5.4% (n=204) in SD. Longitudinal data gave 
similar results, with wild animals accounting for 36.1% (n= 122) of specified deaths in 
ND and 7.6 % (n= 66) in SD. Leopards were the most common predator, accounting 
for 68.6% of wild animal deaths reported in 1991-2 and 81.6% of wild animal deaths in 
cohort studies. 
Results and discussion of cause-specific mortality are presented in Chapters 4 and 5. 
Neonatal mortality 
Mortality in pups less than 3 months of age was significantly higher in ND than in SD 
(X21 = 15.24, p<0.001). There was no significant difference in pup mortality between 
years (X21 = 0.43, p>0.05), nor did year affect the magnitude of regional differences (for 
the year/region interaction term, x21 = 1.46, p>0.05). There was no significant effect of 
the age of dam (x21 = 2.71, p>0.05), nor did age affect the pattern of mortality in 
different regions (region/age interaction: XZ, = 0.3, p>0.05) or years (year/age 
interaction: x2 = 0.1, p>0.05). 
Life Expectancy 
Age-specific life expectancy is shown in Tables 2.5a-c and Fig. 2.4 together with the 
mean life expectancy (L) determined from age-specific values weighted by the age 
distribution. L was similar between years in SD, but varied more in ND with high 
disease-associated mortality among young dogs lowering mean life expectancy in 1994. 
L in ND in the non-epidemic year (1992) was broadly similar to SD, but age-specific 
life expectancy peaked in older dogs. 
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Table 2.5a. Survivorship schedule, Serengeti District (years combined). 
Age Number in Survival Surviva Surviva Lx Tx Lije 
age group rate 1. lx expectancy 
....................................... .................. ........... _..... _....... _. _. _ __...... _................. .... _... _. _.. __..... _.... _........ _............... ..... ...... .......... x 
0-3 mths 563 0.750 
3-12 mths 77 0.571 
0 1.000 1.000 0.714 1.716 1.716 
0-1 yrs 640 0.429 0.429 0.652 0.363 1.002 2.336 
1-2 yrs 85 0.694 0.297 0.425 0.256 0.639 2.152 
2-3 yrs 65 0.723 0.215 0.277 0.173 0.382 1.777 
3-4 yrs 39 0.616 0.132 0.181 0.121 0.209 1.583 
4-5 yrs 23 0.827 0.109 0.118 0.088 0.088 0.807 
>5 33 0.606 0.070 0.070 
MEAN (L) = 1.91 years 
1. Based on longitudinal data from observed survivorship (Eq. 2.5) 
2. Based on cross-sectional data from age distributions (Eq. 2.3) 
For 1992-3, L=1.92 years 
For 1993-4, L=1.91 years 
Life expectancy calculated from cross-sectional I data is 1.97 years. 
Table 2.5b. Survivorship schedule, Ngorongoro District, 1992-3. 
Age Number in Survival Survival L. T. Life 
age group rate 1. expectancy 
ex 
0-3 mths 271 0.639 
3-12 mths 20 0.700 
0 1.000 0.723 1.902 1.902 
0-1 yrs 292 0.447 0.449 0.364 1.179 2.646 
1-2 yrs 27 0.630 0.282 0.259 0.815 2.900 
2-3 yrs 25 0.840 0.236 0.217 0.556 2.355 
3-4 yrs 25 0.840 0.198 0.181 0.339 1.708 
4-5 yrs 17 0.824 0.163 0.158 0.158 0.967 
>5 15 0.933 0.153 
MEAN (L) 2.03 years 
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Table 2.5c. Survivorship schedule for Ngorongoro District, 1993-4 
Age Number in Survival Survival Ls T. Life 
age group rate is expectancy 
........... _ ............................................................................................................................................................................................. .G.............. 
0-3 mths 391 0.470 
3-12 mths 21 0.190 
0 1.000 0.545 0.678 0.678 
0-1 yrs 412 0.090 0.090 0.064 0.133 1.490 
1-2 yrs 29 . 0.414 0.037 0.029 0.007 1.894 2-3 yrs 29 0.586 0.022 0.019 0.004 1.877 
3-4 yrs 32 0.750 0.016 0.014 0.022 1.336 
4-5 yrs 25 0.680 0.011 0.008 0.008 0.730 
>5 37 0.460 0.005 
MEAN (L) = 1.36 years 
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Figure 2.4. Age-specific life expectancy, e1, determined from survivorship studies 
(see Table 2.5). 
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012345 
Age (years) 
Because longitudinal data from SD provide preliminary evidence for stability in the SD 
age distribution, there is justification for using the standing age distribution to calculate 
estimates of lx and ex. and we use this approach to take advantage of the larger volume 
of cross-sectional data. An lx schedule for SD was calculated from age-distribution data, 
using a value of r of 0.09 (from population size estimates), giving a life expectancy of 
2.33 years compared with 1.91 years calculated from longitudinal data. 
Fecundity 
Age-specific fecundity is shown for each year and region in Tables 2.6a and b and in 
Figs. 2.5a and b. A second-order polynomial explained 82% of the variance. There was 
no significant effect of region (F1,21= 0.02, p>0.05) or year (F1,22 = 0.05, p>0.05) on 
age-specific fecundity. 
Per capita rates of birth and recruitment of 3-month old pups are shown in Table 2.7 
together with finite birth rates estimated from the standing age distribution. Per capita 
birth rates differed more between years in ND than in SD. 
Seasonality of Breeding 
The number of litters reported to have been born in each month is shown in Fig. 2.6. 
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Table 2.6a. Fecundity schedule for Serengeti District (years combined) 
Age Number of Number of Mean litter Number of puppies Female births 
(yrs) females litters size per 
femalelyear" 
......................................................................................................................... .......................... 
M6.............. 
0-1 46 0 0 0 0 
1-2 39 14 3.55 1.27 0.64 
2-3 40 33 4.87 4.02 2.01 
3-4 22 21 6.00 5.73 2.86 
4-5 19 19 4.70 4.70 2.35 
>5 19 16 4.82 4.06 2.03 
* Assumes a 1: 1 ratio of females: males at birth 
Table 2.6b. Fecundity schedule for Ngorongoro District (years combined) 
Age Number of Number of Mean litter Number of puppies Female births 
(yrs) females litters size per 
female/years 
................. _... _....................................................................................................................................................... 
Er ............... 
0-1 25 0 0 0 0 
1-2 29 15 5.21 2.69 1.35 
2-3 42 31 5.23 3.86 1.93 
3-4 23 17 5.09 3.76 1.88 
4-5 22 20 5.95 5.41 2.70 
>5 32 26 5.41 4.40 2.20 
* Assumes a 1: 1 ratio of females: males at birth 
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Figure 2.5. Age-specific fecundity determined from questionnaire data. 
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Figure 2.6. Whelping dates recorded from questionnaire surveys. 
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Significantly more litters were born in the dry season (June to November) than in the 
wet season (December to May) (x2, =38.5, p<0.001). The seasonal pattern did not 
differ significantly between regions (x2, = 0.5, p>0.05). Although fewer litters were 
recorded in 1992 than 1994, patterns were consistent across years (season. region 
interaction: x`, = 0.4, p>0.05). 
Intrinsic Population Growth Rates 
Estimates of r, the intrinsic population growth rate per year, were determined from 
survival and fecundity schedules using the Euler-Lotka equation (Table 2.8). Since SD 
survival and fecundity schedules did not differ significantly between years, the range of 
values of r obtained from the Euler-Lotka equation gives an indication of the variance 
associated with this method of estimation. 
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Table 2.8. Estimates of intrinsic growth rate, r using (i) the Lotka equation (Eq. 2.6) 
and (ii) changes in population size estimates across years (Eq. 2.1). 
Region Year 
Euter-Lotka 
equation 
r 
Change in population 
size 
Serengeti District 1992-3 +0.125 A. = 1.15 
(r =0.139) 
1993-4 +0.058 X= 1.10 
(r =0.093) 
Combined data +0.089 
Ngorongoro District 
1992-3 +0.053 A. = 0.927 
(r =-0.076) 
1993-4 -0.419 A. = 0.890 
(r =-0.116) 
Sex Ratios 
From questionnaire surveys, there was no evidence for a sex bias at birth in either SD or 
pastoralist areas (SD : x2, = 0.367, p>0.05; pastoralist: x21 = 0.041, p>0.05). A skewed 
sex distribution was apparent in pastoralist dogs from 3 months of age upwards, with a 
significantly higher proportion of males than females in the population (juveniles: XZt = 
23.1 , p<0.001; adults: X2, = 
52.6 , p<0.001). 
There was no significant male bias 
amongst juveniles or adults in SD (juveniles: X2, = 0.24, p>0.05; adults: x2, = 0.05, 
p>0.05). 
The sex distribution by age, obtained from individual dog data, is shown in Fig. 2.7. 
The zero age class comprises dogs from 3-12 months of age. As expected from above, 
logistic regression analysis of individual data showed a significant regional effect, with 
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Figure 2.7 Sex distribution by age. 
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Age class 0 includes dogs 3-12 months of age but not neonates. 
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proportionally more males in ND than in SD (X2, = 18.0, p<0.001). There was no 
significant effect of age class (0,1,2,3, >3 years), year, or any of their interaction 
terms on the proportion of males in the population (age class: X24 = 6.0, p>0.05; year: 
X 22 = 3.0, p>0.05). 
Vaccination strategies 
Ownership 
There was a high level of ownership of dogs in both areas. Dogs invariably had names 
and they, and their owners, could readily be identified by people in the community. 
During the three study periods, only two unowned dogs were observed. 
Accessibility 
Within 1 Ian of the central vaccination point, a vaccination coverage of 78.4% dogs 
(n=54) was achieved in Matare village (SD), 72.1% (n=43) in Kisangura village (SD) 
and 64.4% (n=45) in Loliondo village (ND). Central point vaccination in three 
pastoralist areas in 1993 was unsuccessful, with a maximum of 11 dogs brought for 
vaccination at any one vaccination station. In 1994,145 dogs in 94 bomas in ND were 
vaccinated by boma-to-boma visits over a ten-day period, achieving a coverage of 67.6 
% of dogs in those bomas visited. 
The theoretical decline in vaccination coverage following a single vaccination campaign 
is shown in Figs. 2.8a and b. In SD, vaccination coverage was maintained above the 
critical threshold, pc, (55%) for longer when only dogs >3 months of age were 
vaccinated than when young pups were included. However, to provide a population 
coverage of 70%, 82% of juveniles and adults would have to be vaccinated. To 
maintain vaccination coverage in SD above 55%, vaccination campaigns need to be 
conducted once every 6 to 8 months. 
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Figure 2.9. Comparison of the theoretical decline in vaccination coverage following a 
single vaccination campaign using different strategies to immunize 70% of the 
population. 
a. Serengeti District. 70% vaccination coverage achieved by vaccinating (i) adults and 
juveniles (-) and (ii) adults, juveniles and pups (....... ). 
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In ND, there was little difference between the duration of coverage when juveniles were 
included or excluded. To provide a population coverage of 70%, 84% of juveniles and 
adults need to be immunised. Coverage was maintained above pc for 10-11 months 
when vaccinating adults and juveniles, but fell below the critical level at about 8 months 
when pups were included. 
Behavioural characteristics 
Function 
Almost all dogs were used for guarding property and/or livestock, and a proportion also 
used for herding livestock and hunting wildlife (28.6% in SD and 58.1% in ND). Dogs 
in pastoralist areas were significantly more likely to be used for herding/hunting than 
dogs in SD (x21 = 42.4, p<0.001). Controlling for regional effects, dogs greater than 
one year of age were significantly more likely to be used for herding or hunting, with 
dogs less than a year of age used predominantly as guard animals, remaining within the 
village (x21 = 14.4, p<0.001). 
Bite History 
Bite wounds were reported more frequently (i) in guard dogs than in herding/hunting 
dogs ()2, = 6.3, p<0.05), (ii) in older dogs (X22 = 10.9, p<0.01) and (iii) in males ()? = 
4.6, p<0.05). 
Wildlife Interactions 
Wild animals were reported close to households in each area (Table 2.9). Almost all 
dogs (96.0%, n=532) responded to wildlife, with 75.9% either chasing or fighting wild 
animals near the home. 
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Table 2.9. The percentage of householders reporting wildlife species close to the home 
(1992). Where figures are marked with an asterisk, sightings of species were made by 
me within study villages. 
SPECIES SERENGETI 
DISTRICT 
n =189 
NGORONGORO 
DISTRICT 
n= 280 
Jackals 40.2 71.4* 
Hyaenas 56.6* 88.9* 
Leopards 12.2 88.9* 
Wild dogs 0.5 10.4 
Mongooses 82.0* 54.3* 
Baboons 12.7* 35.0* 
Illness 
A recent history of clinical disease (unspecified) was reported more frequently in dogs 
from SD than from ND (X2, = 8.6, p<0.01), in older dogs ()? 2 = 7.1, p<0.05), in dogs 
that had been bitten compared with those not bitten (X2, = 12.2, p<0.001), and in more 
dogs in 1992 than in 1994 (X2i = 11.5, p<0.001). There was no significant effect of sex 
or any interaction terms on the proportion of dogs reported to have been ill. Analyses 
of case-specific mortality is presented in Chapter 5. 
Source of Dog 
These data indicate greater movement of dogs between households in SD compared to 
ND, with 71% dogs (n=379) being acquired from other households in SD and 53.8% 
(n=491) in ND (x2' = 16.2, p<0.001). Data on the fate of pups gave consistent results, 
with 70.1% (n=563) surviving pups being given away in SD and 53.1% (n= 662) in 
ND. 
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Confinement 
Only 4 out of 551 juvenile and adult dogs (0.7%) were confined at all times, and all of 
these were in SD. 431 dogs (78.2%) were entirely unconfined and free-roaming. The 
remainder were partially confined at some times of the day or night. 
DISCUSSION 
It is clear that the dynamics of most vertebrate populations can only be well understood 
after intensive long-term studies. Although limited, this study does provide preliminary 
data on the dynamics of domestic dog populations in two areas of the Serengeti, 
pointing to differences between the populations and enabling some predictions to be 
made about the behaviour of microparasites in each area. 
The limitations of short-term studies are illustrated clearly in ND, where a major 
perturbation of the population was associated with an epidemic of canine distemper in 
1994 (see Chapter 5). The rarity or regularity of such perturbations can only be 
assessed over longer time periods. However, until more longitudinal data are available, 
we assume that demographic parameters derived in the non-epidemic years (1992-3) are 
more representative and use these for comparison with SD. In comparison to ND, the 
SD population showed greater stability across years, and we have greater confidence in 
the interpretation and use of demographic parameters derived from this population. 
Transmission and Persistence 
The fundamental epidemiological principle of `mass action' (see Chapter 1) means that 
transmission of microparasite infections should be greatest in large, densely-packed 
populations. The marked difference in the size and density of the study populations 
indicates that directly-transmitted virus infections are likely to spread most rapidly in 
SD. This effect may be enhanced by higher mixing rates in SD because: (i) most dogs 
in SD roam freely within villages, where contact rates are probably higher than for dogs 
herding with cattle, whereas the converse is true in ND; (ii) movement of pups 
between households is greater in SD than ND. These data suggest that epidemics in SD 
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should occur more explosively than in ND and, in Chapter 5, this prediction is examined 
in the light of empirical data on CDV infection patterns. 
In chapter 1, we outlined also the importance of population size and birth rates for virus 
persistence. The greater number and density of dogs in SD and their higher per capita 
birth rates suggest a greater likelihood of disease persistence in SD. The increase in ND 
per capita birth rates in 1994, which are inconsistent with 1994 fecundity data, 
probably resulted from high juvenile mortality, which led to fewer young (non-breeding) 
dogs in the population. 
Consistent estimates of the intrinsic population growth rate, r, indicate that the SD 
population is growing rapidly, at a rate exceeding that of the human population. This 
has also been found in Zimbabwe, where dog populations have grown at a rate of 4.7% 
per annum (Brooks, 1990) and Kenya, with a growth rate of 9% (Kitala and 
McDermott, 1996). Not only are infections more likely to persist in populations that are 
increasing in size and density, but eliminating disease is more difficult (Anderson and 
May, 1991). Furthermore, the problem of budgetary allocations for rabies control, 
already inadequate to purchase the required vaccine doses in many African countries, 
will be exacerbated by a burgeoning dog population. 
In contrast to SD, consistently negative estimates of r support the view of a declining 
ND population between 1993 and 1994, coincident with an epidemic of canine 
distemper. From 1992-3, however, there are inconsistencies between growth rates 
based on survival and fecundity schedules, which indicated moderate growth, and those 
from population size estimates, suggesting a decline. This may arise from the 
assumption of a constant ratio of people to boma in our estimates of ND population 
size. Over the past 30 years, there has been a trend towards fewer people in each boma 
(Jacobs, 1979) and continuation of this trend from 1991 (the year of the aerial boma 
census) to 1994 could have led to progressively lower estimates of dog abundance. 
However, in a short-term study, it is doubtful whether this effect would be of sufficient 
magnitude to significantly affect results. 
97 
Another problem arises because different ratios were used in calculations of dog 
abundance for SD and ND (dog: person in SD, dog: boma in ND). While SD estimates 
based on dog: household ratios may be more comparable to dog: boma estimates, we 
considered them less accurate because they contain a greater number of assumptions. 
We are confident, however, that the conclusion that ND populations are considerably 
smaller and less dense than those in SD is robust, since calculation of SD population 
sizes using dog: household ratios gave higher estimates of abundance than those using 
dog: person ratios. 
Preliminary data on population size, rates of growth and intrinsic population growth 
therefore lead to the prediction that viral infections, such as rabies and CDV, are more 
likely to persist in SD rather than ND dog populations. This prediction is supported by 
observations of rabies and canine distemper in the Serengeti which are presented in 
Chapters 4 and 5, and has important implications for disease control measures in the 
Serengeti. 
Reliability of Questionnaire Data 
Since this study relies largely upon data obtained from householders, reliability of the 
information obtained from questionnaires is a critical issue. In the majority of 
households (68.8%), the number, age class and sex of dogs were verified by direct 
observation. In these households, owners rarely made mistakes in reporting age class, 
sex or number of dogs. In households where dogs were absent, we relied upon the 
information provided by owners, which could have introduced inaccuracies and biases 
in the data set. Re-visiting households early or late in the day when dogs were more 
likely to be present would have improved the reliability of data, but there was 
insufficient time to re-visit all households at these times. Underestimates of population 
size from questionnaire data could arise if people were afraid to report dogs (for 
example, if they were suspicious about possible dog population control). However, 
there was no indication in either SD or ND that people were trying to hide animals or 
that people were suspicious about our motives. Overestimates of dog abundance could 
result from duplicate reporting, which could occur in partially nomadic Maasai 
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populations if members of the same household were interviewed in separate locations. 
To avoid this, questionnaires in ND were conducted only at permanent bomas. 
The method of sampling bomas in pastoralist areas was not randomized because of the 
practical difficulties involved in carrying out extensive visits by foot in remote areas. 
Therefore boma selection was inevitably biased by accessibility. Greater reliability of 
data on dog population size and structure could be achieved by more representative 
sampling of the entire region and sampling a greater proportion of households in each 
area. 
Possible sources of bias in ND data may have been introduced as a result of differences 
in economic status, since villages in the two wards not visited contained a relatively 
large proportion of poor or destitute families, as defined by livestock units/family 
(NCAA/NPW 1994 census, unpublished data). However, at the village level, there was 
no significant correlation between average household wealth and the average number of 
dogs per boma (r = 0.065, n=7). Ideally, to control for economic status and household 
size, data should have been collected on the number of people in each boma and the 
number of cattle and goats owned. However, Maasai elders were often suspicious 
when asked these questions and, in many cases, were unwilling or unable to answer. 
Although during this study I considered it important to be present at all interviews, 
alternative methods of data collection could be attempted, for example, by training 
local representatives to carry out surveys, as for human censuses. In the future, efforts 
will be made to include collection of domestic dog data during human censuses of ND 
and SD. 
The reliability of data obtained in questionnaire surveys could also have been improved 
through assessment of repeatability to investigate possible sources of interviewer and 
respondent bias. Consistency of responses should have been compared between each of 
the two interviewers in each area and between different members of a household. 
Comparison of interviewer data between areas should also be carried out, taking into 
account the fact that interviewees may respond differently to people from different 
regions and tribes than to those that are well-known to them. 
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Age Distribution 
The significant differences in the ND age distribution between years, with a decline in 
the number of juveniles in 1994, reflects an increased rate of mortality observed in that 
age group. This contrasts with the apparent stability of the SD age distribution between 
years, in line with relatively constant rates of age-specific mortality. Differences in 
mortality between districts were associated with distinct patterns of canine distemper 
virus infection, and will be discussed in more detail in Chapter 5. 
Reliability of data 
An obvious weakness of this study is the reliance upon owners to report the dog's age. 
Consistency of age-reporting between years increases our confidence in this method, 
although it may only mean that owners are consistently reporting the wrong age. The 
study could have been improved by checking the accuracy of owners' responses 
through independent validation of other questionnaire data, such as the ages of children 
in the household. Large sample sizes minimise the effect of ageing errors, hence our 
use of more abundant cross-sectional data to provide comparative estimates of 
survivorship and life expectancy. 
A 
Sex 
A male sex bias is a common feature of many dog populations, for example, in the 
Philippines with 63% males (Beran, 1985), Peru 58%-61% (Chomel et al., 1988) 
Ecuador 61% (Beran and Frith, 1988), Tunisia 65%-77% (Matter, 1989), Kenya 60% 
(Kitala et al., 1993), and Morocco 76% (WHO, 1994b). In this study, a male sex bias 
was evident only in ND populations and appeared only at 4-6 months of age, implying 
differential mortality among neonates. Although individual mortality data are not 
available for this age class, anecdotal reports suggest that males are preferred for 
guarding or herding and unwanted female pups abandoned or killed before three months 
of age. Mortality rates among females in the zero age class are therefore probably 
higher than the averaged value shown in Fig. 2.3b, lowering estimates of r for ND and 
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increasing the required frequency of vaccination in ND for strategies that include pup 
vaccination (Fig. 2.8b). 
Seasonality 
The preliminary indication of a breeding season during the dry months needs 
verification. Owners report only the whelping dates they can recall, so these data are 
inevitably biased by the period of data collection, which was predominantly in the late 
dry season. Seasonal peaks in the incidence of rabies and canine distemper have been 
associated with cycles of breeding and dispersal in several wild animal reservoirs, 
including red foxes (Macdonald and Voigt, 1985; Blancou et al., 1991), jackals 
(Foggin, 1988) and racoons (Bigler et al., 1973). However, in racoons and jackals, 
variation in rates of detection and submission may be confounding results (Jenkins et 
al., 1988; Foggin, 1988). 
Too few cases were reported during this study to investigate seasonality of rabies in 
Serengeti, but throughout Africa, there are consistent reports of an increasing incidence 
of canine rabies between June and November (e. g. Ethiopia - Fekadu, 1982; Zimbabwe 
- Foggin, 1986, Nigeria - Tomori and David-West, 1985; Ghana - Addy 1985; Natal - 
Kloek, 1993). A possible link between dog breeding and rabies incidence in Lima has 
been proposed by Malaga et al., 1979, who showed peaks of canine rabies coinciding 
with months when there was a higher proportion of pups in the populations. Another 
study, however reported no evidence for seasonal breeding in dogs, although this was 
based on pedigree dogs registered by the Malaysian Kennel Association (Wong and 
Lee, 1985), which are likely to differ considerably from free-roaming, unsupervised 
village dogs in Serengeti. 
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Calculation of Ro 
In Chapter 1, we outlined two direct methods for estimating Ro. Since the SD 
population is experiencing net population growth, a modification of Eq. 1.4 is used in 
Chapter 5 for calculating Ro for CDV using the reciprocal per capita birth rate B in 
place of L. 
An assumption of Eq. 1.4 (and most simple epidemiological models) is that mortality is 
independent of age (Anderson and May, 1991). Because neonatal mortality is higher 
than juvenile/adult mortality, these conditions are not strictly met. However, above 3 
months of age, SD dogs showed a good approximation to age-independent mortality, 
whereas the ND population showed age-specific rates of mortality, which furthermore 
varied between years. For these reasons, simple models are more appropriately applied 
to SD than ND populations and in Chapter 4, we describe a compartmental 
mathematical model for dog rabies incorporating demographic data from SD. 
The role of neonates in the transmission of microparasite infections in Serengeti is still 
unknown. Most pups remain confined to the house and have little contact with outside 
dogs, so we suspect they are relatively unimportant in disease transmission. Support for 
this view comes from ND neonatal mortality rates, which, in contrast to juvenile 
mortality, did not increase significantly during the CDV epidemic. A low rate of contact 
between neonates and the rest of the population would violate the assumption of 
homogeneous mixing that underlies simple epidemic theory. Furthermore, pups born to 
CDV seropositive dams will be protected by maternal antibody during the neonatal 
period and will not emerge into the susceptible population until 3 months of age (Appel, 
1987). In Chapter 5, we therefore calculate Ro for CDV, ignoring neonates and 
maternal antibody, and use pup recruitment as a measure of the rate at which 
susceptibles are introduced into the population in Eq. 1.4 (Table 2.7). Applying the 
same logic to Eq. 1.3, we use age-seroprevalence data from adults and juveniles only 
for a second estimate of Ro. 
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Vaccination strategies 
The small proportion of ownerless dogs and their high accessibility in SD points to the 
feasibility of attaining a 70% coverage through parenteral vaccination programmes. 
This is true in many parts of the world and a similar coverage has been obtained 
through point vaccination programmes in Nepal (Bögel and Joshi, 1990; Wandeler et 
al., 1993), Sri Lanka (Wandeler et al., 1993), Peru (Chomel et al., 1988), Philippines 
(Beran, 1985) and by house-to-house programmes in Zambia (de Balogh et al., 1993) 
and Ecuador (Beran and Frith, 1988). 
Despite the high level of dog ownership in ND, accessibility for parenteral vaccination 
was much lower than in SD and dogs could be immunised only through time-consuming 
and costly boma-to-boma visits. There are several reasons for this: (i) rabies is 
reported less regularly in ND than in SD (see Chapter 4), and rabies vaccination 
therefore a lower priority for people in ND, (ii) extensive movements of Maasai with 
their cattle means that herding dogs are often away from the boma, (iii) ND dogs are 
less used to handling and restraint, (iv) bomas are highly dispersed and people have to 
travel further to reach vaccination points. To immunise a large proportion of dogs in 
ND, alternative strategies will probably be needed. Fortunately, high-coverage 
vaccination in ND is probably not required to eliminate rabies and canine distemper 
from the Serengeti, as will be discussed in detail in Chapters 4 and 5. 
In the face of an increasing rabies problem throughout Africa, Perry (1993a, 1995) 
suggests that vaccinating young pups may provide a means of achieving adequate 
population coverage and protecting animals that may be more responsible for 
transmission. However, in both SD and ND populations, the higher mortality rates in 
neonates means that vaccine is more efficiently invested in adults or juveniles that are 
more likely to survive until the next vaccination campaign. Furthermore, we suspect 
that young dogs are less important in rabies transmission in Serengeti than has been 
suggested for high-density, urban populations (for further discussion, see Chapter 4). 
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Vaccination campaigns still tend to be organised on an annual basis, but this theoretical 
analysis shows that in SD, vaccination needs to be repeated every six to eight months to 
maintain p, above the critical threshold required to prevent rabies outbreaks. Using ND 
data for 1992-3, an annual vaccination campaign should be sufficient to maintain herd 
immunity if only adults and juveniles are immunised. It should be noted, however, that 
the p, used in this analysis satisfies stringent criteria that are derived from urban 
populations. In practice, a lower vaccination coverage, and hence lower frequency of 
vaccination, may be adequate for rural dog populations, such as in Serengeti. 
To optimise cost-effectiveness of vaccination, other factors must be taken into 
consideration, such as the relative costs of administering vaccine to different age 
groups. For example, vaccinating a litter of pups is quick and simple and probably 
cheaper than immunising the same number of adults; few juveniles and pups in both 
regions are absent from the village with cattle herds, so accessibility is likely to be 
higher and vaccination cheaper. While we have focused on mass vaccination as a 
strategy for disease control, there remain important questions with regard to the 
sustainability of such programmes in rural Africa, particularly if vaccination is required 
more than once a year. Consideration needs to be given to other approaches, such as 
temporal and spatial targeting of vaccination to contain disease outbreaks, and these 
issues are discussed further in Chapter 6. 
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Chapter 3 
RABIES SEROLOGY IN DOMESTIC DOGS: A COMPARISON OF 
NEUTRALIZATION TESTS AND ENZYME IMMUNOSORBENT 
ASSAYS 
* Authors of paper in preparation: Cleaveland S., Barrat J, Barrat M, I., Shuja J 
and Esterhzrysen J. 
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SUMMARY 
The primary function of rabies serological tests has been to measure post-vaccination 
antibody titres in people and animals. In the UK, neutralization tests are mandatory to 
identify dogs and cats that are correctly vaccinated prior to importation without 
quarantine (under the Balai Directive). Currently, only neutralization tests are 
recognized as reference techniques for measurement of antibody to rabies virus. In this 
study, we compare the performance of a neutralization test (RFFIT) with two ELISAs 
(an indirect ELISA, IE, and a liquid-phase blocking ELISA, BE) for measurement of 
rabies antibody in vaccinated and unvaccinated dogs from a rabies-endemic area in 
Tanzania (Serengeti) and two rabies-free countries (Mauritius and UK). Both ELISAs 
showed low variability and high repeatability. However, non-specific reactivity was 
demonstrated with the IE, indicating that this system was not suitable for the 
measurement or detection of rabies antibody in canine sera. Although the variability 
and repeatability of the RFFIT was similar to that of the BE, RFFIT titres were very 
sensitive to changes in protocol. RFFIT and BE titres correlated well for post- 
vaccination sera, but only weakly for sera from unvaccinated Serengeti dogs. The 
RFFIT and BE both detected rabies antibody in a proportion of healthy, unvaccinated 
Serengeti dogs, but identified different dogs as seropositive. Two lines of evidence 
supported the specificity of the BE and the RFFIT for detecting rabies antibody in 
unvaccinated dogs. First, RFFIT and BE titres of UK and Mauritius dogs were 
significantly lower than in unvaccinated Serengeti dogs, and no UK or Mauritius dog 
exceeded thresholds for seropositivity. Second, seroconversion and seropositivity 
detected by the BE and RFFIT were associated with the bite of rabid dogs. Two further 
analyses, however, pointed to the greater specificity of the BE compared with the 
RFFIT. First, there was a close association between the geographic distribution of 
rabies cases and BE seropositives, but not between rabies cases and RFFIT 
seropositives. Second, BE seropositives showed a more vigorous antibody response to 
rabies vaccination than RFFIT seropositives, suggesting previous exposure of BE, but 
not RFFIT, seropositives to rabies virus antigen. These results suggest that the BE is 
the more suitable test for seroepidemiological studies of domestic dogs. Given the high 
specificity, reproducibility and simplicity of the BE, we suggest that blocking ELISAs 
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could also be developed as reference techniques for the detection of antibody in 
vaccinated dogs in importation control. 
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INTRODUCTION 
World Health Organization (WHO) recommendations suggest that a rabies serum 
neutralizing antibody (SNAb) titre of 0.5 International Units (IU)/ml is indicative of 
successful immunization in people (WHO/IABS, 1978; WHO, 1992b). This threshold 
has now been widely adopted as a minimum acceptable titre for demonstrating the 
vaccination status of domestic dogs and has been incorporated into legislation for rabies 
control. Recent changes to the legislation in several rabies-free countries, such as 
Norway and Sweden (Klingeborn and Krogsrud, 1993) and UK (MAFF, 1994), now 
enable dogs to be imported from EU countries without quarantine. Under the Balai 
Directive, commercially-traded cats and dogs may be imported into Britain without 
quarantine providing that the animals have never left the registered premises on which 
they were born, have had no contact with wild animals, are vaccinated against rabies 
and blood tested to show a minimum antibody level of 0.5 IU/ml (MAFF, 1994). 
Recent recommendations of the Commons Select Committee on Agriculture propose 
that quarantine could be replaced by a similar system of dog identification, vaccination 
and blood testing for any dog from an `approved' EU country (Agriculture Committee, 
1994). 
There are several issues relating to serological testing that arise from the legislation and 
proposals. For example, what is the relationship between an antibody titre of 0.5 IU/ml 
and protection against infection? Can rabies seropositivity occur in unvaccinated dogs 
and, if so, do these dogs present a risk for rabies control? How reliably do rabies 
serological tests measure rabies antibody levels and can they accurately distinguish titres 
above and below a threshold of 0.5 IU/ml? 
To investigate the first of these questions, Aubert (1992) and Nicholson (1990) have 
compiled extensive data from dog vaccination trials and shown that the presence of 
SNAb does indeed correlate well with protection. Mortality was reduced by 96% in 
animals with antibody present at the time of challenge, and a 57.5% survival recorded in 
seronegative dogs which has previously shown detectable antibody. However, there are 
cases where dogs with detectable SNAbs fail to be protected against 
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challenge and examples where those with no SNAb resist infection (Sikes et al., 1971; 
Brown et al., 1973; Barth et al., 1985; Bunn, 1991), presumably because of cellular 
mediated and other non-specific immune mechanisms. Although a titre of 0.5 IU/ml has 
been uniformly protective in some studies (Bunn et al., 1984), titres as high as 1 in 750 
(> 0.5 IU/ml) do not always guarantee protection (Nicholson, 1990). 
The possibility that dogs may acquire rabies antibody as a result of non-fatal exposure 
to rabies virus is raised by results from several studies in rabies-endemic areas, reviewed 
in Chapter 1 (see Table 1.1 c). In this chapter we present results of a three-year cross- 
sectional serological survey of unvaccinated domestic dogs in two areas surrounding 
the Serengeti National Park, and discuss the results of our findings in terms of the 
pathogenesis of atypical rabies and implications for rabies control. 
Uncertainties still remain about the reliability of rabies serological tests, which is the 
third of the questions posed above. There are advantages and disadvantages associated 
with both neutralization tests and ELISA techniques, as reviewed in Chapter 1, but 
currently only neutralization tests (the mouse neutralization test and the rapid 
fluorescent focus inhibition tests, RFFIT) are considered reference techniques by WHO. 
In this chapter we assess the comparative specificity, sensitivity, repeatability and 
variability of three rabies serological techniques (an indirect ELISA (IE), a liquid-phase 
blocking ELISA (BE) and a RFFIT) for the measurement of rabies antibody in canine 
sera. We adopt four main approaches to assess the comparative specificity of the RFFIT 
and BE: (i) a comparison of antibody titres in unvaccinated dogs from Serengeti, where 
rabies occurs, and unvaccinated dogs from UK and Mauritius, which are both rabies- 
free (WHO, 1993a, 1993b, 1994a); (ii) an analysis of geographic associations between 
rabies seropositivity in Serengeti and rabies cases; (iii) a qualitative examination of case 
history correlates of seropositivity; (iv) comparison of antibody responses in putative 
seropositives and seronegatives following rabies vaccination. The variability and 
repeatability of tests are determined for sera from both vaccinated and unvaccinated 
dogs, and sensitivity assessed from measurement of early post-vaccinal responses. In 
this chapter we discuss our findings in terms of serological testing for rabies control. 
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In Chapter 4, we go on to explore the use of serology for rabies seroepidemiological 
studies. 
MATERIALS AND METHODS 
Field Studies 
Study Area 
Domestic dogs were sampled from two areas surrounding the Serengeti National Park 
in north-western Tanzania (35° to 36° E, 1°30' to 3° 7' S), Ngorongoro District (ND), 
which comprises the Loliondo Game Control Area (LGCA) and Ngorongoro 
Conservation Area (NCA), and Serengeti District (SD). ND is a multiple-use area, 
inhabited predominately by the Maasai people who practise traditional pastoralism, with 
limited cultivation. In SD, agropastoralism is the predominant pattern of land-use, with 
more extensive areas of cultivation and higher-density human populations (see Chapter 
2 for further details). Data were collected during three field periods: from September 
1992 to February 1993 (referred to subsequently as 1992), September to December 
1993, August to December 1994. 
Rabies Surveillance and Diagnosis 
Records of reported rabies cases for the three study areas were obtained from 
veterinary offices in Mugumu (SD), Loliondo (LGCA) and Ngorongoro (NCA). From 
1992-1994, rabies cases were confirmed by immunofluorescence diagnostic tests 
(Kaplan & Koprowski, 1973) carried out on brain stem samples collected using WHO 
collection kits (Barrat & Blancou, 1988). Tests were carried out at the WHO 
Collaborating Centre for Zoonoses, Centre National d'Etudes Veterinaires et 
Alimentaires (CNEVA), Nancy, France. 
Questionnaire data 
Details of questionnaire surveys are given in Chapter 2. Questionnaires were conducted 
by systematic house-to-house surveys, sampling one in five households in higher-density 
agropastoralist villages and each accessible household (boma) in lower-density Maasai 
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areas. Questionnaires were designed according to WHO guidelines (1987), to obtain 
information on the dog population size of each area (based on the ratio of dogs: people 
or ratio of dogs: household), age and sex structure of the population, mortality rates and 
causes of mortality, and history of dog illnesses and injuries (specifically bite wounds). 
Collection of Serum Samples 
Dogs were manually restrained and muzzled using a simple tape muzzle while blood 
was collected from the cephalic vein. Blood samples were centrifuged within 24 hours 
of collection, serum was stored at -20° C in kerosene freezers and transported to 
laboratories on dry ice. 
Rabies Vaccination 
During the second field period (September to December 1993), 240 dogs from six 
study villages were vaccinated against rabies, by a single sub-cutaneous injection of I 
ml Rabisin (Rhone-Poulenc, Nairobi), an inactivated vaccine. 91 vaccinated dogs were 
re-bled between 28 and 31 days after vaccination to assess post-vaccinal titres. 62 
vaccinated dogs were also re-bled one year after vaccination. Approximately half the 
vaccinated dogs were given ivermectin (Ivomec; MSD Agvet) at the time of 
vaccination, to provide treatment against ectoparasites and nematodes. 
Vaccination Response Trials 
A preliminary trial was carried out to investigate possible anamnestic responses in 
putative seropositive dogs. In the first group, two dogs with rabies antibody and one 
without (determined by BE) were vaccinated and blood samples collected at 3 and 10 
days after vaccination. A second study included a greater number of putative 
seropositives (10 BE, 14 RFFIT) and seronegatives (15 BE, 7 RFFIT ), but animals 
were re-bled only once, 9 days after vaccination. 
Negative control sera 
Serum samples were collected by Dr. J. Shuja from unvaccinated domestic dogs 
brought to clinics of the Mauritius Society for the Prevention of Cruelty to Animals for 
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neutering or for clinical examinations. Sera from UK dogs were obtained from samples 
stored at the Animal Health Trust, Newmarket (donated by Dr. P. Harris), at the 
Veterinary Investigation Centre, Penrith, Cumbria (donated by Mr. A. Holliman) and 
from the Royal Veterinary College, London (donated by Dr. R. Bishop). 
Serological Tests 
Indirect ELISA (IE) 
The indirect ELISA (IE) protocol was based on the Platelia® system, developed by the 
Institut Pasteur, Paris, for testing human sera. The commercial Platelia® kit was adapted 
for testing red fox (Vulpes ti ilpes ) sera at Centre National d'Etudes Veterinaires et 
Alimentaires (CNEVA), Nancy, France and the modified protocol used in this study 
(Fig. 3.1). For preliminary screening, a single serum dilution of 1/50 was used for test 
sera and the negative reference serum (a pool of sera collected from 20 naive laboratory 
dogs). Serial dilutions of the positive reference serum were prepared from 1/50 to 
1/6400. Serum samples were diluted in a solution of 5% skimmed milk powder in PBS 
to block non-specific binding. The positive control serum was a reference serum with a 
titre of 4.69 IU/ml, determined by the standard mouse inoculation serum neutralization 
tests (Atanasiu, 1973). 
Plateliä rabies microtitre plates (Pasteur Diagnostics) sensitized with purified 
glycoprotein antigen were used (Fig. 3.1: step 1). 100 µWwell of dilutions of test 
serum, negative control and positive control sera was added. Each sample was tested in 
duplicate. The plate was incubated at 37°C for 1 hour, serum samples removed and the 
plates washed twice (4 minutes each) with 0.05% Tween (Bio Rad) in 9g/l NaCl (step 
2). 
The peroxidase-conjugated anti-canine IgG (Bio-Sys H+L, B12404) was diluted I in 
4000 by adding 3 µd conjugate to 12 ml skimmed milk diluting solution. 100 tl 
conjugate was added to each well and the plate incubated for 1 hour at 37°C (step 3). 
The wells were emptied and washed as before. Substrate-chromogen solution was 
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Figure 3.1. (a) Schematic representation of indirect ELSA protocol used for 
measurement of rabies antibody in canine sera. (b) Protocol used in non-specific 
binding trial. 
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prepared by adding 10 mg orthophenylenediamine (OPD) to 10 ml citrate buffer, 
comprising citric acid 17.82g/l and Na2HPO4 41g/l, pH 5.6. Immediately prior to use, 8 
µl 3% H202 was added to the solution. 100 µl of substrate-chromogen solution was 
added to each well, the plates incubated in the dark for 30 minutes at room temperature 
and the reaction stopped by adding 50 pl/well 4M H2SO4. Colour development was 
first screened at 690 nm then measured at 490 nm using a microplate reader 
(Labsystems Multiskan MCC/340). 
A specific optical density (OD) value was calculated for each serum sample and positive 
control serum by subtracting the negative control OD from the mean OD of the 
duplicate wells. Titre values for the test sera were determined by comparison of mean 
OD with the OD reference curve of the positive control serum. 
The reference threshold for the test was 0.5 equivalence units (EU)/ml, according to 
Platelia® specifications. This level is considered equivalent to the 0.5 IU/ml international 
standard threshold determined by serum neutralization tests. 
A Non-Specific Binding Trial 
A trial was set up to investigate non-specific binding using the indirect ELISA 
technique. 2% bovine serum albumen (BSA; Sigma A4503) and 5% skim milk (Difco) 
in PBS were used to saturate uncoated 96-well microplates (Nunc, Maxisorp F 16). 
Plates were washed twice with PBS and 300 µl of the saturation solution added to each 
well. Plates were covered and incubated for 2 hours at 37°C, then stored overnight at 
4°C. 
The indirect ELISA protocol was carried out as described above, replacing Platelia® 
coated plates with saturated Nunc plates. Ten sera were tested; five 'seropositive' (SP I- 
5) and two 'seronegative' dog sera (SN 1,2) from Serengeti, one 'seropositive' UK dog 
and positive and negative control dog sera (RS+ and RS-) used previously. Two rows 
of control wells were included on each plate, containing 100 tl of washing solution in 
the place of test sera. 
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Liquid Phase Blocking ELISA (BE) 
The liquid phase blocking ELISA (BE) for measurement of rabies antibody was carried 
out at the Foot-and-Mouth Disease (FMD) Laboratory, Onderstepoort, South Africa 
adapting a technique used for measurement of antibodies to FMD virus developed by 
McCullough et al. (1985) and Hamblin et al. (1986). 
In this technique, which has been described in detail by Esterhuysen et at (1995), 
mixtures of antigen and antibody are transferred to microplate wells coated with 
trapping antibody, after which a conventional sandwich ELISA is performed. Specific 
antibodies in the test sera effectively "block" the antigen and prevent it from reacting in 
the sandwich ELISA (Fig. 3.2). 
The antigen used in this test was an inactivated CVS strain of rabies virus, propagated 
in rolled cultures of BHK 21 cells. The trapping antibody used to coat microtitre plates 
was produced by inoculation of adult rabbits with 1.0 ml (106.8 mouse LDso/ml) Flury 
HEP vaccine. Rabbits were boosted at 28 days with subcutaneous injection of 150 µg 
rabies nucleoprotein (N), expressed by a baculovirus vector and purified according to 
Prehaud et al. (1990). After a further 14 days, rabbits were bled out, serum separated 
and stored at -20° C. Flat-bottomed plates (Nunc, Immunoplate) were coated for 2 hrs 
at 37° C with dilutions of rabbit antisera in carbonate/bicarbonate buffer pH 9.6 (step 
1). Plates were washed with PBS containing 0.05% Tween 20, which was the washing 
buffer used throughout the test. Coated plates were stored for up to one year at -20° C. 
50 pl of dilutions of test sera were mixed with 50 µl of positive antigen and negative 
antigen (cell culture fluids from uninfected BHK cells) in wells of an uncoated 
microplate (step 2) and incubated at 4°C overnight. 50 pi of these mixtures was then 
transferred to a microplate coated with trapping antiserum (step 3). 50 µl guinea-pig 
antiserum at a pre-titrated optimal dilution (1/1000) was dispensed into all wells, plates 
incubated for Ih at 37°C, and then washed (step 4). Guinea pig antiserum was 
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Figure 3.2. Schematic representation of liquid-phase blocking ELSA 
protocol for measurement of rabies antibody in canine sera. 
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collected from guinea pigs inoculated with 1.0 ml Flury HEP and boosted with 150 µg 
purified N protein, using the same schedule as given above. 50 µl of a 1/5000 dilution 
of commercial conjugate (sheep anti-guinea pig IgG peroxidase conjugate; Boehringer 
Mannheim) was dispensed into each well, the plates incubated for 1h at 37°C and then 
washed (step 5). o-phenylenediamine in sodium phosphate/citric acid buffer, pH 5.0, 
was added to all the wells, the reaction was allowed to develop in the dark for 15 
minutes and stopped by the addition of 1.25M H2SO4. The degree of colour 
development was recorded using a Titertek multiscan at 492 nm. 
The serum titre was calculated as the dilution showing 50% inhibition of the maximum 
OD (the average OD of 8 positive control wells minus the average OD of 4 negative 
control wells). Titres were calculated using the Spearman-Kärber method (Lorenz and 
Bagel, 1973). Titres were expressed as the logarithm1o of the reciprocal 50% dilution 
(referred to hereafter as log dilution). Sera were initially screened at dilutions from 1/16 
to 1/128. Any serum showing a titre > 1: 16 (log dilution 1.2) was re-titrated at least 
once using dilutions from 1/16 to 1/1024 and the geometric mean titre used in 
subsequent analyses. 
Neutralization Tests 
The principle of this test is the neutralization in vitro of a constant amount of rabies 
virus followed by infection of susceptible cells, and measurement of infectivity of cells 
by non-neutralized virus. In both protocols used here, the presence of non-neutralized 
virus is detected by fluorescent antibody staining of infected cells and the tests are 
referred to as rapid fluorescent focus inhibition tests (RFFIT). 
Protocol 1: Labtek method 
Serengeti dog sera collected during the first study period were analysed at CNEVA, 
Nancy, using the RFFIT protocol described by Smith et at. (1973). Variations to the 
technique of Smith et al. included a 48-hour, rather than 24-hour incubation of cells 
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with the serum/virus mixture and magnification of 100x rather than 160x for counting 
fluorescent foci in each microscope field. 
Protocol 2: Modification using microtitre plates 
A modification of the Labtek RFFIT technique, was developed at the Institut Pasteur, 
Paris, to use microtitre plates instead of Labtek chambers, based on the techniques of 
Zalan et al. (1979) and Perrin et al. (1985). This technique was adopted by CNEVA for 
all dog sera tested after 1992, to facilitate throughput of large numbers of samples. This 
protocol was therefore used for testing Serengeti sera collected during 1993 and 1994 
and dog sera from Mauritius. Because this modification is not a RFFIT in the strictest 
sense, as described by Smith et al. (1973), some authors prefer the term fluorescence 
inhibition microneutralization test (FIMT). However, for simplicity, we refer to both 
neutralization tests as RFFIT. 
Serum samples were heat inactivated at 56°C for 30 minutes. DMEM medium, 
containing 4.5g glucose/litre (Gibco) with 10% Australian foetal calf serum (Gibco) 
was distributed into each well of a 96-well microtitre plate (Falcon). WHO human 
reference immunoglobulin (30 IU per ampoule, Copenhagen, reconstituted with 5 ml 
distilled water), negative dog sera and test sera were distributed in the first well of each 
of two rows. Three-fold serial dilutions were performed by transferring 50µI into 
successive wells using multichannel pipettes. 50 µl was discarded from the last well. 
Challenge virus (CVS-11, ATCC VR 959) was stored in I ml aliquots at -80°C, thawed 
rapidly and diluted to give a working titre of 100,000 TCID50 /, 50 µl of the CVS 
dilution was added to wells containing control and test sera. The microtitre plates were 
incubated in a humidified incubator with 5% CO2 at 37 °C for 1 hour. A suspension of 
BHK 21 cells (ATCC, CCL-10) was prepared containing 4x 105 cells/ml. 50 µl of cell 
suspension was added to each well and plates incubated at 37 °C for 24 hours. After 24 
hours, the medium was discarded and plates rinsed in PBS (pH = 7.2), then once in 
80% acetone. Plates were fixed in 80% acetone for 30 minutes at room temperature 
without a lid, then dried at room temperature for at least 1 hour. 
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Figure 3.3. The relationship between RFFIT titre in IU/ml and log dilution 
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Fluorescein isothiocyanate anti-nucleocapsid conjugate (Sanofi Pasteur - 72112) was 
reconstituted with 3 ml distilled water then diluted 1: 2 with PBS, just before use. 
Unused conjugate was discarded. 50 t1 of this solution was added to each well and 
plates incubated at 37 °C for 30 minutes. Conjugate was discarded and plates washed 
twice in PBS. The percentage fluorescence over the entire surface of the well was 
determined by visual inspection. The dilution where 50% of fluorescence was inhibited 
(D50) was calculated for control and test sera according the Spearman-Karber method 
(Lorenz and Bögel, 1973). The antibody titre in IU/ml was determined by comparison 
with the WHO standard immunoglobulin. Titres were also expressed as loglo of the 
reciprocal D50 (referred to as log dilution) for comparison with BE titres. The 
relationship between RFFIT titres expressed as IU/ml and as log dilution are shown in 
Fig. 3.3. 
Data Analysis 
Frequency distributions were determined for indirect ELISA (EU/ml), BE and RFFIT 
titres (expressed as log dilution). Indirect ELISA data were analysed using a Poisson 
distribution and parameters of the regression model estimated by maximum likelihood 
using GENSTAT 5.3 (Payne et al., 1993). The residuals were plotted against fitted 
values to check for normality. RFFIT and BE data were grouped into categories 
because of the small number of sera with higher titres. Data were combined in four 
categories in contingency tables and analysed using a x2 test. 
Variability of tests was expressed as the coefficient of variation of multiple repeats of 
the same sera. Repeatability was measured as the mean pair agreement index, Po, as 
shown over, 
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Specificity of tests was investigated through geographic and case history associations 
of seropositivity. Associations between seropositivity and location of rabies cases were 
investigated by calculating odds ratios (OR) expressed with 95% confidence limits 
using EPI-INFO 5.0 (Dean et al., 1990). 
Antibody titres in vaccinated dogs showed an approximately normal distribution and 
were analysed by regression analysis in GENSTAT 5.3. The maximal model included 
age, sex, ivermectin treatment and their interaction terms. The significance of each 
variable was determined by step-wise deletion, as described in Chapter 2, using F- tests 
to measure the change in deviance between successive models (Crawley, 1994). For 
the vaccination response trial, the response variable was taken as loglo of the difference 
between the pre-vaccination and 9-day post-vaccination dilution, which showed an 
approximately normal distribution. 
Risk Assessment in Rabies Control 
The role of serological testing in rabies control is to identify dogs that carry a risk of 
developing rabies on entering the UK (i. e. animals that have not been protected against 
infection after vaccination, and which may be infected and incubating rabies). If we consider 
classic rabies infection, we assume that (i) all dogs with antibody titres > 0.5 IU/ml are 
immune after vaccination (based on 100% survival of 288 dogs with a RFFIT titre > 0.1 
IU/ml; Aubert, 1992) and (ii) dogs incubating rabies do not develop antibodies until, or 
after, clinical signs appear (King and Turner, 1993). We consider in this analysis, that 
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seropositive, healthy dogs should therefore be safe to import, with the caveat that some 
animals vaccinated during the incubation period may become seropositive but still develop 
rabies (Blancou el at., 1989). For seronegative dogs, there is a quantifiable risk that the 
animal may be infected after vaccination and will introduce rabies into the UK. For this to 
occur, (i) the dog must be susceptible to infection despite vaccination (vaccine failure), (ii) 
the susceptible dog must be exposed to rabies virus and (iii) the infected dog must develop 
rabies and become infectious within the UK. We calculate this cumulative probability from 
the incidence of rabies in vaccinated dogs multiplied by the mean incubation period. 
We also consider the risk of introducing rabies in unvaccinated dogs (i. e. those that have 
been fraudulently certified, incorrectly vaccinated or misidentified). The risk associated with 
these dogs is given by the incidence of rabies in unvaccinated dogs multiplied by the mean 
incubation period. 
Here, we use incidence data in France and Africa (Serengeti and Nigeria) to compare the 
risk of rabies entering Britain, with and without the safeguard of serological testing. Further, 
we use comparative measures of test specificity (Table 3.5b) to assess risks when using 
RFFIT and BE tests to detect animals that may be incubating rabies. 
RESULTS 
Sample Sizes 
The number of serum samples tested in each laboratory with each of the three rabies 
serological tests is shown in Table 3.1 a. The number of sera samples analysed using 
neutralization tests and BE protocols is shown in Table 3. lb, by year and area. 
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Table 3.1a. The number of serum samples tested in each laboratory with each of the 
three rabies serological tests. 
Origin of samples Indirect ELISA 
(CNEVA, Nancy) 
RFFIT 
(CNEVA, Nancy) 
BE 
(Onderstepoort) 
Serengeti, 1992 400 368a 372 
Serengeti, 1993 - 134 235 
Serengeti, 1994 - 104 293 
UK 
(Animal Health Trust) 94 - - 
UK 
(RVC, VIC, Penrith - - 96 
Mauritius - 52 99 
a. Samples analysed using the Labtek protocol. 
b. Samples analysed using the microplate protocol. 
Table 3.1b. The number of serum samples from unvaccinated Serengeti domestic dogs 
analysed with the liquid-phase blocking ELISA (BE) and RFFIT protocols in 1992, 
1993 and 1994 
LGCA NCA SD TOTAL 
BE RFFIT BE RFFIT BE RFFIT BE RFFIT 
1992 121 111 115 105 136 152 372 368 
1993 72 27 40 20 123 87 235 134 
1994 50 28 79 0 164 76 293 104 
TOTAL 243 166 234 125 423 315 900 606 
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Indirect ELISA (IE) 
Frequency distribution. The frequency distribution of titres for Serengeti and UK dogs 
is shown in Fig 3.4. Serengeti titres were significantly higher than UK titres (x21 = 8.1, 
p<0.01). 21 unvaccinated UK dogs had titres above the reference threshold for the test 
(0.5 EU/ml) identifying a problem of non-specificity in the system. 
Variability and Repeatability. Results of the IE were highly reproducible, with a 
coefficient of variation (CV) of 3.5% for 40 replicates of a single serum tested on 20 
plates. There was a good correlation between titres of sera tested twice on the same 
plate (r = 0.95, p<0.001, n= 24) and those tested on different days and different plates 
(r = 0.91, p<0.001, n= 38). The repeatability of the IE was high, with Po = 0.921 for 
sera tested on different plates (Table 3.2a). 
Results of the non-specific binding trial are shown in Fig. 3.5. The OD in control wells 
was low for both saturation solutions (OD = 0.011 ± 0.003 for BSA and OD = 0.010 + 
0.002 for skim milk), whereas coloured reactions were observed in wells containing dog 
sera from UK and from Serengeti. This indicated non-specific binding of one, or 
several, components of dog sera to the uncoated plastic plates. Given this problem, 
subsequent serological analyses focused on results obtained from the liquid phase 
blocking ELISA (BE) and neutralization tests (RFFIT). 
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Table 3.2a. Results of samples repeat-tested on IE (titre range 0-3.7 EU/ml). Samples 
considered positive when titre is > 0.5 EU/ml. Po=0.921. 
Sam le 1 
+- 
Sample 2+ 27 0 
-38 
Table 3.2b. Results of samples repeat-tested on BE (titre range log dilution 1.1- 2.7). 
Samples considered positive when titre is > log dilution 1.5. Po = 0.900. 
Sam le I 
+- 
Sample 2+ 40 7 
-5 66 
Table 3.2c. Results of samples repeat-tested using Labtek and microplate technique 
(titre range 0.1 - 2.4 IU/ml). Samples considered positive when titre is > 0.5 IU/ml 
Po = 0.267. 
Labtek 
+- 
Microplate +2 15 
-13 
Table 3.2d. Results of samples repeat-tested using microplate technique (titre range 0.1 
- 4.4 IU/ml). Samples considered positive when titre is > 0.5 IU/ml. Po = 0.867. 
Sam le I 
+- 
Sample 2+ 10 0 
-27 
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Figure 3.4. Frequency distribution of indirect ELISA (IE) titres for 
unvaccinated domestic dog sera from UK and Serengeti. 
0.3 
0.25 
ti 
0.2 
O 
0.15 
0.1 
0.05 
0 
Titre (EU/mi) 
126 
ON It (D co .-N st CO CN ÖÖÖO- 
V-: r .-A 
Figure 3. S. Results of a non-specific binding trial showing optical density 
measurements obtained when the indirect ELISA protocol was performed on 
unvaccinated domestic dog sera from Serengeti, UK and France using uncoated 96- 
well microplates saturated with 2% bovine serum albumen (BSA) or 5% skim milk. 
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Liquid-Phase Blocking ELISA (BE) 
Frequency Distributions 
The frequency distributions of BE values are shown for unvaccinated Serengeti, 
Mauritius (n = 99) and UK dogs (n = 96) in Fig. 3.6. The number of Serengeti samples 
analysed in each year and region is shown in Table 3.1. Using grouped data 
corresponding to Figs. 3.6, there was no significant difference between UK and 
Mauritius distributions (X2 3=4.8, p>0.05). The distribution of negative control dogs 
was significantly different from the distribution of Serengeti dogs (x23= 33.4, p<0.001). 
There was no clear demarcation between a possible seropositive and seronegative 
population in the Serengeti distribution. Tentative cut-off points were therefore 
determined from the mean +2 or 3 standard deviations of negative control dog titres, 
which were log dilution 1.3 and 1.5 respectively. Crude seroprevalences in 
unvaccinated dogs were respectively 7.5% and 2.0% in 1992,9.4% and 4.7% in 1993 
and 10.2% and 5.3% in 1994. 
Variability and Repeatability 
The CV for sera tested on the same plate was 3.0% (n = 10). The CV of titres tested 
on different plates on the same day was 7.3% (n = 14) and the CV of 13 sera tested on 
at least four occasions was between 1.7% and 7.5%. Using a threshold of log dilution 
1.5, the repeatability of the BE, Po, was 0.90 (n = 118) (Table 3.2b). 
Neutralization Tests (RFFI7) 
Frequency Distributions 
The frequency distributions of RFFIT titres from unvaccinated Mauritius dogs (n = 52) 
and Serengeti dogs is shown in Fig. 3.7. The number of Serengeti samples analysed for 
each year and region is shown in Table 3.1. Using grouped data corresponding to Fig. 
3.7, there was no significant difference between Serengeti titres in 1993 and 1994, 
which were measured using the microplate protocol (x23 = 3.7, p >0.05). 
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Figure 3.6. Frequency distribution of liquid-phase blocking ELISA titres for 
unvaccinated dog sera from Mauritius, UK and Serengeti. 
1 
0.9 
0.8 
0.7 
0.6 
0 
0.5 Low 
0.4 
0.3 
0.2 
0.1 
0 
M Mai rtius 
 UK 
Q Serengeti- 1992 
p Serengeti 1993 
0 Serengeti-1994 
129 
<1.2 1.2-1.3 1.4-1.5 1.6-2.8 
BE titre (log dilution) 
Figure 3.7. Frequency distribution of RFFIT titres for unvaccinated dog sera from 
Mauritius and Serengeti. The Labtek techniuqe was used to measure Serengeti sera in 
1992, the microplate technique used to measure Mauritius and Serengeti sera in 1993 
and 1994. 
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However 1993 and 1994 Serengeti titres were significantly different from 1992 titres, 
which were measured using the Labtek protocol (X2 3= 197.3, p<0.001). The 
distribution of Serengeti titres was significantly different from Mauritius titres in 1992 
(X2 3= 27.1, p<0.001) and in 1993/4 (X23 = 172.4, p<0.001). All but one of the 52 
Mauritius sera (tested with microplate protocol) showed titres less than log dilution 1.2. 
With this distribution, a mean +2 or 3 S. D. was not appropriate for defining a cut-off point. 
Therefore, a tentative threshold of log dilution 1.5 was chosen as a cut-off point on the basis 
of the highest Mauritius titre recorded (1.43 log dilution). This cut-off was equivalent to the 
international threshold of 0.5 IU/ml. A higher arbritary threshold of log dilution 1.9 
(approximately equivalent to 1.1 IU/ml) was also adopted in subsequent analyses, assuming 
that this level would more safely exclude false positives. Using these cut-off points, crude 
REFIT seroprevalences were then 7.6% and 0.5% in 1992,49.3% and 11.2% in 1993, and 
50% and 9.6% in 1994. As with BE results, RFFIT seroprevalences were lowest in 1992. 
Variability and Repeatability 
For the microplate method, the CV for a WHO reference immunoglobulin diluted to 0.5 
IU/ml was 14.7% (n = 18). Repeatability was low when samples were compared 
between microplate and Labtek protocols (Po = 0.267) (Table 3.2c). More consistent 
results were obtained when comparing results obtained by the microplate method only 
(Po = 0.867) (Table 3.2d). For all but one sample, titres were higher when using the 
Labtek method. There was a close correlation between titres that were repeat tested 
using the microplate technique (r = 0.90, p<0.001, n= 19). There was a significant 
correlation between titres obtained with the Labtek and microplate protocols (r = 0.57, 
p<0.01, n= 21), but it only explained 30% of the total variance. 
Comparative Assessment of Specificity 
Since non-specific reactivity was identified as a significant problem in the IE system, 
comparative analyses of specificity were carried out only for the BE and RFFIT. 
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(a) vaccination Response Trials 
The BE demonstrated an augmented antibody response in the two dogs that were BE 
seropositive (dogs L25/26, L13/1) compared with a BE seronegative dog (L25/25) (Fig 
3.8a). Results were less clear-cut with the RFFIT, in which dog L25/25 had a 
detectable RFFIT titre at the time of vaccination, but showed no marked response to 
vaccination (Fig. 3.8b). 
For the more extensive trial, higher RFFIT and BE antibody titres were obtained 9 days after 
vaccination from BE seropositives than from BE seronegatives (Table 3.3). There was no 
significant difference in post-vaccination titres between RFFIT seropositives and RFFIT 
seronegatives measured by either test. This analysis was carried out only for seropositives 
defined by the lower threshold, since there were too few BE and RFFIT seropositives at the 
higher cut-off points to test for significance. 
Table 3.3. Results of vaccination response trials, showing the geometric mean antibody 
response to vaccination in putative seropositive and seronegative dogs, as measured by BE 
and RFFIT analyses. 
Geometric mean antibody response 9 days after vaccination 
BE positives BE negatives RFFIT positives RFFIT negatives 
(> log dilution (< log dilution (> log dilution (< log dilution 
1.3) 1.3) 1.5) 1.5) 
2.129 1.198 1.459 1.796 
BE (t = 3.58, df. =23, (t = 0.95, d. f. = 22, 
<0.01) p >0.05 
2.530 1.665 1.906 2.299 
RFFIT (t = 3.09, df. =19, (t = 1.12, df. = 19, 
p<0.05) p>0.05) 
(b) Geographic Associations between Rabies cases and Seropositives. 
The association between the location of seropositives and the location of confirmed and 
reported cases is shown in Table 3.4a. There was a significant overall association 
between BE seropositives and reported/confirmed cases, which was consistent for each 
of the three years of the study. Using the BE, a higher cut-off point produced 
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Figure 3.8. Vaccine response trial in putative seropositive and seronegative Serengeti 
dogs. Antibody responses were measured 3 and 10 days after vaccination (f). 
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more significant odds ratios, despite fewer seropositives. In contrast, RFFIT results 
showed a negative association between the location of rabies cases and seropositives at 
the lower threshold and no association at the higher threshold. No significant positive 
associations were obtained for RFFIT results for any year of the study. 
Table 3.4a. Associations between locations of confirmed and reported rabies cases and 
BE/RFFIT seropositive dogs, expressed as odds ratios (OR) with 95% confidence 
intervals (CI). 
Criteria for 
seropositivity 
Villages wehere 
rabies reported 
OR 
95% CI 
f p Villages where 
rabies confirmed 
OR 
(95% CI 
p n 
BE >1.3 3.65 31.9 p<0.001 3.49 22.0 p<0.001 900 
(2.21-6.04) (1.93-6.28) 
BE>1.5 5.02 25.4 p<0.001 3.96 18.0 p<0.001 900 
(2.41-10.66) (1.88-8.24) 
RFFIT> 1.5 0.62 5.59 p<0.05 0.43 5.0 p<0.05 606 
(0.4-0.94) (0.18-0.96) 
RFFIT> 1.9 1.07 0.03 p>0.05 1.02 0 p>0.05 606 
(0.45-2.5) (0.24-3.75) 
In this study, we use the proportion of seropositives detected in villages with no recent 
history of rabies as a comparative measure of BE and RFFIT specificity. As expected, 
specificity increased at the higher cut-off points. The BE identified fewer `false 
positives' and thus appeared to have a higher specificity than the RFFIT when 
compared at the lower and higher cut-off points (Table 3.4b). 
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Table3.4b. Percentage of seropositives detected by BE and RFFIT from villages with 
confirmed cases of rabies and with no recent history of rabies (`false positives'). 
No. dogs with 
titres 
>BE 1.3 
No. dogs with 
titres 
>BE 1.5 
No. dogs with 
titres 
> RFFIT 1.5 
No. dogs with titres 
>RFFIT 1.9 
All villages where 25/86 (29.1%) 13/86 (15.1%) 8/66 (12.1%) 3/66 (4.5%) 
rabies confirmed 
Villages were rabies 64/521 (12.2%) 11/521 (2.1%) 103/390 (26.4%) 16/390 (4.1%) 
neither confirmed 
nor reported 
(c) Case history data 
Bartanga Village, Serengeti District 
Consistent results were obtained from BE and RFFIT analyses of sera collected from a 
group of 5 dogs bitten by a suspect rabid dog in Burunga village in November 1993. Dogs 
were sampled two to four weeks after having been bitten. At 14 days all dogs were negative 
on both BE and RFFIT. Between 14 and 25 days, one dog died acutely, three remained 
seronegative and healthy, and one dog had seroconverted ("Fatums"; Fig. 3.9a). This animal 
was re-sampled 102 days later, at which time it was still healthy but antibody titres had 
waned. 
Kemgesi Village, Serengeti District 
12 dogs were bitten by a suspect rabid dog in February 1993. Four of 12 dogs were 
seropositive on BE (log titres 1.6-1.8). One bitten BE seropositive and one seronegative 
were seropositive on RFFIT (log titres 1.7-1.8). One of the BE seropositives ("Jeki") 
remained alive and healthy for at least two years, and serum samples collected over a 22- 
month period showed an increasing, then waning titre, on both BE and RFFIT (Fig. 3.9b). 
The suspect dog in Kemgesi was almost certainly rabid as one of the 12 dogs bitten later 
died of confirmed rabies and three died of suspect rabies; all animals were seronegative on 
BE and RFFIT when sampled in February 1993. 
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Figure 3.9. Repeat. samples collected from two unvaccinated domestic dogs from 
Serengeti District, measured by BE and RFFIT (using microplate technique) 
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Comparative Assessment of Sensitivity 
Early post-vaccination titres in 20 dogs were used as a measure of test sensitivity and 
indicated that, at both cut-off points, antibody responses were detected in a greater 
number of vaccinated dogs by RFFIT than by the BE. 
Table 3.5. Detection of rabies antibody by BE and RFFIT in dogs vaccinated 9 days 
previously 
RFFIT >1.5 
BE>1.3 + - 
+ 16 0 
- 3 1 
RFFIT >1.9 
BE>1.5 + - 
+ 13 0 
- 2 5 
Correlation between BE and RFFIT titres 
(a) Unvaccinated dogs 
There was only a weak correlation between BE and RFFIT results obtained from sera 
of unvaccinated dogs: a) 1992, r=0.17, n= 340, p<0.05 (Fig. 3.1Oa); b) 1993, r= 
0.26, n= 126, p<0.01 (Fig. 3.10b); c) 1994, r=0.12, n= 95, p>0.05 (Fig. 3.10c). 
(b) Vaccinated dogs 
There was a closer correlation between BE and RFFIT results from post-vaccination 
sera of dogs collected 9 days (r = 0.91, n= 20, p<0.001) (Fig. 3.1 la), one month (r = 
0.79, n= 103, p<0.001) (Fig. 3.1 lb) and one year after vaccination (r = 0.69, n= 24, 
p<0.001) (Fig 3.11 c). 
There was no significant effect of sex (F1,97 = 3.76, p>0.05), age (F,, 86 = 1.63, p>0.05) 
or ivermectin treatment (F1,85 = 1.19, p>0.05) on post-vaccination BE titres. 
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Figure 3.10. Correlation between titres obtained for unvaccinated Serengeti dog sera 
tested on BE and RFFIT. 1992 samples were analysed using the Labtek RIFIT 
protocol, 1993 and 1994 samples analysed using the microplate RFFIT protocol. The 
BE protocol was the same for all sera. 
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Figure 3.11. Correlation between titres obtained for vaccinated Serengeti dog sera 
tested on BE and RFFIT (measured using microplate technique) at 9 days, one month 
and one year after vaccination. 
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For the RFFIT also, there were no significant effects of age (F,, 74 = 0.03, p>0.05), sex 
(F175 = 0.87, p>0.05), or ivermectin treatment (F1,76 = 0.87, p>0.05) on post- 
vaccination titres. 
Risk Assessment in Rabies Control 
For this analysis, specificity of the RFFIT was determined from the lower threshold shown in 
Table 3.4b, as this was equivalent to the current international standard of 0.5 IU/ml. The 
lower BE threshold was used for comparison. In Table 3.6, the theoretical risks of 
importing a dog that is incubating rabies are shown for dogs from France and those from 
Tanzania, with and without the safeguard of serological testing. 
DISCUSSION 
Indirect ELISA (IE) 
Although indirect ELISA systems using Platelia® plates have been used successfully for 
measuring rabies antibody in human and fox sera, this study demonstrates a problem of 
non-specific reactivity with domestic dog sera and indicates that the protocol used here 
is inappropriate for measurement or detection of rabies antibody in canine sera. This 
problem has also been detected in other laboratories, with non-specificity of the 
Platelia® system observed in sera from dogs but not humans (J. Esterhuysen, 
pers. comm. ). 
The nature of this species-specific reactivity is still unclear. Studies carried out at 
CNEVA, Nancy demonstrated that positive reactions were caused by non-specific 
binding of large molecular weight factors (>200,000) recognised by anti-dog IgG 
(Aime, 1994). Aime suggested that these factors were aggregations of Fc fragments, 
formed during thawing of frozen serum. Dog serum contains a higher concentration of 
immunoglobulins than human serum (Schalm et a1., 1975) and this may contribute to 
the formation of such aggregations. Indeed, the most reactive UK sera in this study 
were those from clinically sick dogs that had elevated globulin levels. High globulin 
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Table 3.6. The estimated theoretical risks of introducing rabies through importation 
of a dog from France or Tanzania, with and without serological testing to detect 
seronegative dogs that may be incubating rabies. Probabilities are determined from 
the incidence of rabies in vaccinated and unvaccinated dog populations multiplied by 
the mean incubation period for dog rabies, in each case taken to be 4.18 weeks 
(Foggin, 1988). 
a. Probability of introducing rabies in dogs imported from France. 
Vaccinated dogs Unvaccinated dogs 
(false certificates/misidentification) 
Probability' Frequency of introduction of Probability= Frequency of introduction 
rabies if 4.000 dogs imported of rabies if 1,000 dogs 
annually imported annually 
No blood test 1.15 x 104 Once every 22,000 4.87 x 10; Once every 21.000 
years years 
With blood 
=tin 
BE 
(12.2% false 1.40 x 10'9 Once every 178,000 5.94 x 10'9 Once every 168,000 
positives) years years 
RFRT 
(26.4% false 3.04 x 10A Once every 82,000 1.29 x 10' Once every 78,000 
positives) years ears 
1. Incidence of rabies in vaccinated dogs in France (1970-1990) =I/(6.98 x 106) per year 
(Aubert, 1992). 
2. Incidence of rabies in unvaccinated dogs in France estimated from (i) 4 cases in France in 1993 
(WHO, 1993c) and (ii) unvaccinated dog population estimated as 6.6 million, from total population 
(9.8 million) less number of vaccine doses used in dogs. This is estimated as 75% of the total number 
of doses sold for use in domestic carnivores (Aubert, 1992). 
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b. Probability of introducing rabies in dogs imported from Tanzania 
Vaccinated dogs Unvaccinated dogs 
(false certificates/misidentification) 
Probability' Frequency of introduction of Probability2 Frequency of introduction 
rabies if 1,000 dogs imported of rabies if 100 dogs 
annually im orted annually 
No blood test 1.29 x 10' Once every 8 3.77 x 10' Once every 27 
years years 
With blood 
estin 
BE 
(12.2% false 1.57 x 10's Once every 64 4.60 x 10'5 Once every 217 
positives) years years 
RFFIT 
(26.4% false 3.41 x 10's Once every 29 1.00 x 10.4 Once every 100 
positives) years years 
1. Based on 4 cases of vaccine failure in 2,500 vaccinated dogs in Nigeria, using Flury LEP 
(Aghomo and Rupprecht. 1990). 
2. Based on one rabies case in a cohort of 213 study dogs in Serengeti in this study. 
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levels in heavily-parasitized human patients have also caused problems for ELISA 
diagnosis of tropical diseases (Venkatesan and Wakelin, 1993) and may have 
contributed to the non-specific reactivity of Serengeti dog sera in this assay. It was to 
address this question that Mauritius dog sera were included in the study as a more 
appropriate negative control population than UK dogs. 
Comparative performance of BE and RFFIT 
Variability and Repeatability 
RFFIT and BE tests showed a similar within-test repeatability and variability. However, the 
weak correlation between microplate and Labtek titres indicates that variations in RFFIT 
protocol have a major impact on results. This reinforces findings from other studies that 
show low comparability of RFFIT titres from different laboratories that use slightly modified 
protocols (Cliquet et al., 1995; Barrat et al., 1995). This study further emphasises the need 
for standardisation of RFFIT protocols for reliable inter-laboratory comparisons. Indeed, 
now that these problems are being recognized, standardised protocols for testing canine sera 
have been developed at CNEVA, Nancy, and are being adopted by reference laboratories. 
The most important modification to the microplate protocol described here has been in the 
determination of end points, with subjective measures of fluorescence being replaced with 
an all-or-nothing assessment. 
Specificity 
Each line of evidence presented in this study supported the specificity of the BE. Thus: i) 
titres of unvaccinated UK and Mauritius dog sera were below our thresholds for 
seropositivity; ii) individual case history reports showed that seropositivity and 
seroconversion were associated with the bite of a rabid dog; iii) there was a close 
correlation between the geographic distribution of BE seropositives and rabies cases; iv) 
anamnestic trial results showed that BE seropositives responded more vigorously to a single 
injection of rabies vaccine than BE seronegatives. 
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For the RFFIT, results were less clear. The specificity of the RFFIT was supported by the 
fact that: i) Mauritius (rabies negative control) sera all demonstrated low titres, below 0.5 
IU/ml (log dilution 1.5) and ii) case history reports from Serengeti dogs showed an 
association between RFFIT seropositivity and seroconversion and a rabid dog bite, 
consistent with BE results. However, iii) there was no association between the location of 
rabies cases and RFFIT seropositives. While we cannot guarantee that rabies has not 
occurred in villages with no reported or confirmed cases, these results contrast noticeably 
with BE findings. Furthermore, iv) anamnestic trials showed no differences in response 
between putative RFFIT seropositive and seronegative dogs. One explanation is that, 
because rabies seropositivity is not lifelong (Chapter 4), we cannot be certain that 
seronegatives (defined on the basis of one or two samples) have not been previously 
exposed to rabies. Nonetheless, significantly higher RFFIT responses were recorded in dogs 
that were BE seropositive than were BE seronegative, which supports the conclusion that, 
in unvaccinated dogs, the BE is more likely to detect specific exposure to rabies antigen. 
Sensitivity 
ELISAs are generally considered one of the most sensitive assays of antibody and, in other 
studies, rabies antibody has been detected at an earlier stage of infection with ELISAs than 
with neutralization tests (Savy and Atanasiu, 1978; Pixley, 1987). Since rabies nucleoprotein 
(N) is produced earlier and more abundantly during an infection than G protein, we might 
expect to detect antibody earlier on the BE (which detects both anti-N and anti-G) than on 
the RFFIT (which is thought to detect mainly anti-G). However, in post-vaccination 
studies, the RFFIT appeared more sensitive than the BE. 
Cut-off Points 
Our conclusions about the relative sensitivity and specificity of BE and RFFIT depend, in 
part, upon the choice of cut-off points. Thus, a higher threshold for the RFFIT reduced the 
number of `false seropositives' in villages with no recent history of rabies. However, using 
the lower threshold, which is equivalent to the international standard, specificity of the 
REFIT was well below that of the BE. In terms of rabies control, specificity is the more 
crucial characteristic. The consequence of a false negative (lack of sensitivity) is merely 
repeat-vaccination and blood sampling, whereas a false positive (lack of specificity) may lead 
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to the importation of non-vaccinated or non-protected animals that carry a risk of incubating 
rabies. 
This study also demonstrates the obvious problem of using an absolute threshold to 
distinguish positive and negatives. Even with highly reproducible tests, a proportion of sera 
with mean titres close to 0.5 IU/ml will inevitably be defined as positive and negative on 
repeat sampling. Currently, there is no standard method among rabies laboratories for 
defining, or dealing with, `borderline' sera. For screening large numbers of dog sera for 
import purposes, practical and economic constraints often mean that a single test result is 
accepted as an absolute, with no repeat testing of doubtful sera. 
We still cannot explain why RFFIT and BE tests produced similar results when measuring 
antibody induced by a known dose of immunogenic antigen (rabies vaccine), but showed a 
very poor correlation when measuring antibody resulting from natural exposure. This is not 
just a matter of titre range, since unvaccinated dogs with high titres on one test had low 
titres on the other, whereas even low post-vaccinal titres correlated more closely. These 
results may simply reflect variability in the test systems, but biological differences in anti-N 
or anti-G responses could also give rise to discrepancies in titre. However, to our 
knowledge there are no data comparing the kinetics of anti-G and anti-N antibody in 
infection. 
One explanation may be cross-reactivity to other Lyssaviruses, such as Mokola, 
Duvenhage and Lagos Bat virus. Since the geographic distribution of Mokola and 
Lagos Bat virus includes southern, central and west Africa as well as Ethiopia (King el 
al., 1994), it is likely that rabies-related viruses also occur in east Africa. Further 
serological studies are required to examine cross-reactivity of antisera to rhabdoviruses 
in both the RFFIT and BE. Because there is no evidence for the existence of rabies- 
related viruses in Mauritius, efforts are also being made to identify a more appropriate 
rabies-negative control population of domestic dogs in East Africa, with similar 
ecological characteristics to those in the Serengeti. 
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Implications for Rabies Control 
Magnitude and Duration of Antibody Responses 
RFFIT and BE results both demonstrated that most vaccinated dogs were seronegative one 
year after vaccination. In some field campaigns, inactivated vaccine (as used here) has 
induced long-lasting antibody responses (Chomel et al., 1988) comparable to those in 
laboratory trials (Gaudry, 1983). However, more commonly, commercial vaccines fail to 
produce consistently high titres under field conditions (Ben Osman and Haddad, 1988; 
Jayakumar et al., 1989; Hlrayama et al., 1990; Tepsumethanon et al., 1991; Sage et al., 
1993). Nonetheless, it is likely that a high proportion of these are protected. In one study, all 
of 18 vaccinated dogs with low antibody titres resisted challenge (Jayakumar et al., 1989), 
probably as a result of cell-mediated immunity to inactivated vaccine (Jayakumar and 
Ramadass, 1990). In another, 47 out of 73 seronegative dogs (74.6%) vaccinated three 
years previously were also protected against challenge (Sikes et al, 1971). 
Aubert (1992) suggests that variations in antibody responses may be due to differences in 
condition and health status of dogs. However studies in Thailand found no association 
between antibody responses and anaemia or the level of blood parasitism (Tepsumethanon et 
al. 1991). In this study, there was no significant effect of age, sex or anthelminthic treatment 
on the magnitude of antibody responses, suggesting relative homogeneity in response to 
vaccine in Serengeti dogs. 
Development of ELISA Systems 
This study provides several lines of evidence to support development of ELISA tests as 
reference techniques for rabies control measures. (i) This study, amongst others, clearly 
demonstrates the sensitivity of RFFIT protocols to variations in methodology. ELISA tests 
are intrinsically more reproducible than serum neutralization tests and more easily 
standardised among laboratories. (ii) These results provide evidence for the greater 
specificity of the BE over the RFFIT, using current international thresholds. (iii) The 
blocking ELISA allows simple and rapid processing of sera. Replacement of UK quarantine 
restrictions by a system of dog vaccination and blood testing would require large-scale 
processing of sera, which is not widely available for the RFFIT. 
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Risk Assessment 
The crude risk assessments carried out in this study provide an indication of the role of 
serological testing in rabies control. The example of Tanzania is included to demonstrate the 
relative importance of serological tests in identifying high-risk dogs from areas with a high 
rabies incidence. This example also shows that the greater specificity of the BE increases the 
probability of detecting dogs that may be incubating rabies. In comparison with Tanzania, 
however, the probability of importing a dog from France that is incubating rabies is so low 
that differences in the specificity of the blood test are relatively insignificant. While this 
study does not intend to provide a comprehensive risk analysis, it is worth noting that the 
probabilities calculated here differ widely from previous estimates, in which rabies was 
expected to enter the UK once every 250 years if 5,000 dogs were imported annually from 
France (Directorate General for Agriculture, 1992). These differences can be accounted for 
by the fact that previous calculations were based on rabies incidence prior to the oral 
vaccination campaign in France (over ten times the 1993 level) and gave no consideration to 
the vaccination status of imported dogs. 
In Tanzania, our calculated risks are probably overestimates for two main reasons. First, we 
used rabies incidence in a cohort of unvaccinated village dogs, whereas most dogs imported 
from Africa would be valued pets, probably confined to the owners' premises and with a 
history of rabies vaccination. Second, recent inactivated vaccines (such as used in Serengeti 
trials) have a lower failure rate than those of the modified live vaccines used in this risk 
calculation. Nonetheless, the substantially higher risks associated with importing a dog from 
a high-incidence area point to the dangers that may arise if dogs are moved from high- 
incidence countries to low-risk EU countries, and from there, are imported into the UK 
without quarantine. 
Atypical iº fections 
With respect to unvaccinated dogs, this study demonstrates that rabies antibody is detected 
by RFFIT and BE in a proportion of Serengeti dogs, without concurrent or subsequent 
illness in the animal. The significance of rabies seropositivity in terms of the pathogenesis 
and dynamics of rabies is discussed in greater detail in Chapter 4. Here, we conclude that 
147 
the detection of RFFIT or BE rabies antibody in dogs from a rabies endemic area does not 
guarantee that a dog has been vaccinated. Although an antibody titre > 0.5 IU/ml confers 
protection against experimental infection in most dogs, no challenge experiments have yet 
been carried out in naturally seropositive dogs and we cannot be certain of the immune 
status of these seropositives. 
While it is not clear what seropositivity means in Serengeti dogs, in experimental situations, 
rabies seropositivity has been associated with a carrier state (Fekadu et al., 1981). Carrier 
animals have also been reported in the field, but only rarely (see Chapter 4). These findings 
have raised concerns about the possible importation of seropositive, carrier dogs into UK 
(Scott, 1994). However, none of some 150,000 vaccinated animals quarantined in Britain 
since 1971 have developed `natural' rabies (two dogs died, but from vaccine-induced rabies 
following administration of live Flury vaccine before importation) (King, 1992). Nor, 
presumably, have any healthy rabies carriers been released from quarantine in UK. This 
suggests that carrier animals either occur very rarely in nature, or that vaccination effectively 
eliminates the carrier state. 
In conclusion, if dogs are to be imported into rabies-free countries without quarantine, the 
mainstay of the control programme must be effective vaccination combined with reliable, 
accurate certification and identification. Serological testing has a role in identifying correctly 
vaccinated animals, particularly from high-incidence areas, but there remain uncertainties 
about the current mandatory serum neutralization (RFFIT) assays and the interpretation of 
a RFFIT titre above or below the arbritary threshold of 0.5 lU/ml. Results from this study 
suggest that the blocking ELISA may overcome some of the problems associated with the 
RFFIT and could be developed as a reference technique. 
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Chapter 4 
RABIES IN THE SERENGETI : DYNAMICS OF A 
MICROPARASITE INFECTING SEVERAL HOST SPECIES* 
* Co-authors of paper in press: Cleaveland, S. & Dye, C. Maintenance of a 
microparasite infecting several host species: rabies in the Serengeti. Parasitology. 
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SUMMARY 
Rabies is a fatal disease of all mammalian species, but not all mammalian species can 
maintain the infection as reservoirs. The approach to control depends on which of the 
affected species do act as reservoirs. Bringing together old and new data, we examine 
here the role of wild and domestic animals in maintaining rabies in the Serengeti region 
of Tanzania, presenting our findings in two parts. In part I, we argue that domestic 
dogs are the likely reservoirs because: (1) rabies has been continuously present in the 
dog population since its (re)introduction in 1977, whilst (2) wildlife cases have been 
very rare over this period, despite intensive study of Serengeti carnivores; (3) outbreaks 
of rabies in wild canids (jackals) elsewhere in Africa (Zimbabwe) have followed, rather 
than preceded, outbreaks in the dog population; (4) all viruses isolated from wild 
carnivores in the Serengeti ecosystem (including the Kenyan Masai Mara) are 
antigenically and genetically indistinguishable from the typical domestic dog strain; (5) 
dog rabies control in the Serengeti between 1958-77 apparently eliminated the disease 
from both dogs and wildlife. Laving identified dogs as reservoirs, part II explores the 
dynamics of infection in domestic dogs. Serological studies demonstrate the existence 
of atypical infection in Serengeti dogs, with rabies seropositivity in a proportion of dogs 
remaining healthy for several months or years. Cross-sectional and longitudinal 
serological data indicate a greater force of infection in SD than ND and provide support 
for a view of rabies endemicity in SD. In theory, infection is more likely to be 
maintained at higher dog densities, and we provide evidence from case incidence data 
that rabies is maintained in Serengeti District (SD) with a dog density > 5/km2, but not 
in Ngorongoro District (ND) with a density < 1/km2. Because 5 dogs/km2 is much 
lower than the expected density required for persistence, we investigate the role of 
atypical infections in Serengeti dogs using mathematical models. Whilst we cannot be 
sure what seropositivity means, persistence in low-density dog populations is more 
likely if seropositives are infectious carriers, rather than slow-incubators or immunes. 
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INTRODUCTION 
Throughout the developing world, rabies is most frequently reported in domestic dogs 
and dogs account for over 90% of human cases (WHO, 1992a). However much of our 
current understanding of rabies epidemiology is based on empirical and theoretical 
studies, not of dogs, but of wildlife populations. Fox rabies (Vzilpes vulpes) in Europe 
(Blancou et al. 1991) is well-documented and relatively well understood, as is rabies in 
gray fox (Urocyon cinereoargenteus), raccoon (Procyon lotor), and skunk (Mephitis 
mephitis) populations in North America (Carey et al. 1978; Winkler & Jenkins, 1991; 
Charlton et al. 1991). 
In many African countries, the current increase in the incidence of domestic dog and 
wildlife rabies (King, 1993; Perry, 1993a; Swanepoel et al. 1993; Bingham & Foggin, 
1993) is a cause for concern, not only for public health, but also for the conservation of 
some endangered canids (Gascoyne et al. 1993b; Macdonald, 1993). In order to control 
the disease effectively, we need to identify which animals are reservoirs and by what 
mechanisms the virus is maintained in reservoir populations. 
A reservoir host is, by definition, capable of independent maintenance of infection and 
can act as a source of infection to other species. Several general predictions about 
reservoirs follow: 1) reservoir host populations should show evidence of persistent 
infection, 2) cases should occur in the reservoir host in the absence of cases in other 
species, whereas the converse should not occur, and 3) outbreaks in other species 
should follow cases in the reservoir host population. 
In Chapter 1, we described the observation that, throughout the world, a single strain of 
rabies virus tends to be maintained in one principal reservoir host. Adopting a one host- 
one virus paradigm for rabies, two additional criteria for reservoirs should therefore 
apply: 4) control of rabies in the reservoir host should result in the elimination of 
disease in all other species, and 5) the virus isolate characteristic of the reservoir species 
should be found in all other species. In part I of this paper, we apply all five criteria in 
evaluating the roles of dogs and wildlife as reservoirs in the Serengeti. 
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Part II is concerned with the dynamics of rabies infections in dogs and mechanisms of 
disease maintenance. 
The transmission rate between animals, and hence the basic reproduction number Ra, 
generally increases with density. A threshold density for an outbreak, ensuring Ro > 1, is 
therefore thought to be a common feature of microparasitic diseases (Nokes 1992) and 
such a threshold has been observed for fox rabies in Europe (Wandeler et al. 1974a). 
However, satisfying the threshold condition is not sufficient to explain persistence. Fox 
rabies, for example, fluctuates in nature as predicted in theory, and there is a high 
probability of disease extinction in cycle troughs. The observation that fox rabies does 
persist between epidemics is not easily explained by existing mathematical models (for a 
review, see Bacon, 1985a; Barlow, 1995). In deterministic models, for example, 
infection is maintained during cycle troughs by unrealistically small fractions of 
infectious animals. Some stochastic models require reintroduction of infection between 
epidemics to avoid disease extinction (Smith, 1985; Voigt et al., 1985). Ecological 
studies of foxes suggest that we need to think about infection in `metapopulations', 
within which extinction is local and infection can be reintroduced from adjacent 
populations through the dispersal of infected animals (Artois et al., 1991). 
Various other mechanisms have been suggested to account for maintenance of 
infection; that there are inapparent reservoir hosts (Carey, 1985), that the survival of 
virus is enhanced in frozen carcasses (e. g. arctic rabies: Wandeler et al. 1994), that 
some animals have highly variable or prolonged incubation periods (e. g. red fox rabies: 
Bacon, 1985b; Aubert et al. 1991; civet rabies: Bingham et a!. 1994), act as carriers 
(e. g. arctic fox rabies: Crandall, 1991) or enter an immune class (e. g. raccoon rabies: 
Coyne et al. 1989). 
Many of these mechanisms can be invoked for dog rabies too. In Chapter 1, we briefly 
reviewed the evidence for atypical rabies infections in dogs, including the finding that 
antibody may be detected in dogs that remain healthy for prolonged periods. The 
possibility that seropositive dogs have innate or acquired immunity in cases of recovery 
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or aborted infection has been suggested by Andral and Serie (1957). This interpretation 
is supported by experiments in which dogs surviving a first challenge have been able to 
resist a second, showing an anamnestic antibody response (Fekadu & Shaddock, 1984). 
Regarding infectious carriers, the dog is the only species for which there is unequivocal 
evidence - some healthy animals have excreted virus for months or years (Table 4.1). 
Although several studies have reported dogs with antibody (Table 1.1 c), and although 
Andral (1964) and Fekadu (1991) have proposed a role for carriers in the persistence of 
dog rabies, no study has yet evaluated these findings and suggestions quantitatively. 
Here we investigate the distribution of antibody in Serengeti dogs and we use simple 
mathematical models to explore, comparatively, the epidemiological significance of 
different maintenance mechanisms. 
MATERIALS AND METHODS 
Study Areas 
The study area was the Serengeti ecological region of Northwestern Tanzania (350 to 
36° E, 1° 30' to 3° 7' S). Villages were selected from three areas adjacent to the 
Serengeti National Park (SNP) - the Serengeti District (SD) and Ngorongoro District 
(ND), comprising the Loliondo Game Control Area (LGCA) and Ngorongoro 
Conservation Area (NCA). These areas are described in detail in Chapter 2. 
Rabies Surveillance, Diagnosis and Virus Characterization 
Records of reported rabies cases for the three study areas were obtained from 
veterinary offices in Mugumu in Serengeti District (1977-1994), and from Loliondo and 
Ngorongoro in Ngorongoro District (1985-1994). Additional information for 
Ngorongoro District came from the Veterinary Investigation Centre, Arusha. 
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Table 4.1. Table reviewing the evidence for the carrier state in domestic dogs. 
Study Virus isolation from saliva Reference 
of healthy dogs 
Surveys from rabies endemic 
areas 
Ethiopia 5/1083 (0.46%) Fekadu (1972) 
Nigeria 4/1500 (0.27%) Aghomo et a!. (1989) 
Argentina 0/430 Bell eta!. (1972) 
India 0/352 Farro et a!. (1974) 
Experimental infection One dog excreted virus for up to Fekadu et a!. (1981) 
305 days after experimental 
infection with Ethiopian street 
virus 
Human rabies infections 
India One dog for 37 months Vecraraghavan (1973) 
Ethiopia -3 human fatalities from Virus isolation not carried out Fekadu (1972) 
bites of 3 dogs that remained healthy 
for > 20 days 
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Beginning in 1991 for LGCA, 1992 for NCA and 1993 for SD, a passive surveillance 
operation was established whereby suspect rabies cases in domestic and wild animals 
were reported by veterinary officers, park rangers and research scientists. Wherever 
possible, brain samples were collected from suspect animals for rabies diagnosis, 
although in many instances, carcasses were lost to scavengers before samples could be 
collected or were too decomposed for retrieval of diagnostic material. Samples were 
also submitted from any wild carnivore carcasses encountered by chance, whatever the 
apparent cause of death. 
Brain stem samples were collected through the occipital foramen into 50% glycerol- 
saline solutions containing 0.01% methiolate as preservative, using World Health 
Organization (WHO) collection kits (Barrat & Blancou, 1988). Immunofluorescence 
diagnostic tests (Kaplan & Koprowski, 1973) were carried out on brain samples at the 
WHO Collaborating Centre for Zoonoses, Centre National d'Etudes Veterinaires et 
Alimentaires (CNEVA), Nancy, France. Inoculation of murine neuroblastoma cells and 
mouse inoculation (Barrat et al. 1988) was carried out at CNEVA to confirm diagnosis 
and for virus isolation. Diagnostic tests on brain samples collected in 10% formol-saline 
were conducted at the Onderstepoort Veterinary Institute using an immunoperoxidase 
technique (Last eta!. 1994). 
Virus isolates were typed at the Central Veterinary Laboratory, UK, using a panel of 
anti-nucleocapsid monoclonal antibodies (Mab-Ns) (King, 1991) and at the Pasteur 
Institute, Paris, by polymerase chain reaction amplification and sequencing of the 
nucleoprotein (N) gene (Bourhy ei al. 1993). 
Rabies Serology 
Details of the protocol for collecting serum samples are described in Chapter 3. 
Longitudinal samples were collected from 89 unvaccinated dogs in two study periods 
and from two unvaccinated dogs in three consecutive years. 
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A liquid-phase blocking ELISA (BE), developed at the Onderstepoort Veterinary 
Institute, South Africa (Esterhuysen et al. 1995), was used to detect antibody to rabies 
virus, as described in detail in Chapter 3. Titres were expressed as logo reciprocal of 
dilution where 50% of the maximum optical density reading was inhibited (abbreviated 
to log dilution). We used BE data in this study because of the greater specificity and 
reproducibility of results compared with results of neutralization tests. Furthermore, 
variation in neutralization test protocols precluded meaningful comparison of cross- 
sectional data between years, or use of longitudinal data. In this study, log dilution 1.5 
was used as the cut-off point for BE seropositivity, as this value more safely identified 
seropositives (see Chapter 3). 
Saliva samples were collected onto swabs (Salivette; Sarstedt) from six seropositive 
dogs. Samples were stored at -20°C in phosphate-buffered saline containing 200 IU/ml 
penicillin and 200 µg/ml streptomycin. Virus isolation was attempted at the 
Onderstepoort Veterinary Institute by mouse inoculation (Kaplan & Koprowski, 1973). 
Analysis of Seroprevalence 
Cross-sectional serological data were analysed as binary data using logistic regression in 
GENSTAT 5.3 (Payne et al., 1993). Seroprevalence was scored as 0 if the dog was 
seronegative and I if it was seropositive. Age was classified into two groups (0-1 
years, >1 year) because this explained a greater proportion of the total deviance than 
age as a continuous variable or other age class groupings. Two analyses were carried 
out using: (A) a model that included data for 1992,1993 and 1994, with year, region, 
sex, age and their interaction terms as explanatory variables; (B) a model that 
additionally included questionnaire data (1992 and 1994 only). For the second analysis 
the full model included age class of dog, year, region, sex, clinical history (illness and 
bite wounds), function (guarding or herdingthunting) and seropositivity to canine 
distemper virus (CDV). A dog was recorded as having been ill if it had shown any 
clinical signs of disease during the past 12 months, whatever the suspected cause (see 
Appendix, Questionnaire B). All interaction terms between age class, region and year 
were included. For the other variables, only interaction terms previously shown to be 
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significant in Chapter 2 were included. For each analysis, the full model was simplified 
by stepwise deletion, as described in Chapter 2, until the minimum adequate model was 
reached, in which all remaining terms were significant. 
For an endemic infection where infected animals can revert from seropositive to 
negative, the proportion of animals infected at age a, p(a), at equilibrium, is given by 
P(a) _A (1-e 
2+p 
(4.1) 
where A is the force of infection, and p the rate of recovery (Dye and Williams, 1993). 
This reversible catalytic model assumes that both rates are constant with respect to age 
and that there is no selective host mortality due to infection. Given that a significant 
proportion of rabies infected dogs die, this model may not be appropriate for 
quantitative estimation of infection rate parameters on the basis of seroprevalence 
curves. However, as a preliminary examination of rabies age-seroprevalence patterns in 
this study, we compare cross-sectional seroprevalences with curves calculated from 
equation 4.1, using seroconversion in surviving dogs as an estimate of X. 
Instantaneous recovery rates were calculated using p= -ht (1 - S/I) /t, where S is the 
number of seronegatives arising from I seropositives after time, 1. The proportion 
seropositive was calculated from Eq. 4.1 using estimates of X (the proportion 
seroconverting) and p (the proportion recovering) from longitudinal data. The fit of 
the curve was compared with observed seroprevalences from cross-sectional surveys. 
To give an indication of the confidence intervals of the calculated age-seroprevalence 
curve, a maximum and minimum asymptote was derived from the upper and lower 95% 
confidence limits of X and p. 
Mathematical Models of Dog Rabies 
A compartmental model of dog rabies was developed with Dr. C. Dye, London School 
of Hygiene and Tropical Medicine. Fig. 4.1 and Box 4.1 depicts classic dog rabies with 
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Figure 4.1. Flow diagrams illustrating the structure of four compartmental models of 
dog rabies. For details of each model, see Box 4.1. 
RA 
ý, 
J susceptible latent l .I 
infectious 
latent I 
fast 
El susceptible infectious 
latent 
slow 
infectious 
rabid 
© susceptible H latent 
infectious 
carriers 
infectious 
susceptible latent 
immune 
11. 
158 
Box 4.1. Differential equations describing four compartmental models of dog rabies in 
the Serengeti illustrated in Figure 4.1. 
MODEL A: 
Model A represents classic dog rabies in a population of size N. Susccptibles (S), having acquired infection 
by contact with infectious dogs (! ) at rate ß. all follow the same route through a latent (incubating) class (L). 
They emerge into the rabid, infectious state at rate a (1/a = average latent period), and die from rabies at 
rate a, which is substantially higher than the rate of mortality due to all other causes, S (l/(a + S) = life 
expectancy of an infectious dog). Formally, 
¢ý= vN - ßS! - 6S (4.2) 
dt 
dt = ßS! - (a + S)L (4.3) 
di 
dl=aL-(a+S)! (4.4) 
dt 
The basic case reproduction number, Ro , is calculated from 
Ro = ONcr (4.5) 
(a+ 6) (a+ S) 
MODEL B: 
In B, the basic model is adjusted to allow a fraction of infected dogs, 4. to become slow-incubators (La), 
emerging into the infectious class at rate as (<a). Equations 4.3 and 4.4 are replaced by. 
(1-0s)PS! -(a+(4.6) 
dt 
d1s = Os3S/ - (as + S) L6 (4.7) 
dr 
l=aL+ as LS -(a+S)! (4.8) 
dt 
whence. Ro = ON F(1-Qsk +_g3] (4.9) 
a+sla+s as+&J 
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Box 4.1. Continued. 
MODEL C: 
Model C allows a fraction, 4;,., of infected animals to emerge from the latent class as healthy, infectious 
carriers, 1, by replacing equation 4.4 with: 
dI=(t - 4)CFL-(a+S) (4.10) 
dr 
dl" = kaL-Sfý (4.11) 
dt 
and then, R, = ML [(. - Qg. + ., 
O,. l (4.12) 
a+S L a+S S1 
Finally in D, a fraction 4 of infected animals enters an immune class (M) following the latent period. Now 
equation 4.4 is replaced by: 
d1=(1-q6»L-(a+S)/ (4.13) 
dz 
ýM= 44, aL-SM (4.14) 
dt 
so that, R, = Na A"_ (4.15) 
(a+S)((x +S) 
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the model (A), extended to allow slow-incubators (B), infectious carriers (C) and an 
immune class (D). Estimates of the latent period (1/a = 4.18 weeks; assumed equal to 
the incubation period) and infectious period (1/y =0.81 weeks) were obtained from data 
in Foggin (1988), who has uniquely recorded the timecourse of natural, rather than 
experimental, dog infections in Zimbabwe. 
Estimates of v, the birth rate, and S, the death rate come from demographic studies of 
SD described in Chapter 2. Because our estimates of per capita birth and death rates 
do not match the intrinsic growth rate, r, we estimate v from r and S. This is based on 
the assumption that per capita birth rates determined from questionnaire data and the 
age distribution of the population are less reliable than mortality rates determined from 
observed survivorship. 
The magnitude of the contact rate, /1, and hence Ro, was guided by the analysis in 
Coleman and Dye (1996), who found Ro for urban dog rabies to be in the range 1.62 - 
2.33. We expect Ro in lower-density, rural dog populations to be less than this, but 
greater of course than the threshold of 1. Precise estimates of Ro are not, however, 
crucial to our analysis, which is essentially comparative. 
Minor adjustments were made in the value of 0 in each of the models a-d in order to 
maintain Ro constant and to allow comparative analysis of the effects of long incubators, 
carriers and immune animals independently of changes in R0. 
RESULTS AND DISCUSSION 
RESERVOIR HOSTS OF RABIES IN THE SERENGETI 
We use the five criteria outlined in the Introduction to evaluate the evidence for 
reservoir hosts in the Serengeti. 
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(i) Evidence for Maintenance in Dogs 
Between 1958 and 1977, rabies was apparently absent from the Serengeti (Rweyemamu 
et al. 1973; Magembe, 1985a). Since 1977, dog rabies cases have been reported almost 
every year in SD, with a peak in reported incidence in 1978 (91 cases in one quarter). 
Although no cases of dog rabies were reported in 1979, two human cases were 
recorded, both attributed to the bite of a rabid dog. Between 1984 and 1986, no records 
were available, however there is anecdotal evidence that dog rabies also occurred 
during this period. In LGCA and NCA, rabies was reported only sporadically, although 
records were more fragmentary. During the course of this study, a total of 15 dog 
samples were submitted for rabies diagnosis, of which 7 were positive (Tables 4.2 and 
4.3). 
Thus, the reported case incidence pattern for the SD is consistent with an epidemic 
beginning in 1977, and with persistence in the dog population thereafter. In LGCA and 
NCA, there is no evidence that rabies persists in dogs. 
(ii) Evidence for Maintenance in Wildlife 
During this study, rabies was only confirmed in two wild animals, both bat-eared foxes. 
These cases were located near the southern and western borders of the Serengeti 
National Park in 1994 and 1995 respectively. No carnivore road kills were rabies 
positive (Table 4.2). 
Although Serengeti's predators have been intensively studied for over 30 years, rabies 
has only ever been confirmed in two wildlife species, the African wild dog (Lycaon 
pictus) in 1990 (Gascoyne et al. 1993a), and the bat-eared fox (Otoc), on megalotis) in 
1987 and 1988 (Maas, 1993), and in 1994 and 1995 (Table 4.3). In the Masai Mara, 
part of the Serengeti ecosystem, four cases of rabies have also been confirmed in 
African wild dogs, (three in 1989 and one in 1991), and a single case confirmed in a 
spotted hyaena (Crocuta crocuta) in 1992 (Alexander et al., 1993). With fewer than 
100 individuals in the Serengeti, African wild dogs are unlikely to act as reservoir hosts. 
162 
As regards bat-eared foxes, the epidemiological pattern in 1987 and 1988 was one of 
explosive outbreaks lasting only 5 and 7 weeks respectively (Maas, 1993). Between 
these outbreaks, and from 1988 to 1994, there was no evidence, from either confirmed 
or suspected cases, that rabies was maintained in the bat-eared fox population. These 
observations suggest that bat-eared foxes are unlikely to be a wildlife reservoir of rabies 
in Serengeti. However, the fact that bat-eared foxes in South Africa are capable of 
maintaining rabies independently of dogs (Thomson and Meredith, 1993), together with 
the finding of recurrent cases in Serengeti, highlights the need for further investigation 
of their role in the Serengeti. 
We expect case surveillance data to show that confirmed rabies cases are most 
numerous in the reservoir host species and that the ratio of rabies positives to samples 
submitted is also higher in reservoir hosts. Table 4.2 shows that, in Serengeti, most 
rabies cases were confirmed in domestic dogs, and that a higher proportion of samples 
were rabies positive in dogs than in other carnivores. 
The predominance of domestic dogs among confirmed and reported cases in Serengeti 
is consistent with reports from the Masai Mara (Alexander et al., 1993b), from 
elsewhere in Tanzania, and from many other African countries (WHO, 1992a; 1993a 
and b, 1994a; Rweyemamu et al. 1973; Magembe, 1985a; King, 1993; Loretu, 1993). 
This has led to the view that domestic dogs are the major reservoir host for rabies in 
these countries. However this may be an artefact of less intense surveillance and under- 
reporting of disease in wildlife (Swanepoel et a!. 1993; Wandeler et a!. 1994). In this 
study too, it is evident that surveillance measures need to be enhanced before definite 
conclusions can be made regarding wildlife reservoirs in the Serengeti. The high 
ambient temperatures, abundance of scavengers and under-developed communication 
system led to the loss of a large proportion of reported carcasses. 
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Table 4.2. Samples submitted for rabies diagnosis between 1991 and 1995. 
Species No. submitted No. showing No. road No. rabies 
neurological kills positive 
signs 
Domestic dog 15 15 0 7 
Cow 2 2 0 2 
Bat-eared fox* 7 5 2 2 
Golden jackal* 1 0 1 0 
Black-backed jackal* 6 0 2 0 
Spotted hyaena* 9 0 7 0 
Striped hyaena 1 0 1 0 
Aardwolf* 1 1 0 0 
Lion* 9 5 0 0 
Leopard* 2 0 0 0 
Cheetah 1 1 0 0 
Serval* 2 0 2 0 
Banded mongoose 1 0 1 0 
Black-tipped mongoose* 1 1 0 0 
Meller's mongoose* 1 0 1 0 
Genet 1 0 1 0 
Civet 1 0 1 0 
Elephant* 1 1 0 0 
Wildebeest* 1 1 0 0 
Grass rat 1 1 0 0 
TOTAL DOMESTIC 17 17 0 9 
TOTAL WILDLIFE 47 16 19 2 
TOTAL 64 33 19 11 
* Some or all samples collected by Dr. M. Roelke-Parker, Chief Veterinary Officer, Serengeti National 
Park. 
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Table 4.3. Details of all confirmed rabies cases in Serengeti since 1987. 
DATE OF 
SAMPLE 
COLLECTION 
SPECIES LOCATION METHOD OF 
DIAGNOSIS' 
VIRUS 
STRAIN 
1987/19882 3 bat-eared foxes Seronera (SNP) 
(Otocvon megalotis) 
23.08.90 African wild dog Eastern Serengeti FAT, CC, MI Serot}pe 1, 
(Lycaon pictus) Plains (SNP) 1. canid" 
virus3 
"Africa lb" 
canid virus' 
14.11.91 Domestic dog Wasso (LGCA) FAT, CC, MI As above 
27.11.91 Cow Enguserosambu FAT, CC, MI As above 
(LGCA) 
6.10.92 Domestic dog Sakala (LGCA) FAT, CC, MI 
30.12.92 Cow Enguserosambu FAT. CC, MI 
(LGCA) Immunoperoxidase 
26.3.93 Domestic dog Masinki (SD) FAT. CC 
31.3.93 Domestic dog Kemgesi (SD) FAT, CC 
17.4.93 Domestic dog Masinki (SD) Immunoperoxidase 
15.4.93 Domestic dog Endulen (NCA) FAT, CC. MI 
31.7.94 Bat-eared fox Ndutu (SNP) FAT, CC, MI Analysis in 
(Otocvon megalotis) progress 
13.10.94 Domestic dog Mugumu (SD) FAT, CC, MI 
8.8.95 Bat-eared fox Kirawira (SNP) FAT, CC, MI Analysis in 
Otocvon ºne alotis) progress 
1. FAT - Fluorescent antibody test (Kaplan and Koprowski, 1973) 
CC - Inoculation of murine neuroblastoma cells (Barrat et a!., 1988) 
MI - Mouse inoculation (Kaplan and Koprowski, 1973) 
Immunoperoxidase (Last et al., 1994) 
2. Data from Maas (1993) 
3. King (1991) - reaction pattern to Mab-N panel 
4. Bourhy et al. (1993) - sequencing of N-protein gene 
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Nonetheless, existing levels of surveillance during this study were sufficient to obtain 
diagnostic material from 16 cases of neurological disease in wildlife. Of these, only two 
cases (bat-eared foxes) were rabies positive compared to 9 cases (5 lions and 4 bat- 
eared foxes) confirmed positive for canine distemper virus (CDV), a disease with 
similar presenting signs (Roelke-Parker et al., 1996). CDV was also detected in road- 
kill carcasses (M. Roelke-Parker, pers. comm. ) whereas all road-kills were rabies 
negative. This contrasts with the Caribbean Island of Grenada, where rabies was 
confirmed in more than 50% road-kill carcasses of Indian mongooses (Herpestes 
auropunctatus), a species known to act as a reservoir on this island (Everard & 
Everard, 1985). In a survey of road-kills in rabies endemic areas of Europe, rabies was 
also found in a greater proportion of foxes (the reservoir host) than other carnivore 
species. Of 131 road-killed foxes, 15 (11.5%) were rabies positive compared with 1/24 
(4.2%) badgers and 2/36 (5.6%) martens (Wandeler et al. 1974a). 
(iii) Sequence of Epidemics in Dogs and Wildlife 
With so little wildlife, and indeed dog, rabies cases in SD, we cannot investigate the 
temporal relationship between dog and wildlife rabies in the Serengeti. We can, 
however, draw on data from Zimbabwe where large fluctuations in disease incidence 
have been seen in both domestic dogs and jackals. Case incidence data presented by 
Cummings (1982) and Foggin (1988) show spatial and temporal patterns of dog and 
jackal rabies. Because jackal epidemics appeared to follow epidemics in dogs, and not 
vice versa, Cummings (1982) concluded that dogs, not jackals, were the reservoir of 
rabies in Zimbabwe. However, a few sporadic cases of jackal rabies have been reported, 
in the apparent absence of dog rabies (Foggin, 1988). 
The number of dog and jackal cases in Zimbabwe from 1950-1991 (Foggin, 1988; 
Bingham, 1993) is shown in Fig 4.2a. The cross-correlation analysis, shown in Fig. 
4.2b, suggests that jackal cases followed dog cases with a lag of one year (r = 0.523, p 
< 0.05). These results support Cummings' view that, in Zimbabwe, it is rabies infection 
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in domestic dogs that drives epidemics in jackals and not the converse. While rabies 
incidence in jackals has been high during epidemics, these epidemics appear to have 
been self-limiting. 
(iv) One host - one virus 
The view of a principal host maintaining a single strain of rabies virus is derived largely 
from patterns of wildlife rabies in Europe and North America, but compartmentalization 
apparently occurs in Africa too. In South Africa, one distinct group of viruses 
("viverrid" rabies) is maintained principally in yellow mongooses (Cynictis penicillata) 
of the central plateau region and probably represents an indigenous African rabies. The 
other type ("canid" rabies), which is thought to have been introduced into southern 
Africa more recently, appears to be maintained independently in domestic dogs in Natal, 
by the black-backed jackal (Canis mesomelas) in Transvaal and the bat-eared fox in the 
western Cape (Swanepoel et al. 1993; Thomson & Meredith, 1993; King et al. 1994). 
In this study, three rabies virus isolates from the Serengeti (from a domestic dog, 
African wild dog, and cow) were found to be antigenically and genetically 
indistinguishable, showing characteristics consistent with southern Africa canid- 
associated virus (Table 4.3). Although limited, these results support the findings of Kat 
et a!. (1995), in which nucleotide sequences of a 304 base pair region of the 
nucleocapsid (N) gene were compared for four African wild dog isolates (including this 
Serengeti isolate) and Kenyan domestic dog isolates. Three wild dog viruses from the 
Masai Mara National Reserve, Kenya, were identical to the isolate from the Serengeti 
wild dog and also identical to four domestic dog isolates collected in the Masai Mara. 
In the Serengeti ecosystem (including the Masai Mara) only one virus strain has thus 
been identified from a range of host species. If the paradigm of one host/one virus 
applies generally for rabies, these data support the idea that domestic dogs maintain a 
single strain of rabies virus in the Serengeti. 
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Figure 4.2a. Yearly incidence of canine (-) and jackal ( -) rabies in Zimbabwe, 
1950-1991. 
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Figure 4.2b. Cross-correlation analysis of dog and jackal rabies in Zimbabwe. The 
correlation coefficient is greatest where jackal rabies follows dog rabies by a lag of one year 
(tinme lag = -1 years). The correlation coefficient is negative where dog rabies follows jackal 
rabies by a lag of one, two or three years. The upper and lower boundary lines indicate 
where the correlation coefficients are significant at the 5% level. 
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(v) Control 
If rabies is maintained in a single host species, elimination of rabies from that host 
should result in the elimination of rabies from all other species. In Switzerland, oral 
vaccination of foxes has resulted in the elimination of rabies from all species, not only 
foxes (Wandeler et al. 1988). The successful elimination of rabies from UK, Japan, 
Malaysia and Taiwan through control of dog rabies alone (Meslin et a/. 1994) provides 
evidence that domestic dogs also can act as the sole reservoir host species. 
In the Serengeti, historical evidence for the maintenance role of dogs comes from the 
observed success of dog rabies control programmes (dog vaccination, movement 
restriction and culling) in the late 1950s and 1960s (Rweyemamu et al. 1973). Between 
1958 and 1977, these measures apparently eliminated rabies from the Mara Region (in 
which Serengeti District is located), with no cases reported in either dogs or wildlife 
(Magembe, 1985a). 
DYNAMICS OF RABIES INFECTIONS IN DOMESTIC DOGS 
Rabies seropositivity in domestic dogs 
We have shown in Chapter 3 that specific serum rabies antibody does occur in 
unvaccinated Serengeti dogs, and these findings provide a basis for (i) sero- 
epidemiological studies and (ii) investigation of atypical infections. 
(i) Seroepidemiological studies 
Analysis of Cross-Sectional Data 
Results of the logistic regression analysis of seroprevalence data are shown in Tables 
4.4a and b. Mean seroprevalences predicted from the logistic model are shown for 
different categories of dogs in Table 4.5 In analysis A, sex (and interaction terms) and 
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the interaction term between year and region were insignificant and not included in the 
minimum adequate model. In analysis B, the following terms were insignificant and not 
included in the minimum adequate model: sex (and interaction terms), year (and 
interaction terms), clinical and bite history (and interaction terms), and seropositivity to 
CDV. 
Rabies seroprevalence was significantly higher in SD than in ND and significantly higher 
in adults (> 1 year of age) than juveniles (0-1 years of age) (Fig. 4.3a, b; Tables 4.5). 
The magnitude of regional differences varied with age, with significantly fewer 
seropositives in young dogs of ND (Table 4.5). The magnitude of regional differences 
varied with age, with significantly fewer seropositives in young dogs of ND (Table 4.5). 
The finding of significant regional differences suggests a higher force of infection in SD 
than ND over the three-year period, which is consistent with rabies persistence in SD 
but not ND. 
An increase in seropositivity with age could occur, for example, under stable endemic 
conditions with age-independent rates of infection, or during an epidemic with higher 
rates of exposure in older animals. In the next section, we use an endemic model to 
examine this question further. In this analysis, however, the significant interaction term 
between region and age class suggests there are different age patterns in each region. 
One explanation for the greater age effect in ND is that contact rates may vary more 
with age in low-density areas than in high-density areas. For example, juveniles, which 
tend to stay close to the home, have less chance of interacting with other dogs in 
remote ND bomas than in SD villages. ND adults, however, that roam and mix freely 
(for example, during mating or when feeding on carcasses) may experience contact 
rates that are more similar to those of SD dogs. We would expect to find fewer 
seropositives in herding or hunting dogs that travel from the village, but this trend was 
only apparent in older dogs (Table 4.5). 
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Table 4.4a. ANALYSIS A: Logistic model of BE seroprevalence (> 1.5 log dilution) 
for data from 1992,1993 and 1994. The model had a total deviance of 345.5 with 791 
degrees of freedom. The chi-square is the difference in deviance between models. 
Models b and c are compared with a (the minimum adequate model), model d with c, 
model e with b, and model g with f. Chi-square values are adjusted for under-dispersion 
by dividing by the dispersion factor (the residual deviance divided by the degrees of 
freedom). Significance levels were recorded as NS p>0.05, * p<0.05, ** p<0.01, 
*** p<0.001. 
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Variable tested 
a 12345 17.2 7 
b 1234 14.3 6 Age class. Region 2.9 0.422 6.9 1 
c 1235 12.6 5 Age class. Year 4.6 0.424 10.9 2 ** 
d 135 12.2 3 Year 0.4 0.423 0.9 2 NS 
e 124 8.6 5 Region 5.7 0.429 13.3 1 ** 
f 123 9.9 4 
g 23 5.3 3 Age class 4.6 0.432 10.7 1 ** 
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Table 4.4b. ANALYSIS B: Logistic model of BE seroprevalence (> 1.5 log dilution) 
including questionnaire data from 1992 and 1994. The model had a total deviance of 
218.5 with 475 degrees of freedom. The chi-square is the difference in deviance 
between models. Models b and c are compared with a (the minimum adequate model), 
model d with c; model e with b, and model g with f. Chi-square values are adjusted for 
under-dispersion by dividing by the dispersion factor (the residual deviance divided by 
the degrees of freedom). Significance levels were recorded as NS p>0.05, * p<0.05, 
** p<0.01, *** p<0.001. 
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Variable tested 
a 12345 15.2 5 
b 1234 12.1 4 Age class. Region 3.1 0.438 6.9 1 
c 1235 9.1 4 Age class. Function 4.6 0.442 13.8 1 *** 
d 125 7.8 3 Function 1.3 0.453 2.9 1 NS 
e 134 9.1 3 Region 3.1 0.451 6.9 1 ** 
f 123 7.4 3 
g 23 6.2 2 Age class 1.1 0.435 2.4 1 NS 
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Figure 4.3. Rabies seropositivity in unvaccinated domestic dogs in 1992,1993 and 
1994. Seropositivity defined as > log dilution 1.5 as measured on the BE. 
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Table 4.5. Table of mean rabies seroprevalence in different categories of dogs 
predicted from the logistic model and standardized for all other significant variables. 
Standard errors are given in parentheses. 
Age Region Year Function of dog 
Group (Analysis A) (Analysis A) (Analysis B) 
Guarding Herding/Hunting 
SD ND 1992 1993 1994 (sta), ing in (often away from 
village) village) 
Juveniles 0.046 0 0.051 0 0.014 0.020 0.095 
(0-1 (+0.020) (+0.024) (+0.014) (+0.014) (+0.050) 
years) 
Adults 0.084 0.046 0.064 0.065 0.067 0.094 0.038 
(> 1 (±0.016) (±0.011) (+0.017) (±0.019) (±0.016) (±0.021) (±0.015) 
ears 
We have insufficient rabies cases to provide support for these interpretations of 
seropositivity, but we can compare our findings with age-specific incidence reported in 
other studies. In contrast to this study, a disproportionately high incidence of rabies has 
been reported in young dogs (3-12 months) in two urban populations; Guayaquil, 
Ecuador, with 51.9% cases in dogs less than a year of age (18% of the population) 
(Beran and Frith, 1988), and Lima, Peru with 43% cases (23% of the population) 
(Malaga et al., 1979). Beran and Frith (1988) consider the relatively high rabies 
incidence in Guayaquil dogs is due to changes in ownership, the natural curiosity of 
dogs at this age, and the onset of first breeding. However our data show that Serengeti 
dogs do not breed until over a year of age, so aggressive interactions during mating will 
be restricted to older animals. In Zimbabwe, a lower incidence of rabies has been 
reported among juveniles (24.1% of cases) than expected from the age distribution 
(33% of the population) (Brooks, 1990). This, together with Serengeti seroprevalence 
data, suggest that, in rural Africa, young dogs are less likely to become infected than 
older dogs. Contrasting conclusions are drawn from urban populations in the Guayaquil 
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and Lima studies, where juveniles are thought to represent the greatest risk and are 
considered the highest priority for vaccination (Beran and Frith, 1988). 
Although there was no significant difference in overall seroprevalence between years, 
trends with age showed significant variation between years, with fewer seropositives in 
younger dogs in 1993 and 1994 than in 1992. The variable effects of age between years 
are difficult to explain, but could arise in part both from the low numbers of 
seropositives, leading to large sampling errors, and the relatively high rates of recovery, 
resulting in a highly dynamic system. 
Longitudinal data 
Table 4.6 shows longitudinal data on seroconversion and `recovery' for a cohort of 91 
unvaccinated dogs. In this context, recovery is defined as reversion from seropositive to 
seronegative. These results demonstrate that seropositivity is not life-long, with six out 
of ten positive animals having reverted to negative a year later (1992-3 and 1993-4 
data). Seroconversion was observed only in SD and only between 1992-3. 
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Table 4.6. Results of longitudinal rabies serological survey in unvaccinated domestic 
dogs of Serengeti District (SD) and Ngorongoro District (ND). Antibody status of dogs 
is defined as + (seropositive) if antibody titre is >1.5 log dilution and - (seronegative) if 
< 1.5 log dilution. 
Antibody status Interval between samples 
1992-1993 1993-1994 1992-1994 
Ist 2nd 
sample sample SD ND SD ND SD ND 
++ 2 0 20 0 0 
+- 1 4 10 1 0 
-+ 3 0 00 0; 0 
-- 27 21 20 19 10 
Endemic Model with Recovery 
Fig. 4.4 shows age-seroprevalence data for ND and SD compared with a fitted age- 
seroprevalence curve from Eq. 4.1. Cross-sectional data were combined across years to 
minimize sampling errors. Longitudinal data in Eq. 4.1 were obtained from 1992-3 
seroconversion rates in SD and recovery rates following vaccination. These were used 
instead of natural recovery rates because of the larger sample size (44/62 vaccinated 
dogs losing antibody within a year, compared with 5/7 natural seropositives becoming 
seronegative between 1992 and 1993). 
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Figure 4.4. Cross-sectional seroprevalence data from SD (N ) and ND (©) using 
combined data from 1992-1994, compared with age-seroprevalence curve calculated 
from Eq. 4.1, using longitudinal data from SD from 1992-3 (- ). = 0.105 yr', P 
1.237 yr"'. 
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The asymptote of the calculated curve was 0.078 for SD, giving a magnitude of 
seropositivity similar to the observed seroprevalence data for SD, but higher than 
observed values for ND. However, the large sampling error associated with our 
estimates of seroconversion and recovery leads to a wide confidence interval for the 
asymptote of the fitted curve for SD (0.030 - 0.127), and suggests that differences 
between SD and ND are not significant. 
Although our estimate of incidence, ?,, is not independent of prevalence, it is not 
inevitable that ?. describes a standard endemic curve. X could have arisen from infection 
that occurred during an epidemic or under stable endemic conditions. In the simplest 
case, infection during an epidemic affects all age classes and ? describes a straight line, 
whereas if infection is acquired under a stable endemic situation, X describes a standard 
endemic curve. Furthermore, use of recovery rates from vaccinated dogs provides an 
independent estimate of p. Although the longitudinal data set was small in this study, 
the fit of the endemic curve is more consistent with an interpretation of simple endemic, 
rather than simple epidemic infection in SD, and provides support for conclusions 
drawn from case surveillance data. 
Case surveillance data suggest that rabies occurs in ND as a sporadic epidemic, in 
which case our expectation is that observed age-seroprevalences should differ from the 
standard endemic curve. Although the asymptote of the ND seroprevalence curve was 
lower than SD, the pattern was broadly similar which raises questions about our 
interpretation. This preliminary interpretation is based on the simplest case, where 
infection is independent of age. However, results of the logistic regression analysis 
suggest that there are regional differences in exposure with age. If young dogs in ND 
are indeed more protected from infection than in SD, the observed age-prevalence 
pattern in ND could be arise from an epidemic affecting mainly older animals. 
More robust estimates of p and A. are clearly needed for confident interpretation of 
these data. However, the low rates of seroconversion relative to recovery, together with 
the short life-expectancy of Serengeti dogs, means that reliable estimates of X will only 
be obtained from frequent and large-scale sampling of the population. In this study, an 
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initial sample of over 600 dogs (in 1992 and 1993) yielded relatively few longitudinal 
data over a 12-month period (Table 4.6). In practice, therefore, it may be difficult to 
conduct cohort studies on the scale required for more reliable estimates of rabies 
seroconversion rates. 
(ii) Atypical Infections 
The decline in antibody levels in a proportion of seropositive dogs that remain healthy is 
consistent with an interpretation of `aborted' infection. Persistent rabies antibody was 
seen only in two dogs from Kemgesi village, as described in detail in Chapter 3. The 
fluctuating titres observed in these dogs are consistent with repeated infection with 
rabies virus or with carrier status. Saliva from persistently seropositive dogs did not 
yield infective virus, but this investigation was extremely limited, as saliva was collected 
on only one occasion and conditions of sample storage were far from ideal. 
There was no significant association between illness and rabies seropositivity (Analysis 
B: x2, = 3.7, p> 0.05) and no case histories indicated that seropositives had recovered 
from neurological disease. The only seropositive suffering from neurological disease 
was sick at the time of sample collection and subsequently died from suspect rabies, 
which is consistent with a classic course of infection. Of the other 32 seropositive dogs, 
no others were reported to have died with signs suspicious of rabies. Nine seropositive 
animals remained alive and healthy for at least two years. In most of these cases, 
therefore, seropositivity was not associated with the immediate onset of clinical rabies; 
it was consistent with `aborted' rabies (Fekadu, 1991). 
The routes of transmission for `aborted' rabies are not known. In Chapter 3, we 
presented circumstantial evidence from case histories that dogs can produce an antibody 
response following the bite of a rabid animal without developing the disease. But not all 
seropositives had a history of bite wounds, nor was a history of being bitten a 
significant risk factor for seropositivity (Table 4.4). We have no evidence in this study 
for other routes of infection in seropositive dogs, but oral transmission remains a 
possibility. 
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MECHANISMS OF MAINTENANCE 
Threshold Poprelation Density 
Dogs. Where dog population densities are higher, Ro is more likely to exceed its 
threshold value of 1. In the last section, we presented evidence that rabies persists in 
Serengeti District (SD), but not in two other districts (LGCA and NCA). In Chapter 2, 
we showed that SD has a dog density exceeding 5/km2, but LGCA and NCA have 
densities below I/km2 (Table 2.3). These figures accord with data from the communal 
lands of Zimbabwe, where dog rabies appears to persist in populations with a mean 
density of 6/km2 (Foggin, 1988; Brooks, 1990). 
Wildlife. The apparent absence of wildlife reservoirs in Serengeti may be a function of 
their relatively low densities. Although precise density measures for wild carnivores are 
difficult to obtain, crude estimates for the Serengeti ecosystem are shown in Table 4.7. 
These figures suggest that overall domestic dog densities in the Serengeti District 
exceed those of major wild carnivores within the ecosystem. Furthermore, densities of 
these species are lower in Serengeti than in areas where they are known to play a 
dominant role in rabies maintenance or transmission (Table 4.7). 
In general, rabies seems unable to persist in the protected wildlife areas of Africa (King, 
1993), even though wild carnivores in several reserves have been affected by rabies 
(Bwangamoi et al., 1990; Macdonald, 1993; Alexander et al. 1993b; Swanepoel el a!. 
1993; Mills, 1993). The explanation may be that no single carnivore species can reach a 
sufficient density for disease maintenance in species-rich conservation areas (Foggin, 
1988). Throughout the world, most of the major wildlife reservoir hosts of rabies are 
opportunistic species, such as foxes, jackals, mongooses and raccoons, that live at 
relatively high densities in agricultural areas or close to human settlements. 
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Table 4.7. Host species population densities in Serengeti and in other rabies endemic areas. 
:. > ýerýsity/km2 Den' i..::.. siQ'I 3' 
. > ......... . . : <. 0 MIC 
Domestic dog 5.7 - SD 
0.5 - ND 
Mongooses 
Banded mongoose 1.721 
(Mangos mungo) 
Dwarf mongoose 3.8' 
(ffelogale parvula) 
Slender mongoose 1.2' 
(fferpestes sanguineus) 
Yellow mongoose 
(Cynictis penicillata) 67 
Orange Free State, South 
Africa2 
123 
Orange Free State3 
Indian mongoose 250-1260 
(Hepestes auropunctatus) Grenada4 
Other Carnivores 0.4-7.1 
Zimbabwes 
Black-backed jackal 4-7 
(Canis mesomelas) 0.25' Botswana' 
22 
Namibia (coast)' 
Bat-eared fox 0.8-0.9 1.1-3.0 Karoo farmland, 
(Otocyon megalotis) (35 km2 area in Masai Mara) ' South Africa" 
Spotted hyaena 0.8110 
(Crocuta crocuta) (central Serengeti) 
0.36' 
ecos stem estimate 
1. Caro and Durant, 1995 
2 Taylor. 1993 
3. Zumpt, 1982 
4. Everard and Everard. 1985 
5. Foggin. 1988 
6. McKenzie. 1993 
7. Hisco&s and Penin, 1989 
8. Malcolm, 1986 
9. Nei, 1993 
10. Hofer and East, 1995 
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Atypical Rabies Infections 
There is more to persistence, however, than ensuring that host population density 
exceeds a threshold. After an outbreak, 'fadeout' (Anderson & May, 1991) is most 
likely in the troughs of ensuing cycles (Fig. 4.5a). The chances that infection will 
disappear are smaller in larger (and more dense) populations, in which a sufficient 
supply of susceptibles can be maintained by birth. But the required population sizes are 
probably much larger than those in the Serengeti. An indication of how large they must 
be for classic dog rabies comes from the city of Guayaquil, Ecuador, in which infection 
was continuously present where dog densities exceeded 600/km2, but only sporadic in 
areas of lower density (Beran & Frith, 1988). These observations, and the fact that 
Serengeti dog rabies seems to persist at 5 dogs/km2, lead us to an investigate the 
possible role of atypical infections in maintenance of infection. 
Atypical infections and rabies dynamics. Our compartmental model of classic dog 
rabies (Fig. 4.1a) is easily modified to explore three different interpretations of 
seropositives - as slow incubators (Fig. 4. lb), healthy infectious carriers (Fig. 4. lc), and 
immunes (Fig. 4.2d). 
The consequence of allowing 5% of infected dogs to have a mean incubation period of 
20 weeks, rather than 4 weeks, is shown in Fig. 4.5b. Prolonged incubation periods are 
often invoked as a mechanism to account for persistence of rabies (e. g. Bingham et al. 
1994; Chaparro & Esterhuysen, 1993). However, this model shows that long incubation 
periods have relatively little impact on the underlying dynamics of the classic disease. 
The straightforward explanation is that in this population with low life expectancies, 
fewer dogs survive longer incubation periods and do not live long enough to become 
infectious. 
In contrast to the effect of long-incubators, inclusion of only 0.1% carrier dogs has a 
marked impact on the dynamics, lowering the probability of extinction (compare Fig. 
4.5c and 4.5a). The relatively few occasions on which the carrier state has been 
demonstrated has led to the prevailing view that carrier dogs are rare aberrants and 
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Figure 4.5 (a) Dynamics of classic dog rabies. S(0) = 960, L(0) = 2, /(0) = 1, 
v=0.00737/week, 5=0.00565/week, r=0.089/year. ß=0.00 15, Ro = 1.139. 
Numerical simulations were carried out with a time step of one week. 
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(b) Dynamics of dog rabies with slow incubators. Initial conditions and paranxters as in 
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Figure 4.5 Continued. 
(c) Dynamics of dog rabies with healthy, infectious carriers. Initial conditions and parameters as j 
Fig. 4.5a, but /c(0) = 0.0 = 0.00 123,4c = 0.999 (0.1ßb carriers). Ro = 1.139. 
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(d) Dynamics of dog rabies with an immune class. Initial conditions and parameters as in Fig. 4.5a 
but M(0) = 0, ß=0.00167, fir,, = 0.1 (10% immune animals). Ro= 1.138. 
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likely to be of little epidemiological significance. What this theoretical study shows, 
however, is that as few as 0.1% carriers, a figure less than has been observed in rabies- 
endemic populations of Ethiopia and Nigeria (Fekadu, 1972; Aghomo et al. 1989), can 
have a marked impact on the dynamics and likely persistence of dogs rabies. 
Fig. 4.5d (compared with Fig. 4.5a) shows that the dynamics are relatively insensitive to 
a fraction (10%) of dogs acquiring immunity following infection. This differs from 
results obtained by Coyne et al. (1989) for raccoon rabies, in which the amplitude and 
damping time of oscillations were noticeably reduced with 10% immune animals. In the 
raccoon model, the damping effect of the immune class appears to result from a 
lowering of Ro. By contrast, Ro in our model was kept constant in order to compare the 
effects of long-incubators, carriers and immunes independently of changes in 
transmission rate. 
IMPLICATIONS FOR CONTROL 
The findings of this study have several important implications for rabies control in the 
Serengeti. First, our conclusion that domestic dogs are likely to be the sole reservoir of 
rabies suggests that elimination of infection from domestic dogs should result in its 
disappearance from all other species. Controlling dog rabies, therefore, provides a 
single mechanism by which to remove the threat of rabies to Serengeti's wild 
carnivores, to its people and to their livestock. Second, the observation of a threshold 
density for persistence of 5 dogs/km2 allows us to target rabies control to higher-density 
agropastoralist dog populations, rather than lower-density pastoralist areas where rabies 
occurs only sporadically. 
The existence of rabies antibody in healthy, unvaccinated dogs at least underlines the 
question of whether carriers can help to maintain infection in Serengeti dog populations. 
If carriers do affect persistence, then they are also expected to influence the success of 
control, in ways that we have not explored here. Given this uncertainty, vaccination 
programmes must aim to satisfy the most stringent control criterion - maintaining 
sufficient herd immunity to keep the case reproduction number below 1, ensuring 
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extinction as well as preventing reinvasion. Both theory (Coleman & Dye, 1996) and 
practice (Beran, 1991) indicate that it should be enough to vaccinate 70% dogs, 
especially as this criterion has been established from experience with high-density, urban 
dog populations, where contact rates are probably higher than those in Serengeti. 
Rabies has been eliminated from the Serengeti before (Magembe, 1985a); presumably it 
can be eliminated again. 
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Chapter 5 
DOMESTIC DOGS AS RESERVOIRS OF CANINE DISTEMPER VIRUS IN 
THE SERENGETI, TANZANIA* 
* Authors of paper in preparation: Cleaveland S, Dye C., Munson L, a nd Appel M. J. G. 
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SUMMARY 
In 1994, canine distemper virus (CDV) was isolated from a domestic dog adjacent to 
the Serengeti National Park (SNP), during an epidemic which also affected lions, bat- 
eared foxes and spotted hyaenas. The domestic dog isolate was indistinguishable from 
viruses recovered from lions, hyaenas and bat-eared foxes, suggesting that one virus 
strain was circulating in a range of carnivores species in Serengeti. In order to 
investigate the role of domestic dogs as possible reservoirs of CDV in the Serengeti, 
data were evaluated from retrospective, cross-sectional and cohort studies of two 
domestic dog populations bordering SNP. Several lines of evidence suggest that CDV 
was stably endemic in higher-density dog populations of Serengeti District (SD) to the 
west of the park but sporadically epidemic in Ngorongoro District (ND), a lower- 
density pastoralist region to the south and east. First, the reported incidence of CDV- 
associated mortality and morbidity varied significantly between years (1991 to 1994) in 
ND but not in SD. Second, significantly more young dogs died in ND during the year of 
a CDV epidemic (1994), whereas there was no significant difference in age-specific 
mortality in SD across years. Third, seropositivity was detected in a proportion of SD 
dogs under 12 months of age in 1992,1993 and 1994, whereas in ND, seropositivity 
was detected in this age class only in 1994. Fourth, age-seroprevalence patterns in SD 
did not differ significantly between years, whereas significant differences were seen in 
the ND population, consistent with exposure of dogs to CDV in 1991 and 1994, but 
not in 1992 or 1993. There were similarities in infection patterns between lion, hyaena 
and ND dog populations, with serological evidence of sporadic exposure to infection. 
In lion and ND dog populations, a CDV epidemic in 1993-4 caused high mortality in 
immunologically naive animals. CDV appeared to be maintained only in higher-density 
dog populations of SD and this population is the most likely reservoir of infection for 
wild carnivores within SNP. However, the mechanisms by which stably endemic CDV 
infection is maintained are not fully understood in theory. 
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INTRODUCTION 
Canine distemper virus (CDV) is most frequently associated with infection in domestic dogs, 
as its name suggests. The virus is a rnorbillh'irus, closely related to measles in man, 
rinderpest in cattle and phocine distemper virus (PDV) in seals. Little is known about the 
dynamics of CDV infection in dog populations, but the abundant data and extensive analyses 
that have been carried out for measles provide a useful starting point for comparison. 
Ostensibly, CDV has similar infection characteristics to measles, with high transmissibility, 
short incubation and infectious periods, followed by death or by recovery with prolonged 
immunity (see Chapter 1). However, there are dissimilarities between measles and CDV in 
several observed epidemiological patterns. 
In large unvaccinated urban communities, measles tends to occur in regular, recurrent 
epidemics with large fluctuations in incidence, as predicted by simple epidemic models (Fine 
and Clarkson, 1982; Anderson and May, 1991). The measles virus is highly transmissible, so 
during an epidemic the supply of susceptibles rapidly becomes exhausted and epidemics tend 
to last only a few months. In contrast to urban measles, the incidence of CD (canine 
distemper) in temperate, urban dog populations tends to show only minor fluctuations. For 
example, before widespread dog vaccination was implemented, the annual incidence in 
Copenhagen varied only between 2% and 6% over a nine-year period (Erno and Moller, 
1961, cited in Gorham, 1966), which is a much smaller fluctuation than observed for 
measles, and suggestive of more stable endemicity. The consistency of serological profiles in 
several urban populations (for example, Stockholm, Copenhagen and Roanoke, USA) 
reinforces the impression of endemicity, with CDV antibody titres in pups increasing from 3 
to 24 months of age, after a decline in maternal antibody (Rockborn, 1958, cited in Gorham, 
1966; Cabasso et al., 1962). The acquisition of acquired immunity with age is also thought 
to explain the higher incidence of CD that has been observed in young urban dogs between 2 
months and 2 years of age (Appel, 1987). 
Typically, measles epidemics last only a few months (Fine and Clarkson, 1982), whereas 
more prolonged epidemics of CD have been reported in both domestic dog and wild 
carnivore populations. For example, two-year epidemics have been reported in dog 
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populations in Denmark (1984-1986) (Blixenkrone-Miller et a!., 1993) and in gray foxes 
and raccoons in Florida (Hoff and Bigler, 1974), and an epidemic among mustelids in 
southern Germany lasted for 12 months (1989-1990) (van Moll et a!., 1995). The quality of 
surveillance data for CDV is undoubtedly lower than for measles, but observations of 
prolonged epidemics for a highly transmissible microparasite are not easily explained by 
epidemic theory. 
In human communities which are smaller than the critical community size (see Chapter 1), 
the rate of generation of new susceptibles (by birth) is thought to be too low to sustain 
infection and measles often disappears in the troughs between epidemics. Similarly, CDV in 
small island dog populations (such as in Alaska and Greenland) also disappears after 
epidemics. In contrast to the pattern of urban CD, the disease in small, isolated populations 
occurs as irregular, explosive outbreaks following the introduction of infected dogs 
(Gorham, 1966), with mortality of up to 50% of the population. 
Incidence data from tropical Africa are sparse, but the impression is that CDV occurs as 
periodic epidemics. Over a three-decade period in Nairobi, for example, CDV outbreaks 
were reported at roughly 10-year intervals (1965-1966; 1974-1978; 1988-1989) 
(Bwangamoi et a1., 1989). Other authors report 5-year cycles of infection in Nairobi and 
Mombasa (Alexander and Appel, 1994; Alexander el al., 1995), but present no data for 
evaluation. It has been suggested that virus persistence is limited in the tropics because high 
ambient temperatures reduce virus survival in the environment (Appel, 1987). However, 
although low winter temperatures have been associated with an increased incidence of CD in 
some temperate populations (Gorham, 1966), there is scant evidence to suggest that 
environmental persistence plays a role in maintaining CDV. It is likely that seasonal factors 
affecting social behaviour and contact rate are probably more important, as for measles (Fine 
and Clarkson, 1982). 
Because of the many wildlife species that are susceptible to infection and potentially capable 
of transmitting the disease to dogs (reviewed in Chapter 1), it is commonly held that 
elimination of CDV in dogs is not feasible (Appel, 1987; Chappuis, 1995). Indeed, Gorham 
(1966) considered the concept of eradicating CDV "a prediction for the unenlightened". 
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However, there are few epidemiological data on which to base this premise. To act as 
reservoirs, wild carnivores must be able to maintain infection independently of dogs, but 
rarely has this question been addressed. 
Most wildlife outbreaks have been reported as explosive epidemics with only short-term 
maintenance of virus in populations (Montali et al., 1987). But for raccoons, there is 
evidence that CD persists in some populations. In New Jersey, for example, raccoon CD has 
been reported for each of 15 years (1977-1991) and infection appears to be maintained in 
the population as shifting, localised epidemics which, in any given location, occur at 4-year 
intervals (Roscoe, 1993). In a larger area covering 10 southeastern States, CD was also 
detected in gray foxes in 16 out of 18 years. Although CD was reported to be widespread, 
detailed temporal and geographical incidence data were not presented in this study 
(Davidson et al., 1992). Mustelids have been proposed as a reservoir for CDV infection in 
dogs on the basis of antigenic similarities between canine and mustelid morbillivirus isolates 
(Alldinger ei al., 1993). However, the fact that the 1989 German mustelid epidemic 
followed a distemper epidemic in dogs in France and did not initiate an epidemic in dogs in 
nearby Saarbrucken (van Moll el at., 1995), argues against the view of CD in dogs being 
driven by epidemics in wildlife. Similarly, during a gray fox and raccoon epidemic in Florida, 
" the incidence of CD in dogs did not increase (Hoff and 
Bigler, 1974). 
The difficulties of disease surveillance in wildlife mean that CDV may become apparent only 
during epidemics or when infection occurs in a conspicuous species. Although serological 
studies have demonstrated exposure of many wild populations to CDV (reviewed in Chapter 
1), these have usually been restricted to single cross-sectional surveys. Little is still known of 
age-incidence and age-seroprevalence patterns in wildlife, of longer-term trends in infection 
rates, or of the relationship between infection and mortality and morbidity patterns in host 
populations. 
Following outbreaks in the Serengeti-Mara ecosystem, CD has become a conservation issue. 
A CD epidemic in domestic dogs of the Masai Mara in 1991 may have contributed to the 
concurrent disappearance of endangered African wild dogs, Lycaoni pious (Alexander and 
Appel, 1994). In 1994, CD was also confirmed in a range of wild carnivores in the 
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Serengeti National Park, affecting lions (Panthera leo), spotted hyaenas (Crocuta crocruta) 
and bat-eared foxes, Otocyon megalotis (Roelke-Parker et al., 1996) . 
Because CDV is 
perceived as a threat to vulnerable carnivore populations, such as the wild dog, control of 
the disease in the Serengeti has recently become a goal for conservation. However, the 
efficacy, feasibility and design of any CDV control programme can only be determined once 
the epidemiology of the disease is understood and reservoir populations have been identified. 
In this chapter, data are presented from retrospective, cross-sectional and cohort studies, 
which include: 1) reported CD-associated morbidity and mortality (retrospective and cohort 
studies); 2) overall mortality rates (cohort studies); 3) CDV age-seroprevalence patterns 
(cross-sectional survey); 4) antigenic typing of CDV isolates. We use these findings, in 
combination with published data from wildlife studies, to explore the dynamics of CD 
infection in different Serengeti dog populations, with the following aims: (i) to investigate 
temporal and regional patterns of CDV infection, (ii) to investigate age-specific rates of 
infection and (iii) to identify possible reservoir populations of CD in the Serengeti. 
MATERIALS AND METHODS 
Study Areas 
The study area was the Serengeti ecological region of Northwestern Tanzania (350 to 
36° E, 10 30' to 30 7' S). Villages were selected from two regions adjacent to the 
Serengeti National Park (SNP) - the Serengeti District (SD) and Ngorongoro District 
(ND) (see Fig. 2.1). The Ngorongoro District comprises the Loliondo Game Control 
Area (LGCA) and the Ngorongoro Conservation Area (NCA). These regions are 
described in detail in Chapter 2. 
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Serum Samples 
Serum samples for cross-sectional surveys were collected from September 1992-February 
1993 (referred to as 1992), September-December 1993 and August-December 1994. Serum 
samples were collected from different dogs in each of the three years. Households within a 
village were visited systematically and, where possible, dogs restrained for collection of 
blood samples. Blood was collected from the cephalic vein, serum separated within 24 hours 
and stored for up to 3 years at -20°C before analysis. 
Diagnosis and Virus Isolation 
Tissue samples were collected from a domestic dog suspected of dying from CDV in 
Nainokanoka (NCA). Tissues were collected into 10% formalin and stored fresh in liquid 
nitrogen. Histopathology was conducted by Dr. L. Munson at the University of Tennessee, 
USA. Tissues for histopathology were embedded in paraffin, sectioned at 5 to 7 tm and 
stained with haematoxylin and eosin (H&E). For immunohistochemical examination, 
paraffin-embedded tissues were deparafnized, treated to remove endogenous peroxidase 
and incubated with a mouse monoclonal antibody to CDV-N protein (Mab N3.991)(Örvell 
et al., 1985). A commercial avidin-biotin kit was used to identify sites of Mab binding to 
tissues (Roelke-Parker et al., 1996). Negative controls were duplicate sections stained using 
a Mab for influenza virus replacing CDV Mabs, and positive controls were brain sections 
from a confirmed case of CD in a domestic dog. 
Virus isolation was carried out by Dr. M. Appel at Cornell University, USA, using canine 
blood lymphocytes as described by Appel et a!. (1992). The monoclonal antibody (Mab) 
binding pattern of the virus isolated was compared with those isolated from a Serengeti lion, 
bat-eared fox and spotted hyaena and with virulent strains of CDV isolated from dogs in 
1958 (Rockborn CDV strain) and 1975 (A75-17 1975). Mabs (donated by Dr. C. Örvell, 
Hudding, Sweden) were directed against viral nucleoprotein (N), polymerase (P), fusion 
glycoprotein (F), and haemagglutinin glycoprotein (H). 
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Clinical Disease 
Retrospective clinical histories of dogs were obtained from owner questionnaires, for the 12 
months prior to the study (see Appendix, Questionnaire B). Full questionnaire surveys were 
conducted in 1992 and 1994 (see Chapter 2), so morbidity data are available for the period 
1991-2 and 1993-4 only. Since these data apply only to dogs alive at the time of the survey, 
we use morbidity to refer to animals showing clinical signs of disease and recovering. 
Clinical signs that could be clearly described were coded and included vomiting, coughing, 
nervous signs, diarrhoea, anorexia, wounds/injuries and skin lesions, "worms", and weight 
loss/wasting. Dogs that appeared sick at the time of the visit were given a brief clinical 
examination. 
Since dogs with CD can exhibit a wide range of presenting signs (Appel, 1987), two 
estimates of CD morbidity were determined using different clinical criteria; i) dogs that had 
been vomiting and coughing and ii) dogs showing any of the following signs: vomiting, 
coughing, nervous signs, diarrhoea and anorexia. An indication of the relative specificity of 
these criteria for identifying CD was obtained from analysis of associations between CDV 
seroprevalence and CDV morbidity, using odds ratios (OR) expressed with 95% confidence 
limits calculated in EPI-INFO (Dean et al., 1990). Recovery from clinical CD was 
determined from CD morbidity as a proportion of total CD cases (morbidity plus mortality). 
Morbidity was analysed as binary data, with dogs having shown clinical signs consistent with 
CD scored as 1, and those that had not scored as 0. Binary data were converted into 
probability values by fitting a logistic regression model, using the logit link function with 
binomial errors (McCullagh & Neider, 1989). The parameters of the model were estimated 
by maximum likelihood using GENSTAT 5.3 (Payne eta!., 1993). The process of model- 
fitting was based on stepwise deletion, described by Crawley (1993) and in Chapter 2. 
Explanatory variables in the full model included region and year with an interaction term 
between year and region. 
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Mortality 
The following measures were used to investigate patterns of mortality: 
Age: The ages of dogs included in the cohort studies and cross-sectional serological surveys 
were determined from questionnaires and, for young dogs, by visual inspection (see Chapter 
2). 
Death rates: Two sources of data were available for mortality. First, causes of mortality 
were determined retrospectively for 1991-1992 through questionnaire surveys of 273 
households carried out in 1992. Second, mortality rates in cohorts of 330 dogs (1992 to 
1993) and 380 dogs (1993 to 1994) were determined from longitudinal studies. The age and 
sex of dogs that died could not be determined reliably from retrospective questionnaires, so 
age- and sex-specific mortality rates were available only for cohort studies of 1992-3 and 
1993-4. In each study, an indication of the cause of death (categorized as disease, predation, 
disappeared/stolen, other) was obtained by questioning owners. If the dog was reported to 
have died from disease, the owner was questioned on clinical signs and duration of illness. A 
death was recorded as suspected CD when owners reported that a dog had shown vomiting 
and coughing (see Table 5.2). 
Analysis of mortality from cohort data was carried out in Chapter 2 for SD and ND 
separately to investigate age-specific mortality rates for each region. Here, we aim to 
compare mortality between SD and ND, so include region in the full model together with 
age class, year, sex and their interaction terms. Mortality was analysed as binary data, as 
described in Chapter 2. 
In order to use questionnaire data from 1991-2, CD case-mortality was analysed as a 
proportion of total deaths for 1991-2,1992-3 and 1993-4. A cause of death could not be 
assigned for each dog dying, so results were used only comparatively to investigate patterns 
between regions and years. These data were analysed as binary data, with a dog scored as I 
if it had died showing clinical signs consistent with CD, and 0 if it had died from other 
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causes. Explanatory variables in the model included region, year and a region. year 
interaction term. 
Measurement of Antibodies to CDV 
Serum neutralizing antibodies to CDV were measured at Cornell University, USA, by Dr. 
M. Appel, using a microneutralization test. The technique is described in detail elsewhere 
(Appel and Robson, 1973). Briefly, three-fold dilutions of test serum were prepared and 
added to each of four rows of a microtitration plate. 50 µl of virus (Ondersterpoort strain of 
CDV adapted to Vero cells) were added to each serum dilution and incubated at 20° to 25° 
C for two hours. 50 µl tissue culture medium containing approximately 12,000 Vero cells 
were then added to each well and incubated at 36° C in a humidified 5% CO2 incubator for 3 
days. Cells were fixed in methanol and stained with Giemsa stain for 20 minutes. Cells were 
examined microscopically, infected cells identified by the presence of mutinucleated giant 
cells. Titration end points were calculated by the Spearman-Kärber method and expressed 
as logto of the reciprocal end-point dilution (abbreviated to log dilution). 
Analysis of Seropreºalence 
CDV seropositivity was analysed as binary data, with dogs scored as 1 if seropositive and 0 
if seronegative. Explanatory variables in the full model included age class, region, year, sex 
and their interaction terms. The full model also included the following behavioural 
characteristics, which were considered possible risk factors for CDV infection: a history of 
having been bitten, function of dog (guarding property or herdingthunting), and origin of 
dog (born from own bitch or acquired from elsewhere). Interaction terms for these variables 
were included in the full model only if the association had previously been shown to be 
significant (Chapter 2). 
A simple endemic model was fitted to age-seroprevalence data, using an expression derived 
from Equation 4.1 with p=0. With no recovery from seropositive to seronegative we 
therefore assume that once infected, animals become seropositive and acquire life-long 
immunity (seropositivity). 
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The model is given by the equation: 
42= A(1-p) 
da 
(S. 1) 
where p is the proportion seropositive at age a. As with Equation 4.1, this assumes a 
constant force of infection, X. From this, 
-eý`' p=1 (5.2) 
and bi (1-p) =- Aa (5.3) 
or bi (SIN) = -la (5.4) 
where S is the number susceptible (seronegative) at age a and N the total number sampled at 
age, a. 
Linear regression was used to investigate the goodness-offit of this model to seroprevalence 
data (the number of seropositives as a proportion of all dogs in each region and year). The 
analysis was carried out in GENSTAT 5.3 (Payne et a!., 1993) using the log link function 
with Poisson errors and log number as an offset (Crawley, 1993). 
A linear regression analysis, carried out in GENSTAT 5.3, was used to investigate the 
relationship between age and antibody titre in seropositive dogs. 
Calculation of Ro 
Calculation of the basic reproduction number, Ro, allows an estimate of the critical 
percentage of the population that needs to be immune, p, to prevent outbreaks of disease 
(Anderson and May, 1991), described by Equation 1.5. 
As discussed in Chapter 2, there are several methods of calculating R0, each with differing 
assumptions. Here we estimate Ro using two approaches based on modifications of 
Equations 1.3 and 1.4. In using seroprevalence data (Equation 1.3), we ignore neonates for 
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the reasons discussed in Chapter 2, and calculate the fraction susceptible, x, from the 
proportion seronegative in each class multiplied by the proportion of dogs in each age class. 
In the second method of calculating Ro, we use a modification of Equation 1.4 as follows, 
Ro =I+B, IA (5.5) 
where Bp is the reciprocal of the per capita rate of recruitment of pups, and A the average 
age to infection. 
In Chapter 2, we showed that SD is a growing population with births exceeding deaths, so 
the rate of generation of susceptibles is more accurately described by birth rates rather than 
life expectancy. We adopt a further modification by using the rate at which 3-month old 
pups are recruited into the population, rather than actual birth rates, to avoid dealing with 
possible heterogeneities in mortality and mixing in this age group (Chapter 2). From 
estimates of r and per capita death rates, we obtain an estimate of the SD per capita birth 
rate as 0.383/year. We use neonatal survivorship data to obtain an estimate of pup 
recruitment, BP, as 0.287/year. The average age to infection, A, is determined from l/X, 
where X, the force of infection, is expressed as the slope (with standard error, SE) of the 
linear expression in Equation 5.4. 
RESULTS 
Sample Sizes 
A proportion of the total number of sera collected during this study (shown in Table 5.1) 
was analysed for CDV serology, because laboratory constraints precluded analysis of the 
entire sample set. Sera were selected for this analysis to provide a representative sub-sample 
across age groups, years and areas. 
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Table 5.1. The number of blood samples analysed for CDV serology by year and area.. 
Year Serengeti District 
(SD) 
Ngorongoro District 
(ND) 
1992 38 75 
1993 42 56 
1994 82 125 
Case Morbidity and Mortality in Domestic Dogs 
Veterinary observations. In 1994, local veterinary officers in LGCA reported an apparent 
increase in CDV incidence between March and May. No cases were reported in NCA until 
September 1994, when one case was confirmed on the northeastern rim of the Ngorongoro 
crater (see below). Four out of 11 dogs in the same household were showing clinical signs 
consistent with CDV at this time. 
During a 10-day period in November 1994,8/131(6.1%) dogs observed on the western and 
northern borders of the Ngorongoro crater (NCA) were suffering from clinical disease and 
all showed signs of mucopurulent bilateral ocular/nasal discharge, enlarged submandibular 
lymph nodes, coughing, vomiting, and anorexia. One of the 8 dogs exhibited myoclonus 
(rhythmic twitching) of the hind limb and hind-limb ataxia. 
Con firmed Case. Tissues from the CDV-infected dog in NCA showed signs of non- 
suppurative encephalitis, severe suppurative pneumonia and lymphoid hyperplasia with 
histiocytosis in the lymph nodes. Viral inclusions were identified in the lymph nodes and 
these were confirmed as CDV using anti-CDV monoclonal antibodies. 
The virus isolate showed a identical monoclonal antibody reaction pattern to isolates 
obtained from a lion, hyaena and bat-eared fox during the 1993-4 epidemic (Fig. 5.1). These 
were furthermore indistinguishable from virulent CDV dog strains isolated in 1958 and 
1975 
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Figure 5.1. Monoclonal antibody (Mab) binding pattern of CDV isolates from a domestic 
dog, lion, bat-eared fox and hyaena from the Serengeti compared with virulent strains of 
CDV isolated from dogs in 1958 (Rockborn CDV strain) and 1975 (A75-17 1975). Solid 
squares designate binding of Mab to the virus, open squares designate lack of binding. 
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Morbidity reported by owners. Estimates of CD morbidity obtained from questionnaire 
surveys are shown in Fig. 5.2. Of dogs that had been ill, those that had been vomiting and 
coughing were more likely to be CDV seropositive than those showing other clinical signs: 
for dogs showing vomiting/coughing OR = 3.70 (1.1-12.5); n= 60; p<0.05 (Table 5.2a); for 
dogs showing any of the following signs, vomiting, coughing, diarrhoea, nervous signs, or 
anorexia, OR = 2.33 (0.7-8.3), n= 60; p>0.05 (Table 5.2b). 
Table 5.2. (a) Proportion of CDV seropositives in dogs that had shown clinical signs of 
vomiting and coughing during the past year compared with those with other clinical signs. 
Dogs that were 
vomiting and 
coughing 
CDV antibodies 
+- 
-7 15 
+ 24 14 
Table 5.2. (b) Proportion of CDV seropositives in dogs that had shown vomiting, 
coughing, diarrhoea, nervous signs or anorexia, compared with those with other clinical 
signs. 
Dogs showing any 
of the above 
clinical signs 
CDV antibodies 
+- 
12 10 
I+ 28 10 
Since dogs recovering from CD develop antibodies (Appel, 1987), this analysis indicates 
that fewer false positives (CDV seronegatives) were detected when using the more specific 
combination of vomiting and coughing only. These clinical signs were therefore used as 
criteria for defining CD-associated mortality and morbidity in subsequent analyses. 
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Figure 5.2. Reported cases of disease with clinical signs consistent with canine 
distemper. Data are from owner questionnaires about the clinical history of dogs alive at 
the time of the survey. 
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Figure 5.3. Proportion of deaths attributed to canine distemper from questionnaire 
surveys (1991-2) and cohort studies (1992-3 and 1993-4). 
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From the logistic regression analysis, CD morbidity was significantly higher in ND than in 
SD when controlling for year (x21 = 8.3, p<0.01), and significantly higher in 1993-4 than in 
1991-2 when controlling for region (x21 = 18.4, p<0.001). The regional pattern differed 
significantly in the two years, with more cases in ND in 1993-4 than in 1991-2 but fewer in 
SD (x2, = 19.9, p<0.001). 
Reported mortality due to CD. The number of dogs dying with clinical signs attributed to 
CDV is shown by region and year as a proportion of total mortality (Fig. 5.2). There were 
significant differences in the proportion of deaths attributed to CD between years, with the 
highest proportion of case fatalities reported in 1993-4 (x22 = 24.0, p<0.001). Overall, there 
was no significant effect of region alone (x21 = 3.7, p>0.05), but there were significant 
regional differences in the patterns between years, with a greater increase in case fatalities in 
ND in 1993-4 than in SD (X22 = 14.2, p<0.001). 
Mortality. Mortality rates have previously been shown for each region in Figs. 2.4a and b. A 
minimum logistic model for mortality is shown in Table 5.3. The greatest proportion of total 
deviance was explained when age was classified into three groups; 0-1 years, 1-2 years and 
>2 years. Controlling for age, mortality was significantly higher in 1993-4 than in 1992, 
however this was driven largely by reduced survival in ND. In SD alone, age-specific 
mortality did not vary significantly between years (see Chapter 2). The significant interaction 
term between age class and region is partly explained by disproportionately high mortality in 
young dogs (0-1 and 1-2 year-olds) of ND. There was no significant difference in mortality 
rates between females and males (x2, = 0.4, p>O. 05). Nor did sex influence the magnitude of 
age (x22 = 0.9, p>0.05) or regional effects (X21= 0.9, p>0.05). 
Recovery from clinical CD. Recovery from clinical disease could only be determined for 
1994, this being the only year for which both longitudinal mortality and morbidity data were 
available. For SD, CD was reported in 8/177 (4.5%) surviving dogs and in 11/253 (4.3%) 
dying dogs, giving an estimated recovery rate of 4.5/8.8 = 51.1%. For ND, CD was 
reported in 44/258 (17.1%) surviving dogs and 21/203 (10.3%) dying dogs, giving a 
recovery rate of 17.1/27.4 = 62.4%. 
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Table 5.3. Minimum adequate model of mortality in a cohort of dogs (> 3 months) from 
1992-3 and 1993-4. The model had a total deviance of 789.7 with 614 degrees of freedom 
The chi-square value is the difference in deviance when two models are compared. In this 
analysis, models b and c were compared with model a, d compared with b, and models f 
and g compared with model e. Significance levels were recorded as NS p>0.05, * p<0.05 
and *** p<0.001. 
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Seroprevalence in Domestic Dogs 
The frequency distribution of antibody titres, shown below, indicates bimodality in the 
distribution of values. 
Figure 5.4. Frequency distribution of CDV antibody titres in Serengeti domestic dogs. 
70 
60 
50 
9 40 
E 
z 30 
20 
10 
0 
0 0.5 1 1.5 2 2.5 3 3.5 4 
L. oglo dilution 
The cut-off point for the microneutralization test was reported by Cornell University as loglo 
dilution > 1.0. On the basis of qualitative evaluation of the frequency distribution of 
Serengeti domestic dog titres, this value was also adopted here. 
Results of a minimum logistic model for CDV seroprevalence are shown in Table 5.4. 
Seroprevalence increased significantly with age in all areas (Figs. 5.5a and 5.5b). Controlling 
for age, there were significantly more seropositives in 1994 than in either 1992 or 1993. This 
effect varied significantly between regions, with proportionally more seropositives in ND in 
1994 than in SD. Year and regional differences were also affected by age class, with 
disproportionately high seropositivity in young dogs in ND in 1994. There were no 
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Table 5.4. Logistic model of seroprevalence data. The model had a total deviance of 
529 with 382 degrees of freedom. The chi-square value is the difference in deviance 
between each model and the one above it, except for model f which is compared with 
model d, and model g which is compared with model c. This measures the deviance 
explained by each variable while controlling for the effects of all other significant terms. 
Significance levels were recorded as NS p>0.05, * p<0.05 and *** p<0.001. 
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significant effects of sex, bite history, function of dog, origin of dog or rabies seropositivity 
on CDV seropositivity. 
Figs. 5.5a and 5.5b demonstrate the yearly differences in age-seroprevalence pattern in each 
region. Seropositivity was detected in pups in each of the three study years in SD. In ND, no 
pups were seropositive in 1992 (n = 7), and no pups (n = 17) or yearlings (n = 12) were 
seropositive in 1993. In ND in 1994, seropositivity was relatively constant across all age 
classes. 
There was no significant effect of age on the geometric mean titre of seropositive dogs 
(FI, 126 = 0.51, p>0.05). 
Endemic Infection Model 
In both SD and ND there was a significant effect of age on seropositivity (SD: X2, = 11.8, 
p<0.001; ND: x21 = 12.4, p<0.001) (Fig. 5.6). Seropositivity increased at a rate, %, of 
0.0264/month (SE = 0.008) in SD at a rate, X, of 0.0224/month (SE = 0.006) in ND. In 
SD, there was no significant difference in the fit of the model between years (x22 = 0.2, 
p>0.05), whereas there were significant year-to year differences in ND (X22 = 6.3, p<0.05). 
These estimates of X give an average age to infection of 37.9 months (95% C. I = 29.1 - 54.3 
months) for SD and 44.6 months (95% C. I. = 35.2 - 61.0 months) in ND. 
Calculation of Ro 
Because of the variability in infection pattern across years and the apparent instability of the 
population in ND, Ro was calculated for SD only. From age-seroprevalence data, the 
fraction susceptible was estimated as 0.530, giving a value for Ro of 1.89, and pc as 47.1 %. 
Using per capita rates of pup recruitment in Equation 5.5, the estimate of Ro was 2.10 (95% 
C. I. = 1.78 - 2.44) giving an estimate ofpp as 52.4% (95% C. 1. = 43.8% - 59.0%). 
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Figure 5.5. CDV age-seroprevalences for 1992,1993 and 1994. 
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Figure 5.6. Seroprevalence against age for SD (0 ) and ND () dogs, with all years 
combined. The solid lines are the fit of Equation 5.2, with 7. = 0.0264 for SD and X_ 
0.0224 for ND. 
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DISCUSSION 
Infection Patterns in Domestic Dogs 
The isolation of CDV from a domestic dog during a reported outbreak in NCA in 1994 
confirms the presence of the virus in domestic dog populations of the Serengeti. The 
histological findings were consistent with acute distemper encephalitis, similar to those seen 
in young dogs suffering from acute infection in other studies (e. g. Krakowka et al., 1985; 
Baumgartner et al., 1989). The consistency of clinical signs in 12 other sick dogs leads us to 
assume that the observed disease outbreak in the Ngorongoro area in late 1994 was also due 
to CDV infection. 
Although the clinical criteria used in this study to define CD cases inevitably include both 
false positives and false negatives, significant trends emerge from reported morbidity and 
mortality that provide supportive evidence for distinct patterns of disease in different 
populations. These data indicate that, in ND, two separate outbreaks of CD have occurred - 
one in late 1991 and one in early 1994, with no reported cases between outbreaks. In 
contrast to this episodic pattern of infection in ND, CD cases were reported during each 
year of the study in SD. 
In a stably endemic population, we would expect to see less variation in disease-specific 
mortality than in populations that experience sporadic epidemics. In populations infected 
sporadically, we would also predict that case-mortality would occur primarily in younger 
dogs that had not been alive at the time of previous outbreaks. Although CD is clearly only 
one component of mortality, the age-specific mortality data are in he with these predictions, 
with little variation in age-specific mortality in SD between years, but disproportionately 
high mortality in younger dogs in ND. 
Serological studies provide further evidence for differences in CDV infection patterns 
among dog populations of different geographic areas. Thus, the logistic regression analysis 
and the fit of the endemic model indicated that age-seroprevalence data in ND were 
significantly different between years whereas SD seroprevalence patterns were more stable. 
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Further, seroprevalences in pups (< 12 months of age) and yearlings suggest a pattern of 
periodic exposure to infection in ND, compared with persistent infection in SD. 
In ND, the ages of seropositive dogs sampled in 1992 (> 1 year) and 1993 (> 2 years) 
suggests that this population was exposed to CDV in 1991 and is consistent with a 
southward spread of a CD epidemic reported in the Masai Mara in 1991 (Alexander and 
Appel, 1994). In 1991, all study packs of African wild dogs disappeared or died in the 
Serengeti (Burrows, 1995) and these results are consistent with a hypothesis that CDV was 
a factor in their demise (Macdonald et a!., 1992; Ginsberg eta!., 1995). 
While CDV appears to have been absent in ND in 1992 and 1993, sample sizes are small 
and we cannot rule out low-level infection in these years. Seropositivity in 2-year olds 
sampled in 1993 was also higher than in 1-year olds sampled in 1992, suggesting exposure 
to CDV between 1992 and 1993. This result may be biased, however, by the sampling 
locale. In 1992, dogs were sampled broadly across the Loliondo and Ngorongoro areas, but 
in 1993, sampling effort was restricted to higher-density villages where we might expect 
infection rates during an outbreak to be higher. 
An increase in seroprevalence with age may result from (i) a constant force of infection in 
an endemic area, (ii) differential rates of exposure in populations experiencing sporadic 
outbreaks or (iii) an increase in disease resistance with age, such that a greater proportion of 
older dogs survive infection to become seropositive. For CDV, age-related susceptibility to 
infection has been shown experimentally to be highest in neonatal pups (<4 weeks), but 
when older than 4 weeks, juveniles show no higher CDV-induced mortality than adults 
(Krakowka and Koestner, 1976). Failure to identify significant behavioural risk factors for 
infection suggests relative homogeneity in contact and mixing rates. The most plausible 
explanation for the observed age-seroprevalence pattern in SD is therefore one of stable 
endemic infection. 
However, this interpretation is not easily reconciled with theoretical predictions of recurrent 
epidemics for highly transmissible microparasites. The possibility that CDV can be 
maintained as a stable endemic infection is supported by historical data from large, urban 
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populations (Gorham, 1966) and raises questions about our assumptions concerning the 
transmission dynamics of CDV in natural populations. A recent study of hyaenas in the 
Masai Mara, Kenya reinforces these uncertainties, with the demonstration of a low rate of 
horizontal transmission between members of the same clan and no consistent relationship 
between the serological status of mothers and cubs (Alexander et al., 1995). Although, in 
experimental infections, all animals become infectious (Appel, 1987), these epidemiological 
observations suggest there may be greater individual heterogeneity in natural situations. 
A further inconsistency arises between observations of persistent infection and estimates of 
? derived from the simple endemic model. In SD, this gave an average age to infection (38 
months) that is longer than the estimated life expectancy of the SD population (23 months - 
Chapter 2), implying that dogs, on average, do not live long enough to become infected and 
the virus should therefore disappear from the population. 
However, the catalytic model used here may be inappropriate for estimating X since this 
assumes there is no selective host mortality due to infection, whereas it is clear that 
CDV does cause significant mortality. As has been shown for other infections, such as 
shistosomiasis, ignoring host mortality may substantially modify estimates of parameters 
obtained from catalytic curve analysis, leading to underestimates of the force of 
infection (Cohen, 1973). Therefore, an improved model for CDV should explicity 
include a term for CDV-induced death. 
Failure to account for selective mortality may also explain why the asymptote of the 
curve in Serengeti dogs does not reach 100%. There are several other possible explanations 
for this: (i) dogs lose seropositivity over time (as observed for rabies in Chapter 4), or (ii) 
there is a refuge of protected animals in the population that are never exposed to infection. 
However, in classic CDV, seropositivity in dogs is prolonged, if not life-long. We 
furthermore have no evidence from behavioural observations for refuge from infection 
within the population. 
The mechanisms underlying persistence of morbilliviruses are still unclear and there are 
currently no mathematical models that adequately explain both virus persistence and the 
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observed infection dynamics. Simple compartmental models of phocine distemper virus 
(PDV), for example, predict virus extinction from North Sea seal populations following the 
1988 epidemic (Grenfell et al., 1992). Yet the virus continues to persist, with antibody 
detected in both gray seal and harbour seal pups born since the epidemic (Visser et al., 
1993). Among gray and harbour seals, there is evidence that some animals may remain 
infectious for several months (Visser et al., 1989), and it has been suggested that prolonged 
excretors may play a role in PDV persistence (Visser et al., 1993). In dogs, too, periods of 
virus excretion of up to 90 days have been recorded in sub-acute CD (Greene, 1984) and, 
although it is generally considered that morbilliviruses are unable to induce an asymptotic 
carrier state, the isolation of infective CDV from tissues of persistently-infected dogs 
(Imagawa et al., 1980) at least raises the possibility of prolonged infectiousness in chronic 
CD. It is clear that there is considerable variability in the outcome of CDV infections, and 
their quantitative significance for maintenance of disease warrants further examination. As 
demonstrated for rabies, even if carriers occur only rarely, they may have a significant impact 
on disease dynamics (Cleaveland and Dye, 1996; Chapter 4). 
Antigenic Characteristics of rims Isolates 
The finding of indistinguishable strains of CDV isolated from a domestic dog, lion, hyaena 
and bat-eared fox, provides support for the view of a single virus strain circulating, and 
causing disease, in both wildlife and domestic dog populations of the Serengeti. Molecular 
and monoclonal studies further show that the Serengeti virus is not a new or separate felled 
morbillivirus, but closely similar to pathogenic strains of domestic dog CDV (Harder et at, 
1995; Roelke-Parker et al., 1996). Although these findings show that the 1994 Serengeti 
virus strain is pathogenic to a wide range of wildlife species, and is transmissible between 
these species and domestic dogs, it does not resolve the question as to which populations 
are acting as reservoirs hosts. 
Comparison of Infection Patterns between Domestic Dogs and Wildlife 
The CDV epidemic in 1993/1994 caused an estimated 30% mortality in the Serengeti lion 
population as well as confirmed cases in hyaenas and bat-eared foxes (Hoofer and East, 
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1995; Roelke-Parker et al., 1996). Immunological naivity of the lion population was 
suggested, first, by the similarity in mortality rates of cubs and adults in 1994, and second, 
by the absence of CDV antibodies in all of 25 animals sampled before the epidemic (1990- 
1992) (Roelke-Parker et al., 1996). In hyaenas, too, both cubs (Hofer and East, 1995) and 
adults (Roelke-Parker et a!., 1996) died during the epidemic. The first diagnosis of CD in 
lions and hyaenas was recorded in 1994, but in both populations, seropositivity was detected 
during the 1980s, suggesting prior exposure to the CDV (Hofer and East, 1995; Roelke- 
Parker et al., 1996). These findings suggest first, that the 1994 virus more virulent for felids 
and hyaenids than the virus infecting these populations in the 1980s, and second, that CDV 
infection in lions and hyaenas occurs only sporadically. 
Support for sporadic exposure of the Serengeti hyaena population comes from the Masai 
Mara, Kenya, where no seropositives were found in 1979, whereas seropositivity was 
detected in hyaenas of all age groups from 1980-1982 (Alexander et a!., 1995). There are 
also similarities between pastoralist dog populations of the Masai Mara and those of ND, 
with both populations experiencing episodes of infection, but appearing unable to maintain 
infection between epidemics. Thus, in the Masai Mara, CDV seroprevalences of only 1.8% 
were recorded in dogs in 1989 and 1990, which rose to 76% in 1991 following an epidemic 
that caused high mortality (Alexander et al., 1993a; Alexander and Appel, 1994). 
Drawing together the available data from domestic dog and wildlife populations, we 
conclude that CDV is maintained in domestic dogs, and not wildlife populations of the 
Serengeti, and that domestic dogs of higher-density populations in SD are the most likely 
reservoir of infection. 
Transmission 
Although the exact routes of transmission between dogs and wildlife are unknown, there are 
many opportunities for CDV to be passed from the putative reservoir dog population in SD 
to wildlife within the park. In areas of SD neighbouring the park, frequent, often aggressive, 
encounters occur between several wildlife species and domestic dogs (see Chapter 2). 
These are probably most common when large numbers of wildebeest (and associated 
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predators) pass through SD during the annual migration to and from the Masai Mara. 
Hyaenas, in particular, may travel large distances following wildebeest, spending several 
days on foraging trips before returning to the clan's territory inside the park (Hofer et al., 
1993). This `commuting' behaviour, together with their proximity to other carnivores at 
kills, provides an effective potential route for transmission of CDV to wild animals not 
directly in contact with dogs. Supportive evidence for a link between domestic dogs and 
hyaenas comes from the Masai Mara, Kenya, where low-ranking hyaenas, that scavenge 
more in villages, had higher CDV seropositivity rates than high-ranking animals (Alexander 
et al., 1995). 
Implications for Control of CD V 
The conclusions of this study have important implications for CDV control. First, if dogs of 
SD are indeed the only population capable of maintaining infection, elimination of CDV in 
this population should prevent future outbreaks in wildlife. Second, preliminary estimates of 
Ro suggest that endemicity in SD is fragile, and that vaccination of 55% of dogs should 
provide the theoretical vaccination coverage required to prevent outbreaks of CD in the 
Serengeti. However, further estimates of Ro and p, need to be obtained using a recovery 
model that accounts for significant levels of disease-induced mortality. 
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GENERAL DISCUSSION 
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Rabies and Canine Distemper in the Serengeti 
In Chapter 2, we demonstrated significant differences in the demographic and 
behavioural characteristics of domestic dog populations in an agropastoralist region to 
the west of the Serengeti National Park (Serengeti District - SD) and those in 
pastoralist regions to the south and east (Ngorongoro District - ND). Because 
demography is both a determinant and a consequence of fatal microparasite infections, 
these observations led to the prediction that infection patterns for rabies and canine 
distemper virus (CDV) were likely to differ in SD and ND, dog populations. Evidence 
was presented in Chapters 4 and 5 to support the view that rabies and CDV persist only 
in the higher-density domestic dog population of SD and that this population is the 
reservoir of both diseases in the Serengeti. Infection with rabies and CDV occurs 
sporadically in ND domestic dogs, as well as in several wild carnivore populations, but 
these populations appear unable to maintain infection. 
We aim to test the robustness of these conclusions by controlling disease in putative 
reservoir populations through vaccination. We therefore plan to carry out vaccination 
trials in SD dogs to assess the effect of vaccination on viral persistence and endemicity. 
Further, we aim to test the theoretical prediction that endemicity of CDV and rabies is 
fragile and that vaccination of 70% of the population should therefore reduce the 
effective population below the threshold for persistence. 
The Design of Domestic Dog Vaccination Programmes 
Results of this study demonstrate that accessibility of dogs to parenteral vaccination in 
SD is high and that attaining a vaccination coverage of 70% should be feasible through 
central-point vaccination. Awareness and concern about rabies undoubtedly stimulated 
the high turn-out in our trials, but several other elements contributed to the positive 
public response to vaccination, particularly the concurrent administration of ivermectin. 
Accessibility was much lower in ND and alternative strategies are probably required if a 
high vaccination coverage of ND dogs is to be achieved. However, if our conclusions 
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are correct, vaccination of SD should eliminate rabies and CDV in ND without the need 
for widespread vaccination of ND dogs. Nevertheless, concerns about the vulnerability 
of small, high-density wild carnivore populations within the Ngorongoro Crater, for 
example, may warrant localised vaccination of dogs in this area. 
Results presented in Chapter 2 suggest that the theoretical decline in vaccination 
coverage is less rapid when older dogs are vaccinated than when young pups are 
included. We suspect, however, that the benefits of prolonging the duration of 
coverage may be offset by the higher costs of reaching sufficient numbers of adults. 
Two trials would be of interest in this respect. First, a cost-effectiveness study of 
different vaccination strategies, and second, a field assessment of the efficacy of rabies 
and CDV vaccines in young pups. In the Serengeti trial described above, we aim to 
address the second of these questions by including young pups in the 70% of the 
population vaccinated. 
While it is clear that mass vaccination of dogs can eliminate canine rabies, continued 
efforts are required to prevent reintroduction of disease, particularly in areas that are 
not geographically isolated. This has been clearly shown by recent mass vaccination 
campaigns in several countries, where temporary elimination of rabies has been 
followed by outbreaks several years later, once vaccination coverage has fallen (Meslin 
et al., 1994). For Serengeti, too, there remains an important question of sustainability 
of dog vaccination programmes. While we have focused on targeting reservoir 
populations and segments within that population, we have not considered more detailed 
spatial and temporal aspects. An alternative strategy to mass vaccination could, for 
example, include local vaccination in response to an outbreak, with the aim of 
containing the spread of infection. Any theoretical justification of such a strategy, 
however, would need careful evaluation in the light of economic, logistic and political 
considerations. 
For example, in an area with poor communication and transport systems, how confident 
can we be of detecting cases and responding sufficiently quickly? Since transport costs 
are one of the highest components of dog vaccination in Serengeti, what are the 
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additional costs of vaccinating dogs in a village which will anyway be visited for disease 
surveillance? What would be the public perception of vaccinating dogs only after an 
outbreak of rabies has been reported, when people are likely to have been exposed to 
infection? How would the costs of human post-exposure treatment compare to those 
of sustained dog vaccination? Is the required vaccination coverage less likely to be 
achieved during sporadic visits than when conducted as a routine operation, as for 
rinderpest vaccination in cattle? Clearly, many questions remain, but we can start to 
address these issues through implementation of a vaccination trial, and by exploring 
viable long-term strategies for funding. Such funding could be developed, for example, 
from a small fraction of the tourist and hunting revenues generated in the Serengeti 
region. Rabies affects people, domestic animals and wildlife of the Serengeti, and an 
integrated approach to its control must surely be the way forward. 
Rabies Serology in Domestic Dogs 
The problems of disease surveillance in domestic dog and wildlife populations of the 
Serengeti led us to explore the use of serology for rabies epidemiological studies, and 
this is the first time such an approach has been adopted. However, difficulties arose in 
the interpretation of serological tests. An indirect ELISA protocol, chosen because of 
its successful use in human rabies serology and convenience for large-scale studies, was 
shown to be unsuitable for measuring rabies antibody in canine sera as a result of non- 
specific reactivity. Results from a serum neutralization test (RFFIT) and liquid-phase 
blocking ELISA (BE) correlated only weakly when measuring sera from unvaccinated 
Serengeti dogs, raising questions about the reliability of current serological tests, the 
use of results in seroepidemiological studies, and the interpretation of seropositivity in 
terms of rabies pathogenesis. 
Epidemiological and case history correlates of seropositivity, together with vaccine 
response trials, indicated a greater specificity of the BE over the' RFFIT for detecting 
exposure to rabies virus in unvaccinated seropositive dogs. The BE was therefore 
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considered the most appropriate test for seropepidemiological studies of unvaccinated 
dog populations. 
Of the tests examined in this study, only the RFFIT is considered a reference technique 
by the World Health Organization (WHO) for serological testing of vaccinated dogs in 
importation control. However our results raise questions about its reliability and 
specificity. This study indicates that the BE is not only suitable for large-scale 
serological testing of vaccinated dogs, but could also overcome some of the biological 
and practical disadvantages of the RFFIT, such as low inter-laboratory comparability, 
the requirement of specialised laboratory facilities and relatively high costs. A 
recommendation of this study is therefore the development of suitable ELISA protocols 
as WHO reference techniques for rabies serological testing of canine sera. 
The Value of Rabies Serology for Epidemiological Studies 
Analysis of BE seropositivity demonstrated both the potential value of rabies serology 
as an epidemiological tool and its limitations. The short duration of rabies antibody 
following natural exposure suggests that seropositivity could be used as a comparative 
measure of incidence in the absence of case surveillance data. However, rapid reversion 
from seropositive to seronegative (recovery) generates complex seroprevalence 
patterns, which are exacerbated in this study because of low seropositivity rates. 
Nonetheless, the general agreement between observed SD seroprevalences (combined 
across years) and endemic recovery models provides support for the view of rabies 
endemicity in SD. 
Serological approaches to rabies epidemiology may be limited in domestic dog 
populations because of widespread vaccination, however this study points to their 
potential application in wildlife populations. In populations with low seropositivity 
rates, it may be difficult to obtain sufficient samples for rabies serological analysis. 
However, in higher-incidence areas, seroprevalences may be higher than in Serengeti. 
Furthermore, seroconversion and recovery rates are likely to vary both with host 
species and virus strain. A combination of these factors probably explains why, in 
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Grenada for example, much higher seroprevalences were recorded in Indian mongooses 
(Herpestes auropunctatus) than in Serengeti domestic dogs and why antibodies 
persisted for longer (Everard et at., 1981). In contrast, yellow mongooses (Cynictis 
penicillata), which are the reservoir of rabies in central South Africa, have extremely 
low seroprevalences, despite a high incidence of disease (Chaparro and Esterhuysen, 
1993). While inter-specific comparisons of infection rates will be difficult without 
detailed longitudinal data, preliminary sampling of several wild carnivore populations in 
a rabies endemic area may point to possible `indicator species', in which seropositivity 
is high enough to permit feasible epidemiological analyses. 
Data quality in epidemiological studies 
As well as the specific question of reliability in rabies serological testing, the problems 
encountered here raise a general issue about data quality in epidemiological studies, 
particularly with respect to diseases in natural animal populations. The results of this 
study reinforce many of the familiar problems of serological testing. For example, most 
rabies serological tests used for dogs and wildlife have been based on protocols 
developed for human serology, and cut-off points are freely extrapolated across species. 
The widespread use of a threshold of 0.5 IU/ml is a case in point. This value derives 
from a recommendation of WHO that 0.5 IU/ml indicates successful immunization in 
people (WHO/IABS, 1987), but this threshold has rarely been validated for other 
species. The sensitivity and specificity of serological tests continues to be problematic 
and is exacerbated by the need to select cut-off points. While cut-off points are 
important for diagnosis, seroepidemiological studies need to explore new approaches 
for comparative analysis of data that are generated in the form of continuous 
distributions. 
Practical difficulties in detecting disease often limit epidemiological studies of natural 
populations, and disease surveillance was a problem in this study too. Despite 
considerable efforts, only a few cases of rabies and CDV were confirmed in the 
Serengeti and these undoubtedly represent a tiny fraction of the true number. There are 
clearly many unresolved questions about the impact of diseases in inconspicuous or less 
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well-monitored species in the Serengeti, and the possible role of these species in disease 
dynamics. Future studies will develop `active surveillance' measures, which have 
increased rabies detection rates forty-fold in Machakos, Kenya (Kitala et a!., 1994). 
Despite these caveats, however, the fact that a relatively sparse data set can yield useful 
epidemiological information should provide encouragement for other studies in natural 
populations. 
Application of epidemiological theory 
This study demonstrates the value of combining empirical and theoretical elements in an 
epidemiological study of natural populations. The application of endemic theory in 
Chapter 5, for example, allowed us to estimate epidemiological parameters, such Ro, 
and hence the critical proportion of the population that needs to be vaccinated to 
prevent outbreaks of CDV. Several inconsistencies arise between theoretical predictions 
and observations, which raise important questions about the transmission dynamics of 
CDV. First, the observation of stable endemicity in SD dog populations is difficult to 
explain for a highly transmissible parasite with short infectious periods. Second, 
estimates of the average age to infection from CDV age-seroprevalence data suggest 
that CDV should not be able to persist in SD dog populations, despite serological 
evidence of viral persistence for at least the three years of this study. The use of 
endemic recovery models need to be adopted that account for CDV-induced mortality. 
These may help explain persistence of CDV in SD dogs, and will also provide more 
accurate estimates of the vaccination coverage required to prevent outbreaks of CDV. 
These findings suggest that we need to question some of our assumptions about CDV 
infection in domestic dog populations. Similar conclusions can also be drawn from 
theoretical studies of morbillivirus infections in seals (Grenfell et al., 1992). For CDV, 
some questions come immediately to mind. For example, what proportion of animals 
show prolonged periods of virus excretion, such as the 60- to 90-day periods reported 
in sub-acute infection (Greene, 1984)? Is CDV equally transmissible in the acute and 
sub-acute forms of the disease? Are we confident that a carrier state does not exist, or 
that recrudescence of infectiousness cannot occur in chronic CDV? While there are 
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likely to be no immediate answers to these questions, they at least point to future 
directions for empirical and theoretical studies of CDV, and may be relevant for other 
morbillivirus infections in natural populations. 
The Significance of Atypical Infections 
The questions posed for CDV raise the general issue of the role of atypical infections in 
the dynamics of infectious diseases. In Chapter 4, we used simple compartmental 
models to quantify the effect of three atypical infections on the dynamics of dog rabies 
in the Serengeti, showing the greater sensitivity of infection dynamics to the presence of 
a small number of carriers than to either an immune class or long incubators. This 
comparative analysis emphasises the potential epidemiological significance of atypical 
infections, which may otherwise be considered unimportant because they occur only 
rarely. Further, this approach demonstrates the value of mathematical models to study 
rare events that are difficult to measure in nature. 
A final comment concerns the enduring need for empirical data. This study 
demonstrates, for example, the value of longitudinal data for understanding the 
dynamics of microparasite infections, but few longitudinal studies have been carried out 
in free-living animal populations. Where such data are available, the potential for 
quantitative epidemiological analysis has often been under-exploited. A notable 
exception has been the cross-sectional and longitudinal serological studies of 
leishmaniasis in dogs and foxes (Courtenay el al., 1994). This study also points to the 
need for information on the variability of host responses to infection and, wherever 
possible, data that are derived from natural rather than experimental infections. Such 
data are not easily obtained, but effort is likely to be rewarded if we can harness the 
potential of epidemic theory to study the ecology of infectious diseases in natural 
populations. 
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APPENDIX 
QUESTIONNAIRE SURVEY 
A. HOUSEHOLD INFORMATION 
1. Household number .................... 
2. Date ............................. 
3. Interviewer ..................... 
4. Village ..................................... 
5. Head of household ............................ 6. 
Tribe .................... 
7. Age of respondent ................... 
8. How long have you lived here? ............................................ 
9. How many people live in your house? Adults ....... 
Children (< 18 years) .......... 
10. GPS location of household ................................................. 
11. How many dogs do you have in your house'? Males Females 
Pups (0-3 months) ......... ........... 
Juveniles (4-6 months) ......... ........... 
Adults ......... ........... 
12. If no dog, why do you not have a dog? ....................................................................................... 
13. Have any dogs died, been killed or disappeared during the past 12 months? YES () NO () 
How many were: 
Killed by people ............ 
Killed by animal .......... 
Died from disease 
.............. 
Disappeared .................. 
Other (specify) ............................................................ 
If disease, describe ........................................................................................................... 
14. Do wild animals come near your home? YES () NO () 
Jackals () Hyaenas () Wild cats () Baboons () Monkeys () 
Mongooses () Civets () Leopards () Wild dogs ( 
15. Have any members of your family been bitten by a dog or wild animals during the past 12 months? 
Dog YES () NO () 
Wild animal YES () NO () Species ................................... 
16. What did they do when they were bitten? 
Treat the wound at home () 
Go to a hospital/dispensary () 
Go to a local doctor () 
Describe the treatment received ......................................................................................................... 
17. Are there dogs without owners that come around your home? YES () NO () 
18. Have you seen any cases of rabies in this village? This year YES () NO () 
Last year YES () NO () 
19. Do you know how people get rabies? ................................................................................. ............. Do you know how dogs get rabies? ...................... ......................................................................... 
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QUESTIONNAIRE SURVEY 
B. DOG INFORMATION 
1. Household number .................... 
2. Date ..................... 3. Interviewer ............. 
4. Head of household .......................... 
5. Dog number ........ 6. Age of dog ............... 
7. When was your dog born? 
If exact age unknown: Pup (0-3 months) Juvenile (4-6 months) () Adult () 
8. Sex of dog: Male () Female () If female: Pregnant () Lactating 
9. How many litters has she had? ............. 
In which month was her last litter born? ................ 
In her last litter: 
How many pups were born? ...................... 
How many pups died? ...................... 
How many were given away? ............ ""........ 
How many died? ...................... 
10. Where did you get your dog from? 
Own dog () Neighbour's dog () Outside the neighbourhood () Other () 
11. What do you use your dog for? 
Guarding () Herding () Hunting () Other () 
12. Is your dog confined/tied up? 
At night () During the day () Never () Sometimes () 
13. What does your dog do if it sees wild animals? .................................................................... 
14. Has your dog been sick in the past 12 months? YES () NO ( 
Describe 
...................................................................................................................................... 
Vomiting () Coughing () Incoordination () Diarrhoea () 
Skin problems () Wounds/injuries () "Worms" () Anorexia/ weight loss 
Was the dog treated (describe) ........................................ 
Has it recovered? ....................................... 
14. Has your dog been bitten during the past 12 months? YES () NO () 
Bitten by dog () 
Bitten by wild animal () 
15. Has your dog been vaccinated against rabies? 
YES () NO () Date vaccinated ............... 
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